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GENERAL OVERVIEW 
Coronary flow reserve is the capability of the coronary artery to 
dilate in response to myocardial metabolic requirements (I). It exhausts 
itself when the vasodilatation is extreme: this means, in a normal 
subject, a four-fold increase in the resting flow. 
Myocardial ischemia results from a supply-demand imbalance 
between coronary blood flow and myocardial metabolic requirements. 
The commonest mechanism of ischemia is due to a reduced 
subendocardial coronary blood flow secondary to a fixed stenosis: 
the severity of stenosis determines the clinical scenarios (2). An 
advanced degree of coronary arterial obstruction may exist without 
signs of myocardial ischemia or underperfusion at rest (3). Ischemia 
can be induced by stenoses of lesser severity if they prevent the 
development of coronary hyperemia in response to increased oxygen 
demand (4). 
Myocardial ischemia in a single territory is associated with three 
clinical manifestations: abnormal regional left ventricular function, 
BCG changes, and chest pain (5-7). 
The sequence of functional events induced by ischemia begins 
with diminished left ventricular diastolic compliance followed by 
decreased myocardial contractility and increased left ventricular end-
diastolic pressure. 
The correlation between myocardial flow and contractility is well 
know. In 1935 Tennant and Wiggers showed in a dog that occlusion 
for several minutes of a proximal LAD resulted in a reduction of 
regional myocardial contraction (8). Deprivation of the myocardium 
of oxygen rapidly leads to a depression of its contractile function. 
The various stress tests to detect or assess coronary artery disease 
reproduce the imbalance between myocardial demand and supply 
which precipitate ischemia. (9). 
Provocative stress tests can be divided into two groups according 
to their pathophysyologicalmechanism of ischemia: 
- stress modalities that primarily increase myocardial oxygen 
demand by increasing heart rate and contractility such as physical 
exercise, atrial pacing and inotropic agents. These include dobutamine 
and arbutamine (10-17). 
- stress modalities that primarily reduce myocardial oxygen supply 
by inducing or enhance maldistribution of myocardial blood flow. 
These include pharmacologic coronary vasodilators such as 
dipyridamole and adenosine (18-20). 
Echocardiographic techniques used with physical exercise or in 
conjunction with phannacological agents, have been shown to providc 
information regarding the presence, severity and distribution of 
coronary artery disease with a comparable accuracy to others 
techniques (21-24). 
Exercise echocardiography has several advantages: it represents 
the most physiological stress to the cardioeirculatory system, it gives 
information about exercise capacity and the ischemic threshold can 
be estimated. However it is technically demanding because adequate 
images are difficult to record during exercise ancl hypcrventilation-
induced artefacts are rather common Post-exercise recording of the 
cchocarcliographic images has been reported but results in false 
negative studies due to rapid resolution of ischemia. These factors 
decrease the sensitivity of the method. 
Pharmacological stress overcomes most of these disadvantages. 
The test can be performed in patients unable to exercise. Dobutamine 
and dipyridamole are the most commonly used pharmacologic agents 
in conjunction with echocardiography in the diagnosis and prognosis 
of patients with coronary artery disease. 
Background of dobutamine-atropine stress echoeardiography 
Dobutamine is a synthetic sympathicomimetic amine which stimu-
lates 5 I, 52 and a I receptors and is currently used for the short-term 
treatment of patients with heart failure due to its positive inotropic 
and chronotropic effect (15). Dobutamine increases myocardial oxygen 
demand through a positive chronotropic and inotropic effect on the 
heart (25) and is therefore regarded as an exercise-simulating agent. 
The marked inotropic effect is mcdiated by both a I and 5 I receptor 
stimulation, while 51 stimulation is responsible for its chronotropic 
effect. Dobutamine causes an increase in cardiac output, due to an 
increase in stroke volume and a decrease in systemic vascular 
resistance due to a secondary reflex withdrawal of sympathetic tone. 
In the peripheral vasculature the a I mcdiated vasoconstriction is 
balanced by the 52 mediated vasodilation. Consequently, systemic 
blood pressure usually remains unatlected during dobutamine infusion 
or may moderately increase. 
Low-dose dobutamine (up to 10 Ilg/kg/min) infusion causes a 
nearly maximum positive inotropic effect without a significant increase 
in heart rate. This may improve the contractile function of hibernating 
or stunned myocardium and allow its detection. The increase in 
myocardial oxygen consumption during high dose dobutamine 
infusion (up to 40 ~tg/kg/min), closely resembles physical exercise 
(15), is related to its chronotropic (26) rather than its inotropic 
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response. Besides an increase in myocardial oxygen demand, 
dobutaminc may also induce a maldistribution of coronary blood flow 
due its coronary vasodilator effect with an endo-epicardial 
mal distribution further potentiating the ischemia effect (27). In patients 
who fail to reach the test end-point (target heart rate or signs or symp-
toms of ischemia) with maximal dobutamine dose, atropine (28) may 
be added to "boost" the heart rate by its vagolytic action thus 
potentiating the positive chronotropic effect of dobutamine. Starting 
dose is 0.25 mg i.v. up to a maximum of 1.0 mg. 
EcllOcardiography: The signs and symptoms of myocardial 
ischemia follow a "cascade" of events, starting with perfusion 
heterogeneity between subendocardial and subepicardial regions, 
metabolic changes, disturbance of ventricular relaxation, decrease in 
contractile function and late appearance of electrocardiographic 
changes and chest pain (29). Echocardiography allows to detect 
ischemia induced wall motion abnormalities which occur at an early 
stage of this sequence: reduced wallthickcning andtransicnt regional 
wall motion abnormalities. These are divided into three degrees of 
severity: hypokinesis (reduction of systolic movement), akinesis 
(absence of systolic movement), and dyskinesis (paradoxical systolic 
movement). The normal myocardium shows an increase of normal 
movement and thickening during dobutamine infusion. 
Image allalysis: In areas with a normal resting echocardiographic 
wall motion some investigators use absence of wall thickening as an 
early sign of ischemia, but is rather difficult to assess. This may be 
classified as "relative" hypokinesia (30). Other investigators use the 
combination of reduced wall thickening and wall motion as a more 
definite marker. In practice wall motion and wall thickening abnor-
malities always occur simultaneously, with a few exceptions as seen 
in the interventricular septum after cardiac surgery. Wall motion score 
is determined at rest and during stress using a semi-quantitative 
assessment. The left ventricular wall is divided into 16 segments (31) 
and each is scored using a 4-point scale: 1= normal, 2= hypokinetic 
(decrease of movement and systolic thickening), 3= akinetic (absence 
of movement and systolic thickening), and 4= dyskinetic (paradoxical 
outward movement). 
The interpretation of wall motion changes in areas with resting 
abnormalities is more difficult but any deterioration of wall motion is 
considered abnormal. However, an akinetic segment at rest which 
does not improve during low-dose dobutamine stimulation but 
becomes dyskinetic at peak stress should be considered as a mechanical 
phenomenon compatible with scar tissue (32). 
Pharmacological stress echocardiography has been shown to have 
good reproducibility (33,34) and to provide a useful tool for assessing 
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disease progression and the effects of therapeutic drugs in patients 
with coronary artery disease. 
Interpretation of dobutamine stress testing is subjective. Despite 
this, the inter- and intra-observer variability in different studies have 
been reported to be good (35), but the inter-observer variability is 
relative low among different centers. In a recent study Hoffmann shows 
that the heterogeneity in data acquisition and assessment criteria among 
different centers results in low interinstitutional agreement in 
interpretation of stress echocardiography. Agreement is higher in 
patients with no or advanced coronary artery disease and substantially 
lower in those with limited echocardiography image quality. To in-
crease agreement, he suggested a better standardization of image 
acquisition and reading criteria of stress echocardiography (36). 
The diagnostic accuracy of stress echocardiography depends on 
the "expertise" of the investigator and there is definitely a "learning 
curve". Training is necessary and Picano et al (37) suggest that 100 
stress echocardiographic studies should be analysed under expert 
supervision. 
Dohl/tamine iJ{fllSioll protocol: at the Thoraxcentrecenter a "stand-
ard" dobutall1ine stress protocol has been developed which is now 
increasingly being used by others (28). This protocol allows patients 
to continue their anti-anginal medication, especially beta blocking 
agents which may diminish the action of dobutamine. This effect can 
be counteracted by the addition of atropine in patients who do not 
reach the target heart rate atll1aximal dose dobutall1ine infusion. The 
safety of the addition of atropine has been demonstrated (38). 
Patients undergo a precordial two-dimensional echocardiographic 
examination alI·est. A 12-lead EeG and standard apical and parasternal 
vicws are recorded on video tape and stored on an optical disk. 
Dobutamine is then administrated intravenously by infusion pump. 
"Low-dose" dobutamine echocardiography has been proposed for 
the evaluation of myocardial viability. Low-dose protocol starts at 5 
~tg/kg/minute for 3 minutes up to 10 Ilg/kg/minute for 3 minutes. 
High dose dobutamine starts at 10 Ilg/kg/minute for 3 minutes, 
increasing by 10 Ilg/kg/minute every 3 minutes to a maximum of 40 
~lg/kg/minute (stage 4), and continued for 6 minutes. In patients not 
achieving 85% of their age predicted maximal heart rate who had no 
symptoms or signs of ischemia, atropine starting with 0.25 mg 
increasing to a maximum of I mg is given intravenously at the end of 
stage 4, while dobutamine infusion is continued. Throughout 
dobutamine infusion the EeG is continuously monitored, the 12-lead 
EeG is recorded each minute and the blood pressure is measured by 
sphygmomanometer or an automatic dcvice every 3 minutes. The cross 
sectional echocardiogram is monitored and digitally recorded and dis-
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played on quad screen for side by side comparison at the end of every 
stage. The stress images are also recorded on video tape during the 
final minute of each stage. Metoprolol (I to 5 mg IV) is used to reverse 
the effect of dobutamine or dobutamine-atropine combination if this 
does not occur spontaneously and quickly. Atropine is used if 
bradycardia and hypotension occur. Off-line assessment of 
echographic images is usually independently performed by two 
investigators. In case of disagreement, a third investigator reviews 
the images and a majority decision is achieved. 
Test elld-poillt of do/;lIfalllille-atropille stress lest: test end-point 
is a target of 85% of maximal heart rate (male: 220-age[years] X 
85%; female: 200-age[years] X 85%). Interruption criteria for the test 
are: a new wall motion abnormality, horizontal or downsloping ST 
segment depression >2 mm at 80 ms after the J point, ST segment 
elevation, signi ficant chest pain, reduction in systolic blood pressure 
>40 mmHg from that at rest, hypertension (systolic blood pressure> 
220 mmHg), decrease of heart rate> I 0 beats per minute from that at 
rest, or any other side effect regarded as being due to dobutamine. 
Dobutamine stress testing is feasible and safe (38). Poldennans 
showed that during 652 examinations the test was not completed in 
16 patients despite absence of signs or markers of ischemia for limiting 
adverse effects, yielding an overall feasibility of 98%. These results 
are comparable with dipyridamole echocardiography (39), which 
showed a feasibility of 99%. Adverse effects consisted mostly of 
hypotension and cardiac arrhythmia's (40,44). As shown by Marwick 
(45) and Salustri (46) in their studies about 30% of patients developed 
significant dose-limiting side-effects. The frequency and severity of 
side-effects varies between studies; if all side-effects are included 
they may be recorded in up to 82% of patients (47), while a frequency 
of only 5% has been reported if only serious, dose-limiting side-effects 
are considered (48). 
During the last few years many clinical studies have been 
performed at the Thoraxcenter of the Erasmus University Rotterdam, 
addressing the role of stress echocardiography in different clinical 
scenarios. 
The studies present in this thesis were designed to further explore 
the clinical value of dobutamine and exercise stress echocardiography 
in patients with suspected or proven coronary artery disease and 
compare it with nuclear imaging. 
The specific aims and topics of the studies were the following: 
Chapter I 
Digital acquisition and display of echocardiographic images is 
mandatory particularly when exercise stress is used. In this chapter 
the principles of digital stress echocardiography are described. 
5 
Chapter 2 
The safety and feasibility of any new stress test is a major issue 
before it can be implemented in clinical practice. In this chapter the 
safety and the feasibility of high dose dobutamine-atropine stress 
echocardiography has been studied in a large series of consecutive 
patients. 
In particularly, the incidence and clinical significance of 
hypotension and tachyarrhythmias have been studied. 
Chapter 3 
The interpretation of stress echocardiography is semi-quantitative. 
Although the inter- and intra-observer variability of the interpretation 
in some centers have been reported to be good, no study has reported 
the inter-observer variability of stress echocardiography results among 
observers belonging to different centers. In this chapter the inter-
observei' variability of the results from five centers with a well-
established experience of stress echocardiography is reported. 
Chapter 4 
Although many studies using stress echocardiography have been 
publ ished, only sparse data are available on the relationship bet ween 
exercise echocardiography and quantitative coronary arteriography. 
In this study a group of patients with no previous myocardial infarction 
and a moderate to severe stenosis of one coronary artery, underwent 
both exercise echocardiography (bicycle ergo me try, post-exercise 
echocardiography) and coronary arteriography with quantitative 
analysis. The study aimed to assess which angiographic parameter 
and which cut-off of each angiographic parameters was the best 
predictor of an ischemic response on the echocardiography. 
Chapter 5 
This study has a similar design to that presented in Chapter 5, but 
included a homogeneous group of patients with proximal left anterior 
descending artery disease. To obtain additional information on 
myocardial perfusion MIBI SPECT was performed simultaneously 
with exercise echocardiography. 
Chapter 6 
Dobutamine-atropine stress echocardiography was compared to 
quantitative coronary arteriography in a consecutive group of patients 
without previous myocardial infarction and single vessel coronary 
artery disease. Similarly to chapters 4 and 5, the specific aim of the 
study was to investigate which is the best quantitative angiographic 
descriptor of an ischemic response during high dose dobutamine-
atropine echocardiography. 
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Chapter 7 
The presence of a len bundle branch block has always represented 
the "Achilles' heel" of noninvasive imaging methods in the diagnosis 
of coronary artery disease. In particular, stress-redistribution perfusion 
scintigraphy has a high sensitivity but a low specificity. 
The aim of the study which was undertaken in cooperation with 
the University of Brussels (B), was to test the hypothesis that, using 
dobutamine stress, the mechanical marker of ischemia (a new wall 
motion abnormality) has a beller diagnostic accuracy when compared 
with scintigraphic markers (transient perfusion abnormalities) for the 
diagnosis of coronary artery disease. 
Chapter 8 
The assessment of myocardial ischemia in regions with abnormal 
wall motion in a resting condition, and in particular the akinetic regions 
is problematic. In this chapter we have studied akinetic segments 
becoming dyskinetic during high dose dobutamine-atropine stress 
testing. The study was designed to test the hypothesis that akinetic 
regions becoming dyskinetic at peak dobutamine stress without 
improvement of wall thickening during low dose dobutamine are 
consistent with the presence of infarcted myocardium without ischemic 
areas which could be considered for revascu!arization. Perfusion 
scintigraphy simultaneously performed with echocardiography as a 
reference for the characterization of the absence of ischemia. 
Chapter 9 
Nuclear methods have recently are considered as the best approach 
to demonstrate myocardial viability. 
However the merit of the newest technetium 99m labeled 
radiotracers, like Tc 99m MIBI, compared to the more established 
thallium 20 I and PET tracers (FDG, ammonia), remains controversial. 
Also the concordance between stress echocardiography and MIBI 
SPECT for the assessment of myocardial viability has not been 
validated. 
This chapter we report data of a study in which we analyzed the 
agreement betwcen MIBI-SPECT, thallium and low-dose dobutamine 
echocardiography to detect myocardial viability. 
Chapter 10 
The pre-operative prediction of improvement of left ventricular 
dysfunction after coronary revascularization is clinically important. 
We compared the low-dose dobutamine cchocardiography and of 
thallium scintigraphy to identify viable myocardium in a group of 
patients with severe chronic left ventricular dysfunction prior to 
successful surgical coronary revascularization. In particular, we 
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compared the relative role of low-dose dobutamine echocardiography 
with thallium SPECT to predict the improvement of regional wall 
motion three months after revascularization. 
Chapter II 
The pre-operative identification of patients at increased risk of 
peri-operative cardiovascular complications undergoing a major 
noncardiac vascular surgery is an important clinical issue. On average 
10% of these patients have a cardiac complication, even in the absence 
of a history of coronary artery disease. They are mostly old and unable 
to perform an exercise test which prevents an adequate cardiovascular 
evaluation. Dipyridamole thallium scintigraphy has been shown to 
be useful in this clinical setting, but the specificity of this approach to 
identification of patients at risk is still too low. In a previous study at 
our center we have shown that dobutamine stress echocardiography 
is an alternative useful method for the identification of low risk 
patients. However this study was relatively small and the analysis of 
the stress echocardiography results was highly simplified, since the 
outcome of the test was limited to a binary classification of the test as 
positive or negative. Accordingly, in the present study we doubled 
the size of the patient group and we analyzed in more detail the stress 
echocardiography results, considering the extent, the severity and the 
threshold of ischemia as well. Our purpose was to identify a group at 
risk as small as possible, improving the specificity and, possibly, the 
cost-effectiveness of the test, if it will be used for screening in future 
risk reduction trials. 
Chapter 12 
The data in this study represent an extension of those in chapter 
II. All patients who survived vascular surgery were followed-up for 
an average period of 19 months. The specific aims of this study were: 
I) to describe the incidence of the overall long term cardiac and 
noncardiac mortality and morbidity in this population; 2) to assess 
the value of clinical and stress echocardiographic results performed 
before surgery to predict the late occurrence of cardiac mortality and 
morbidity. 
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CHAPTER I 
ok 
DIGITAL STRESS ECHOCARDIOGRAPHY" 
During the last few years stress echocardiography has grown to 
become an established technique for assessing patients with proven 
or suspected coronary disease (1,2), 
Several stress modalities have been applied to stress 
echocardiography, including physical exercise, atrial pacing and 
pharmacological methods, like dipyridamole, adenosine and 
dobutamine (1-3). 
The aim of stress echocardiography is to detect a mechanical 
marker of myocardial ischaemia, which is the worsening of wall 
thickening at peak stress. More recently, it has been demostrated that 
stress echocardiography is also useful for detecting myocardial 
viability of dyssinergic segments, if an improvement of wall thickening 
is observed during the infusion of low-dose dobutamine (5 or 10 Ilg/ 
kg/min) (4,5). 
The echocardiographic markers of myocardial ischaemia and 
viability are mostly rather subtle and often difficult to detect unless 
I) an optimal echo quality, and 2) an easiness of comparison between 
resting and stress imaging. 
How can computer technology be useful for an easier and more 
efficient implementation of stress echocardiography? 
Computer technology has played a crucial role in nearly all methods 
of cardiac imaging, including radionuclide imaging, X-ray computed 
tomography, magnetic resonance imaging and echo cardiography (6-8). 
The impact of computers has been on several aspects of cardiac 
imaging, like acquisition, formation, management, display, 
enhancement and analysis of the images. 
The term digital stress echocardiography is a term indicating a 
combination of ultrasound and digital technology for a better 
acquisition, display, analysis, storage and retrieval of the 
echocardiographic results. 
Videotape has become the medium which is universally used for 
recording two-dimensional echocardiograms. However, and in 
'" Fioretti PM, Borden vd B. Arnese M, Vletter W. Linker DT.In:Computerizcd 
Echocardiography.Domenicucci S, Roeland! J, Pezzano A. (cds), Publisher: Centro Scientifico 
Editore,Torino, 1993; Pagcs:57-67. 
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particular in the setting of stress echocardiography, this has some 
disadvantages, compared to digital recordings (table I). 
Table 1 
Digital cine-loop vs videotape recording in stress echocardiography . 
Digital Vldeolape 
cine-loop 
Image quality +++ ++ 
Editing +++ -
Interpretation +++ + 
Respiratory artefacts - ++ 
Quantitative analysis +++ ++ 
Reporting +++ + 
Communication +++ -
Diagnosis ++(+) ++ 
Echo monitoring - +++ 
Costs +++ ++ 
As also underscored by Feigenbaum (8), trying to analyze serial 
studies recorded on videotape is very cumbersome and time 
consuming. Salustri et ai, from our group (9), has demostrated that 
the interpretation of dobutamine stress echo from videotapes and cine-
loops provide a simi lar information in patients with normal or near 
normal wall motion at rest. However, the interpretation from cine-
loops was quicker and easier. It is also expected that the interpretation 
from videotapes is even more cumbersome in patients with severe 
left ventricular dysfuncion and multiple dyssinergic regions, where 
too many wall motion abnormalities have to be memorized and 
compared. 
By a proper selection of the best cardiac cycle, the generation of a 
continuous cine-loop of a single high quality cardiac cycle is also 
very helpful for the elimination of respiratory artifacts, which 
represents a major drawback in exercise echocardiography. 
Also, the continuous cine-loop display will allow an unlimited 
time for review and facilitate a frame by frame analysis. This may 
improve the ability to detedt subtle wall motion abnormalities. 
Anothcr advantage of digital stress echocardiography is the 
possibility of a side by side display (Fig. I) of different conditions 
(base vs peak stress, or at different stages of stress, especially during 
pharmacological stress), that may further refine the diagnosis on the 
presence and the timing of occurrence of wall motion abnormalities. 
A continuous cine-loop recording is obtained by the use of a digital 
frame grabbing instrument. The sequence is initiated at the peak of 
the R wave of the electrocardiogram and subsequent frames are 
digitized at pre-set time intervals to allow the acquisition of the the 
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Figure 1 - Example of a side by side display of 2 cine-loops and scoring system for 
visual analysis. 
whole systole and eventually some systems allow the display of the 
whole cardiac cycle. 
There arc c1ifferentmethods for the ECG triggering. The use of an 
external ECG signal has the greatest success rate and is the most 
reliable. In alternative, the use of the ECG signal on the video tape is 
a more difficult and less reliable method for triggering. 
Time Compensation 
If we compare two or more cine-loops side-by-side, the rate of 
contraction and time of end-systole are not synchronous, even though 
the start of systole has been synchronized using the ECG. If we collect 
the same number of images during the resting study and at peak 
exercise, we must lose part of systole during the rest study, or include 
part of diastole in the stress study (Fig. 2). This is due to the shortening 
of the cardiac cycle with stress. Full coordination of the loops we 
wish to compare should make it easier to detect abnormalities, although 
this has not been proven. 
Technically, there are two ways which have been used to address 
this problem. Thc first is to adjust the rate of acquisition of frames 
based on the heart rate. At higher heart rates, the rate of frame 
acquisition would also be higher. During playback, the frame rates 
would be the same (Fig. 3). This gives a partial compcnsation for the 
changes in systolic duration, but it is not necessarily accurate, since 
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we know that diastole shortens more than systole at higher heart rates. 
This means that there will still be a residual asynchrony. The major 
advantage is that the compensation is completely automatic. 
The second method is to acquire the images at a fixed rate, but to 
adjust the rate of playback so that the systolic period at rest and 
maximum stress are the same (Fig. 4). This cannot be completely 
automated, but has the advantage that it correctly adjusts both systole 
and diastole. 
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Figures 2 to 4 ~ Different solutions for time compensation in rest and stress images. 
For details see text. 
Data acquisition 
There are three different ways of collecting the echocardiographic 
data in digital form for analysis. Bach has advantages and 
disadvantages. The simplest, conceptually, is to capture video directly 
from the ultrasound machine, using a second cable for the BeG 
triggering (Fig. 5). Second in complexity is using the ecg signal on 
the video itself for triggering (Fig. 6). This frees us from the constraint 
of only doing real-time acquisition. We can just as easily use images 
which have been recorded on video tape. The problem is that using 
the image for BeG triggering is more machine dependent, due to 
differences in BeG display on various machines, and therefore less 
reliable. 
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The last method avoids video altogether, by using a direct, digital 
data link to the electronics of the ultrasound machine itself (Fig, 7), 
This allows very high quality data to be captured, even at frame rates 
higher than video rates, The disadvantage is that it is only possible to 
capture data in realtime, and the interface can only work with a specific 
ultrasound machine, due to internal differences, 
There are some features of digital stress echocardiography in which 
the technology is not necessary, but helpful, Among them the 
possibility of scoring the regional wall motion while reviewing the 
cine-loops allows an automatic gencration of a report and storage of 
the data (Fig. I). . 
Further, it is also easier and faster to apply a quantitative analysis 
of regional wall motion on the cineloop systems. A quantitative 
assessment of regional wall motion has not become a part of the routine 
clinical practice. In view of the recent availability of soft wares for the 
automated edge detection, it might happen that quantitative methods 
wi II be more widely used for the analysis of stress echocardiography. 
The design of a digital stress echo system can be different: one 
possibility is its integration in the ultrasound instrument (in this case 
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19 
the acquisition will be optimized to the specific ultrasound instrument). 
The other possibility is to have a stand alone system. 
A stand alone system can be dedicated to a specific ultrasound 
machine (useful if different echo machines of the same manufacturer) 
or universal (using a video signal). 
The advantage of having a universal stand alone system is that of 
having the possibility of attaching this unit to any echo machine. Also, 
such a system allows to see the echo images being acquired with no 
interruption of the echo monitoring. 
The integrated digital stress echo system can be also differentiated 
in two types, the first having a single monitor, for echo acquisition 
plus digital acquisition, and the second having 2 separate monitors, 
one for echo monitoring and the other for the digital acquisition and 
display. 
Digital stress echocardiography also has major advantages 
compared to videotapes, for the greater efficiency in storage and 
retrieval of serial studies. 
The review of serial studies from video tapes is extremely time 
consuming and tedious. This is a lesson that we have already learned 
from other imaging modalities, like nuclear cardiology: since the 
newest storage media like the optical disks are used, the retrieval and 
comparison of "old" studies for serial studies have become easier and 
frequently done. A simi lar trend is expected for stress 
echocardiography. 
The relative merits of the individual storage media are summarized 
in table 2; the decision over the convenience of selecting one or the 
other should be based on the individual requirements and resources. 
Another important issue is the usefulness of having a separate 
work station, to complement a digital stress echo machine. Hopefully, 
in the next futurc we will be able to use workstations for the storage 
and retriaevalnot only of stress echo but of a complete clinical status. 
This will be incorporated in a comprehensive network (Fig. 8) 
including a variety of clinical information and images, like coronary 
angiography, nuclear studies and echocardiographic images. 
In the future the costs, the format compatibility and a strict selection 
of the relcvant clinical information will be crucial for the feasibility 
of the implementation of these new communication techniques (II). 
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Table 2 
Digital ~tress echocardiography, storage and retrieve media 
storage RetrIeval Price 
capacity speed 
Floppy disk + + + 
Hard disk ++ +++ ++ 
Optical disk +++ ++ +++ 
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CHAPTER II 
SAFETY OF DOBUTAMINE-ATROPINE STRESS 
ECHOCARDIOGRAPHY IN PATIENTS WITH 
SUSPECTED OR PROVEN CORONARY ARTERY 
DISEASE* 
SUlllmary 
The purpose of this study was to establish the safety of high-dose 
dobutamine-atropine stress echocardiography in patients with sus-
pected or proven coronary artery disease. Six hundred fifty conseClI-
tive examinations were completed. Mean age of patients was 61 years; 
300 had a previous myocardial infarction. Hearl rate increased from 
73 to 129 beats/min during stress testing, blood pressure did not change 
significantly (from 140/81 to 150/80 nUll Hg. Atropine was added to 
dobutamine in 239 patients when no ischemia was induced with 
dobutamine alone and the peak heart rate was <85% of the theoreti-
cal maximal heart rate. Atropine lVas more frequently administered 
to patients taking ~-blockers (77 vs 27 %, p< 0.00 I). New wall mo-
tion abnormalities developed in 243 patients (37%). Significant or 
symptomatic cardiac tachyarrhythmias, or both, developed during 24 
examinations: I patient developed ventricular fibrillation, 3 patients 
developed sustained ventricular tachycardia « 10 beats) and 8 pa-
tients had paroxysmal atrial fibrillation. Cardiac arrhythmias were 
more frequent in patients with a history of ventricular arrhythmias 
(ventricular tachycardia and fibrillation) (odds ratio 9.9, 2.0 to 45) or 
left ventricular dysfunction at rest (wall motion score ~ 1.12) (odds 
ratio 2.9, 1.1-7.6), but not associated with atropine addition. No death 
or myocardial infarction occurred. The full dose was not given to 13 
patients despite absence of signs or markers of ischemia for limiting 
side effect, yielding an overall feasibility of the stress test of 98%. 
Thus, dobutamine-atropine stress echocardiography is relatively safe 
and highly feasible test with few adverse effects; its highest risk of 
significant arrhythmias occurs in patients with a history of vcntricu-
lar arrhythmias or left ventricular dysfunction, or both. 
* Poldennans D, Fioretti Plvl, Boersma E, Forster T, Van Urk H. CorncJ JH, Arncse i\'1, 
Roelandl JRTC. Am J Cardinl 1994;73:456-459. 
23 
I ntl'oduction 
Dobutamine-atropine stress combined with echocardiography was 
recently proposed for the diagnosis of coronary artery disease (I). 
The test provides diagnostic information (2-4). High-dose dobutamine 
is potentially arrhythmogenic: hypotension has been report to occur, 
and the safety of adding atropine to potentiate the test has not been 
extensively reported. So far only the study of Mertes et at (5) has 
described the results of a large series of patients on ihe safety and 
hemodynamic effect of the test. The aim of the present study is to 
describe the safety, feasibility and adverse effects of dobutamine stress 
echocardiography, particularly when atropine is used for the 
potentiation of the dobutamine stress test (1-3,6). 
Methods 
Patients characteristics: Six hundred fifty-two examinations were 
attempted in 626 consecutive patients (494 men, mean age 61 years, 
range 22 to 90) with known or suspected coronary artery disease. A 
previous myocardial infarction was present in 300 patients. Angina 
pectoris was present in 281 patients. Antianginalmedication was non 
discontinued before the study, including b blocker medication in 268 
cases. Indication for examinations were chest pain evaluation (n=440) 
and preoperative cardiac risk stratification before non-cardiac sur-
gery (n=212). 
Dohl/tamine stress echocardiography: The dobutamine stress 
echocardiography protocol was approved by the hospital ethics com-
mittee and was performed as described previously (I). Brietly, after 
giving verbal informed consent, patients underwent a resting 2-di-
mensional precordial echocardiographic examination. Standard apical 
and parasternal views were recorded on video tape and a 12-lead elec-
trocardiogram was recorded. Dobutamine was then administered in-
travenously by infusion pump, starting at 10 /lg/kg/min for 3 min-
utes, increasing by I 0 ~tglkg/min every 3 minutes to a maximum of 
40 /lg/kg/min (stage 4), and continued for 6 minutes. In patients not 
achieving 85% of their age-predicted maximal heart rate (in men [220-
agel x 85%, in women [200-age 1 x 85%) who had no symptoms or 
signs of ischemia, atropine (beginning with 0.25 mg and increasing 
to a maximum of I mg) was given intravenously at the end of stage 4, 
while dobutamine infusion was continued. Throughout dobutamine 
infusion the electrocardiogram was continuously monitored, the 12-
lead electrocardiogram was recorded each minute and blood pressure 
was measured by sphygmomanoemtry every 3 minutes. The 2 
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dimensional echocardiogram was continuously monitored and re-
corded on video tape during the final minute of each stage. Quad 
screen display for side-by-side examination of rest and stress images 
have become routine during the last 200 studies. Metroprolol was 
available and used (I to 5 mg intravenously) to reverse the effects of 
dobutamine or dobutamine-atropine combination if these did not revert 
spontaneously and quickly. Atropine was also used as an antidote if 
bradycardia occurred after dobutamine. Off-line assessment of 
echocardiographic images was performed by 2 experienced 
investigators without knowledge of the patients' clinical data but with 
knowledge of the doses of dobutamine and atropine used. For this 
semiquantitative assessment the left ventricular wall was divided into 
14 segments (7) and each was scored using a 4-point scale: -[ = normal, 
2= hypokinetic, 3= akinetic, 4= dyskinetic. Wall motion score index 
at rest (total score divided by the number of assessable segments) 
was calculated for each patient. An increase in score between rest 
and stress in I or more segments, which is a new or worsened wall 
motion abnormality, constituted a positive test. 
Interruption criteria for the test were a horizontal or downsloping 
ST depression> 2 mm at 80 ms after the J point, ST elevation, sig-
nificant chest pain, reduction in systolic blood pressure> 40 mmHg 
from that at rest or systolic blood pressure < 100 n1lll Hg, significant 
cardiac arrhythmias, or any side effect regarded as being due to 
dobutamine. A new wall motion abnormality was considered as an 
interruption criteria in absence of adverse effects or other markers of 
ischemia only if it was severe or extensive. 
Statistical analysis: Univariate analysis for categorical variables 
was performed using chi-square test with Yates 'correction or Fisher's 
exact test. Continuos variables were analyzed using Student's t test. 
The difference in risk was expressed as the odds ratio (OR) with the 
corresponding 95% confidence intervals (CI).Differences were con-
sidered significant if the null hypothesis could be rejected at the 0.05 
probability level. To compare and visualize the predictive value for 
cardiac arrhythmias of wall motion score index at rest, we used re-
ceiver-operator characteristics curves. 
Results 
The dobutamine-atropine stress test was attempted 652 times. In 
13 cases the test was nondiagnostic because it was prematurely stopped 
despite absence of signs or markers of ischemia for limiting side ef-
fects (chills [n=6], hypotension [n=2], hypertension [n= I], cardiac 
arrhythmias [n=2] and poor echo images [n=2], yielding an overall 
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feasibility of the test of 98%, There were no deaths or myocardial 
infarctions, 
In 587 tests (90%) the target heart rate (85% of theoretic maximal 
heart rate) was reached, During 63 examinations, the following symp-
toms caused the test to be stopped: (I) severe chest pain in 30 pa-
tients (4,6%); (2) electrocardiographic changes in 9 patients (1.4%); 
(3) new wall motion abnormalities in I study (0.2%); (4) hyperten-
sion (systolic blood pressure => 220 m111 Hg) in one patient (0,2 %); 
(5) hypotension (systolic blood pressure decrease> 40 nUll J-Ig com-
pared with baseline) in4 patients (0.6%); and (6) cardiac arrhythmias 
(ventricular fibrillation in 1, sustained vcntricular tachycardia in 3, 
and paroxysmal atrial fibrillation in 8) in 12 patients (1.9%) and chills 
in 6 (0,9%). 
Patients were divided into 2 groups: the first group (n=411) 
received dobutamine alone and the second (n=239) rcceived 
dobutamine plus atropine. A comparison of clinical characteristics, 
adverse effccts and reasons for stopping the test in the 2 groups arc 
presented in Table I and II, Atropine was administered more often in 
patients taking p-blocker medication (OR 5.4, 95% CI 3,8 to 7.9), 
TIUIU! I Clinical Characteristics in Patients With and Without 
Atropine 
Group I Group II 
Clinical Data (n = 411) (n = 239) 
Age (years) ± SO 63 ± 12 58 ± 12 
, 
-
P = 0.0001 OR, 95% CI, 
~ blockers (%) 110 (27) 158 (66) 5.4,3,8--7,9 
History 01 angina (%) 165 (40) 116 (48) 1.3,0,9-1.8 
History of infarction (%) 184 (45) 116(48) 1.1,0,6-1.7 
Diabetes mellitus (%) 33 (8) 19 (8) 1.0,0,5-1.9 
Male sex (%) 308 (75) 186 (78) 0,9,0,6-1.3 
CI = cOl'lfiden(e interval; Grou~ I _ stress test with dobutamine alone; Group II -
dobutamirie stress test with addit on of atropine; OR "" oods ratio. 
One or more markers of ischemia wcre detccted during the test in 
a substantial proportion of patients: as ischemic ST depression (;:>.1 
mm) was documented in 151 patients (24%) and STelevation in 57 
patients (9%), Chest pain was seen in 145 patients (22%) and new or 
worsening wall motion abnormalities in 243 patients (37%). 
HemodYllamic chal1ges durillg dohutamille-atropille stress test: 
Heart rate and blood pressure values during stress test are listed in 
Table III, There was no significant change in blood pressure during 
peak stress. 
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TIUIU: II Comparison of Adverse Effects and Reasons for 
Stopping Stress Test in Patients With and Without Atropine 
Group I Group II 
(n = 411) (n = 239) OR,95%CI 
Adverse Effects 
Arrhythmias (%) 15 (3.6) 9 (3:7) 1.1, 0.4-2.8 
Chills (%) 7 (1. 7) 5 (2) 1.1,0.3-2.7 
Hypotension 
20-40 mm Hg (%) 23 (5.6) 7 (2.9) 0.8,0.4-1.5 
>40 mm Hg(%) 2 (0.5) 2 (0.8) 1.4,0.5-3.7 
Hypertension 1 (0.2) 0 
Interruption Criteria 
Target heart rate (%) 379 (92) 214 (90) 1.2,0.7-2.3 
Hypotension> 40 mm Hg (%) 2 (0.5) 2 (0.8) 1.8, 0.2-12.3 
Arrhythmias (%) ? (1.4) 6 (2.5) 1.7,0.5-5.4 
Angina pectoris (%) 19 (4.6) 11 (4.6) 1.2,0.8-1.7 
ECG changes (%) 3 (0.7) 6 (2.5) 1.1,0.8-1.5 
NWMA(%) 1 (0.2) 0 
Hypertension (%) 1 (0.2) 0 
Arrhythmias =< ventriCular fibrillation, sustained ventricular tachycardia (> 10 
beatN. noosustained ventricular tachycardia « 10 beats) and parolo.)'5mal atrial 
fibrillationj [CG :c ekclrocardiogra~hicj Hypotension c decrease in systofic bfood 
pressure compared with baseline: WMA = new wan motion abnormalities: other 
abbreviations and explanations as in TaWe I. 
Side efFects: Hypotension and cardiac arrhythmias were the 2mosl 
observed side effects of the stress test. 
Hypotension, when defined as a decrease in systolic blood pressure 
of> 20 mm Hg compared with baseline, occurred during 34 (5.2%) 
examinations. Although most patients were able to continue the test 
without discomfort, 4 discontinued the test because of severe 
hypotension (decrease in systolic blood pressure> 40 mI11Hg). There 
was no correlation between hypotension and clinical data or stress 
results, but patients with concurrent b-blocker medication had 
significantly less hypotension (OR 4.1, 95% CI 2.1 to 8.7). 
Hypotension was not related to the dose of dobutamine (OR 0.8, 95% 
CI 0.4 to 1.7), nor was it alleviated by the addition of atropine (OR 
1.2, 95% CI 0.7 to 2.1). In 7 patients with a systolic blood pressure 
decrease of 20 mm Hg during large-doses of dobutamine, atropine 
was added without inducing more adverse effects comparecl with a 
similar group of23 patients without atropine (OR 1.2,95% CI 0.3 to 
5.0). 
Significant or symptomatic cardiac tachyarrhythmias, or both, 
occurred in 24 examinations: Besides arrhythmias leading to 
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iAilUl! H' Hemodynamic Effects of Dobutamine·Atropine 
Stress Test 
Group I Group II 
(n=411) (n = 239) 
Heart rate ~ats/min) 
Rest 75 ± 14 66 ± 12' 
Dobutamine 129 ± 19 95 ± 22' 
Dobutamine + atropine - 129 ± 1BI 
Systolic BP (mm Hg) 
Rest 142 ± 25 135 ± 22' 
Dobutarnine 153±32 146 ± 25' 
Dobutamine + atropine - 149 ± 271 
Diastolic BP (mm Hg) 
Rest B2 ± 13 79 ± 121 
Dobutamine 79 ± 17 72 ± 21' 
Dobutamine + atropine - 7B ± 131 
·N value < 0.001 between groups II and f at lhe same staf:' . 
t 0 significant difference betw~n pe~k dobulamine group Il/dobulamine + 
alropmt! (group 11), 
tpvalue::: 0.02 between groups II and I al the same stage. 
Data are expressed as mean j;·SD. 
BP"" bfoext pressure; other explanat}ons as in Tabfe I. 
interruption of the test, 12 patients experienced nonsllstained 
ventricular tachycardia. Ventricular premature complexes occurred 
in 64 examinations and was not considered as a serious side effect. 
The patient with ventricular fibrillation had previous symptomatic 
ventricular arrhythmias and myocardial infarction. Wall motion score 
index at rest was 1.56. During dobutamine infusion (40 f.lg/kg/min), 
this patient developed new wall motion abnormalities, rapidly followed 
by ventricular fibrillation, and was successfully resuscitated (I single 
countershock) without evidence of a new cardiac infarction. Sustained 
ventricular tachycardia occurred in 12 patients at a heart rate of 160 
to 180 beats/min, lasting no > 2 minutes, and abated by metoprolol 
instantly in 2. There was no occurrence in the hours after the test. 
The incidence of dobutamine-induced cardiac arrhythmias was 
increased in patients with a history of previous ventricular arrhythmias 
(ventricular tachycardia or fibrillation) (OR 9.9, 95% CI 2.0 to 45) at 
rest wall motion abnormalities, defined as resting with wall motion 
score index:? 1.12 (OR 2.9, 95% CI l.l to 7.6). Other stress test 
results, including the ischemic signs or markers were no predictive of 
arrhythmias. There was no correlation between atropine addition and 
arrhythmias (OR 1.2, 95% CI 0.4 to 3.3). Bradycardia accompanied 
by hypotension OCCUlTed in 2 patients, both with stress-induced inferior 
wall ischemia. Both patients were given atropine (0.25 mg 
intravenously) and recovered without complications. 
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Discussion 
Dobutamine-atropine stress is a new and promising test for the 
detection of coronary artery disease. During 652 examinations the 
test was not completed in 16 patients despite absence of signs or 
markers of ischemia for limiting advU'se effects, yielding an overall 
feasibility of 98%. These results are comparable with dipyridamole 
echocardiography (8), which showed a feasibility of 99%. 
Target heart rate as test end point was reached in 90% of the 
examinations. This is higher than studies, such as that of Mertes et al 
(5) in which target heart rate was achieved in52% and that of Mazeika 
et al (9) in which it was reached 18%. This can be partly explained by 
a di fferent stress protocol because there was no interruption for (l) 
"moderate" hypotension (decrease in systolic blood pressure 220 
mmHg to < 40 mm Hg compared with baseline); and (2) new wall 
motion abnormalities unless severe and extensive or accompanied by 
other markers of ischemia, and atropine was always given to patients 
who were unable to reach test end point (target heart rate or any sign 
or marker of ischemia). Despite this more "aggressive" approach there 
were no tiltal complications or myocardial infarctions. 
Adverse effects consisted mostly of hypotension and cardiac 
arrhythmias. Hypotension, if defined as a decrease in systolic blood 
pressure of > 20 mm Hg, is the most frequent adverse effect (34 
examinations), leading to a premature end of the test in only 4 instances 
in which systolic blood pressure decrease> 40 mm Hg compared 
with baseline value. We do not consider a systolic blood pressure 
decrease of 220 to <40 mm Hg during the test has a serious side 
effect, in contrast to other investigators ( 9,10). In our experience 
there were no complications as long as the patient is monitored closely 
and can be given atropine safely if the target heart rate is not reached 
with dobutamine alone. 
Possible mechanisms of dobutamine-atropine-induced 
hypotension are (I) poor left ventricular function during stress because 
of extensive wall motion abnormalities, (2) vasodilator effect of 
dobutamine, (3) development of subaortic stenosis, (4) atropine 
administration, and (5) vasodepressor reflex induced by vigorous 
contractions as suggested by Mazeika et al (II). Our findings support 
options 2 and 5. Similar to others (12, 13), we observed that 
hypotension occurred less frequently in patients taking ~-blockers. 
Cardiac arrhythmias are the second most noted adverse affects. 
Our study shows an incidence of significant arrhythmias (ventricular 
fibrillation, sustained/nonsustained ventricular tachycardia, atrial 
fibrillation/atrial flutter) in 24 patients (3.6%), similar to the study of 
Mertes et al (5), who found an incidence of 48 of 1,118 (4,3%). There 
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was a strong relation between a history of previous ventricular 
arrhythmias (ventricular tachycardia or fibrillation) or diffuse wall 
motion abnormalities at rest (both indicating a poor left ventricular 
function) and cardiac arrhythmias during the test. There was no 
correlation with signs or markers of ischemia during the test or with 
the addition of atropine. 
In conclusion, dobutamine-atropine stress echocardiography is a 
safe and feasible test. Some caution should be used in patients with a 
history of ventricular arrhythmias or poor left ventricular function at 
rest, in whom the test may induce serious arrhythmias. In these patients 
comparative studies with other stress modalities like dipyridamole 
are required. 
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CHAPTER III 
ANALYSIS OF INTERINSTITUTIONAL OBSERVER 
AGREEMENT IN THE INTERPRETATION OF 
DOBUTAMINE STRESS ECHOCARDIOGRAMS* 
Abstract 
Objectives: The degree of interinstitutional agreement in the in-
terpretation of dobutamine stress echocardiograms was to be deter-
mine. 
Backgroul/d: Dobutamine stress echocardiography involves sub-
jective interpretation. Consistent methods for acquisition and inter-
pretation are critically important for obtaining high interobserver 
agreement and for facilitating communication regarding the results 
of a test. 
Methods: Five experienced centers were asked to each submit 30 
dobutamine stress echocardiograms (dobutamine up to 40 ~tg/kg/min 
and atropine up to I mg) performed on patients undergoing coronary 
angiography. Thus, a total of 150 dobutamine stress echocardiograms 
were interpreted by each center unaware of any other patient data. 
Left ventricular wall motion was assessed using a 16 - segment model 
but was otherwise not standardized. No patients were excluded due 
to low image quality or inadequate stress level. Echo image quality 
was assessed on a five point scale. 
Results: Angiographically significant coronary artery disease 
(>50% diameter stenosis) was present in 95 patients (63%): based on 
a majority decision (3 or more centers), the sensitivity, specificity 
and accuracy of dobutamine echocarcliography were respectively 76%, 
87% and 80%. Abnormal or normal results of stress echocardiography 
were agreed upon 4 or 5 of the five centers in 73% of patients (mean 
kappa = 0.37). Agreement on the LAD territory (78%) was similar 
compared with the combined RCNLCX territory (74%) and for 
specific segments the agreement ranged from 84% to 97%, being 
highest for the basal anterior! segment and lowest for the basal inferior 
* Hoffmann R, Lehen H, i'vlarwick T, Arncse t"f, Fioretti P, Pingitore A, Picano E, Buck T, 
Erhel R, FlachskampfFA, Hamalh P. J Am Call CardioI1996;27:330-336 
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segment. Agreement was higher in patients with no coronary artery 
disease (82%) and in patients with 3 vessel disease (100%), and lower 
in patients with I and 2 vessel disease (61 and 68%, respectively). 
For those patients with highest image quality agreement on positively 
or negativity of a stress test was 100% while it was only 43% for 
those with the lowest image quality (p " 0.003). 
COllclusiolls: The current heterogeneity in data acquisition and 
reading criteria between different centers results in a rather low 
interinstitutional agreement in interpretation of stress 
echocardiograms. Agreement is higher in patients either without or 
with advanced coronary artery disease and substantially lower in pa-
tients with limited echo image quality. To increase interinstituional 
agreement, a better standardization in image acquisition and reading 
criteria of stress echocardiography is recommended. 
Introduction 
Dobutamine stress echocardiography is an accurate non - invasive 
technique for the diagnosis of coronary artery disease (1,2). As the 
assessment of improvment or deterioration of regional wall motion 
during the test is subjective, not only the accuracy but also the agree-
ment between interpreters are important considerations in the 
expansion of the test to the clinical arena. This is because inter-ob-
server agreement influences the ability of physicians to communicate 
with each other regarding the test results and their therapeutic 
imp lications. 
Most diagnostic methods have been examined for observer vari-
ability of assessment including clinical examination (3, 4), BCG (5, 
6), exercise BCG (7), perfusion scintigraphy (8) and coronary 
angiography (9, I 0). Wall motion analysis by means of 
echocardiography is an example of the difficulty with interobserver 
agreement because interpretation of test results is inherently subjec-
tive. The interobserver variability of stress echocardiography has al-
ready been examined in a small patient groups (II) but this study was 
confined to readers from the same institution and the results may have 
been influenced by local standards and conventions not explicitly 
stated, which may influence diagnostic decisions expecially in border 
line situations. To circumvent these considerations we designed a 
multicenter study to assess the interobserver agreement of experienced 
readers from diffrent institutions in interpreting dobutamine stress 
echo images without any additional clinical data. This report presents 
the analysis of agreement within a panel of five readers who 
independently read ISO dobutamine stress echo studies submitted in 
equal shares by all five institutions. 
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Methods 
Patients. At each of the five institutions thirty consecutive patients 
scheduled for angiography due to suspected coronary artery lesions 
underwent dobutamine stress eehocardiography. 
The results of strress echocardiography did not influence the de-
cision to perform angiography. No patients were excluded of basis of 
poor cchocardiographic image quality. Patients with prior Q-wave 
myocardial infarction were not included in the study, as well those 
with congestive heart failure, severe congenital or acquired valvular 
heart disease, or documented cardiomyopathy. A total of 146 patients 
were investigated, 4 patients underwent a second examination after 
interventional therapy had been performed. There were 116 men and 
30 women with a mean age of 46± 12 years. Previous myocardial 
revascularization had been performed in 26 patients (20 with coronary 
angioplasty and 6 patients with coronary artery bypass grafting) and 
14 patients had non-Q-wave infarction. One-hundred thirteen patients 
had angina at the time of examination. Antianginal therapy prior to 
the examination consisted of nitrates in 78 patients, calzium channel 
antagonists in 48 patients and beta-receptor blockers in 45 patients. 
In 39 patients anti anginal medication was stopped prior to stress 
echocardiography. 
Dobl/tamine stress protocol. Dobutamine was infused 
intravenously, starting at a dose of 5 /lg/kg/min for 3 minutes, 
increasing the dosage every 3 minutes to 10, 20, 30 and 40 ~tg/kg/ 
min. 
[n case 85% of age predicted maximal heart rate was not reached, 
additional atropine was given intravenously in 0.25 mg steps every 
minute, up to a maximal dosage of 1.0 mg. The infusion was stopped 
before reaching maximal pharmacological stress for any of the 
following reasons: the development of new wall motion abnormali-
ties, progressive and severe angina, more than 0.3 111 V of downsloping 
ST-segment depression, the development of symptomatic hypotension 
(decrease in systolic blood prcssure ? 20 mm Hg), significant 
hypertension (systolic blood pressure> 240 mmHg), dyspnoe or severe 
ventricular arrhythmias. 
Monitorillg. Blood pressure and 12-lead EeG recordings were 
performed at baseline and at the end of each dobutamine stage or 
before the premature cessation of the test. The presence of horizontal 
or downsloping ST -segment depression of a least 0.2 m V, 0.08 sec 
after the J-point compared with baseline was considered diagnostic 
for myocardial ischemia. The double product was calculated by mul-
tiplying systolic blood pressure and heart rate. 
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III/age acquisitioll. Image acquisition was performed with the 
patient in the left lateral decubitus position before, during and after 
dobutamine infusion. No patient was excluded because of low image 
quality. In each patient, imaging was attempted in the parasternal long-
axis and short-axis as well as the apical four-chamber and two-chamber 
views: in 32 patients, one or more views were not recorded because 
of insufficient acoustic windows. All views obtained at baseline were 
re-acquired at the end of each dobutamine stress level and when new 
wall motion abnormalities or worsening of pre-existing wall motion 
abnormalities occurred; however, only the images at rest and peak 
stress conditions were selected and stored for exchange. Individual 
centers maintened their standard practice for image acquisition, so 
that in 82 patients (from 3 centers) images were recorded on video 
tape only, and in 68 patients (from 3 centers) images were digitized 
on-line into a quad-screen cine-loop [oona!. In all cases, recorded 
images were transferred to SVHS-video tapes to have a uniformly 
readable media and distributed to all centers for interpretation 
For those studies being primarily digitized and transfered onto 
video direct comparison of resting and stress images in the a quad-
screen cine-loop format was still possible because long session of 
the digitized images were taped. 
Stress echo illtelpretatioll To base interpretation exclusively on 
imaging data, each of the 5 centers evaluated all ISO dobutamine 
stress investigations using a standardized report form without 
knowledge of any patient data apart from the echo images. Thus, no 
information on maximal dobutamine/atropine dosage and reason for 
termination of the dobutamine stress test was given. Clinical or 
angiographic data of these patients were also not available. 
For the analysis for wall motion the left ventricular walls were 
divided according to a 16-segment model (Figure I). The two region 
distribution of coronary circulation was used for further analysis of 
segmental wall motion abnormalities related to coronary circulation 
with segments 3, 6, 7, 9,10, II, and 12 being part of the combined 
right coronary/left circunflex territory, opposed to the left anterior 
descending territory including the rest of the segments. Segmental 
wall motion was evaluated and scored according to the method of the 
American Society of Echocardiography as normal (score of I), 
hypokinetic (score of2), akinetic (score of 3), or dyskinetic (score of 
4). The dobutamine stress echocardiogram was considered positive 
if the score increased by a least one level in at least one segment with 
stress. Resting wall motion abnormalities not deteriorating with stress 
were not considered as positive test results. Other interpretive criteria 
were not stipulated. 
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Figure 1 - Sixteen-segment scheme according to regional wall motion eva/utation 
with a two-region distribution of coronary circulation. Leftward hatching ~ left 
anterior descending distribution; rightward hatching ~ right coronary/left circumflex 
distribution; numbers are segment numbers. 
Echo image quality was assessed by the co-ordinating center for 
each stress test on a five point scale whereby an A quality showed 
complete endocardial definition and wall thickening with exactly 
similar images views at rest and during dobutamine, an B quality 
allowed visualization of all segments, however not completely ful-
filling the before mentioned criteria, a C quality did not allow detec-
tion of one or two segments, but adjacend segments within the same 
territory could be visualized, a D quality did not allow interpretation 
of 3 or more segments, but adjacend segments of the same territory 
could be visualized, an E quality precluded interpretations of segments 
comprising one or more whole territories. 
Corollary al/giography al/d al/giopraphic al/alyses. The coronary 
anatomy of all patients was evaluated by coronary angiography, with 
the degree of coronary artery stenoses being detennined by caliper 
method in at least one projection. Significant coronary artery stenosis 
was considered present when ~ 50% reduction of vessel diameter 
was observed in at least one major coronary artery. 
Statistical al/alysis. Calculations of sensitivity, specificity and 
diagnostic accuracy of dobutamine stress echocardiography for the 
detection of significant coronary artery disease were performed on 
the basis of the majority opinion (three or lIlore centers). In addiction 
calculation werc also persormed with the criteria of a ~ 70% luminal 
diameter narrowing. 
Concordant interpretation was identify in the presence of identical 
readings in 4 or 5 of the five interpreting centers. In addition to 
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analyzing the overall agreement of dobutamine stress 
echocardiograpphic interpretation between all institution, the role of 
variation in acquisition and interpretation were invcstigated by 
focusing on echocardiograms sub milled and interpreted at individual 
institution, respectively, 
The inrluence of severity of coronary artery disease, echo image 
quality and the recording system on the reproducibility of data were 
similarly recorded. 
The kappa test was used to test the hypothesis that agreement was 
greater than chance alone (12). Average coefficients of agreement 
(kappa) were computed for the five readers of the diffcrent institutions. 
Results 
Coronary angiography. Coronary angiography identified 
significant coronary artery disease in 95 patients. One-vessel disease 
was seen in 59 patient (62% of those with significant coronary artery 
disease), two-vessel disease in 22 patients (23%) and three-vessel 
disease in 14 patients (15%). Distribution of affected vessels was: 
left anterior descending coronary artery in 62 (41 %), circumflex artery 
in 33 (22%), and right coronary artery in SO (33%) patients. Bypass 
graft stcnosis was counted equivalent to stenosis of the grafted native 
vessel. 
DoiJlltallline stress test. The average maximal dobutamine dosage 
was 3S±8.3 ~lg/kg/min. In S3 patients additional atropine was given. 
This resulted in an increase of the heart rate from 67± 12 (range 4S-
lOS) beats/min at baseline to 122±27 (range 40-210) beats/min at 
peak stress. Double product increased from 10964±2623 mmHg min-
1 to 20 I 36±S245 mmHg min-I with max imal phannacological stress. 
Fifty-seven patients developed angina during the stress test. 
Dobutamine stress was stopped prematurely in 37 patients. Signifi-
cant ECG-changes with maximal stress developed in 41 patients. 
Echocmdiography. There was a significant difference between 
the centers in identifying dobutmnine stress tests as positive. On an 
average 67 stress tests were evaluated as being positive, but these 
results ranged from 38 to 102 between centers (figure 2). 
Sensitivity, spec(ficity al/{I diagl/ostic accuracy. Using majority 
opinion (three or more) of the 5 centers to define the presence of 
positive or negative results in all 150 patients, (\obutamine stress 
echocardiography had a sensitivity of 76% for the detection of 
significant coronary artery disease. When studies submitted by 
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Flgre 2 - Evaluation of negativity (solid bars versus positivity (open bars) for the 
150 dobutamine stress echocardiograms by institution. Numbers above bars = 
number of patients. 
different Institutions were compared, the sensitivity ranged from 67% 
to 79% . The average specificity was 87% (range: 73-100%) and 
accuracy for detection of coronary artery disease was 80% (range 77% 
to 87%). Regarding those lesions having a2.70% diameter stenosis, 
sensitivity, specificity and accuracy were: 83%, 83% and 83%, 
respectively. 
Agreemellt betweell illstitlltiolls. For or five of the five institutions 
agreed on dobutamine stress test abnormality or normality in 110 of 
the 150 studies (73%). The average coefficient of agreement among 
readers from different institutions for normality or abnormality of 
dobutamine echo stress test (kappa) was 0.37. For those 31 studies in 
whom the majority of the observer identified a baseline wall motion 
abnormality majority agreement was slightly smaller (71 %) than for 
those I 19 studies without baseline wall motion abnormality (74%). 
Considering only those left ventricular segments suppl ied by the left 
anterior descending artelY agreement concerning the presence or absence 
of new wall motion abnormalities was 78% (mean kappa = 0.37), similar 
to the combined RCNLCX territory in whom a majority agreement of 
74% (mean kappa=0,33) was reached. Agreement in specific segments 
ranged from 84% to 97%, being highest for anterior segment (segment 14 
on the 16 segment model) and lowest for the basal inferior segment 
(segment 6 on the 16 segment model) (Figure 3). 
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Figure 3 - Majority interinstitutional agreement on a fOUf of five or five of five basis 
for positivity or negativHy of dobutamine stress test results by specific coronary 
territory and for each of 16 ventricular segments. LAD ~ left anterior descending 
coronary artery; RC/Le :;: right and left circumflex coronary arteries. 
Agreelllent corresponding to disease severity. For patients having 
no coronary artery disease (n= 55) majority agreement on the 
dobutamine stress echo result was 82% on a 4/5 or 5/5 basis. In those 
patients having a three-vessel disease (n= 14) majority agreement was 
100% exceeding the concordance of results in patients having only a 
one-vessel or two-vessel disease (Figure 4). 
Agreement omitting one analysing institlltion. Due to the 
observation that the centers had different rates of positive stress echo 
evaluations the agreement on dobutamine stress echo positively or 
negati vity was evaluated for the remaining four centers after omitting 
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Figure 4 - Majority interinstilutional agreement on positivity or negativity of dobutamine 
stress echocardiographic results by severity of coronary artery disease (CAD) 
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the interpretations of one center. Majority agreement (3/4 or 4/4 
centers) on overall positively or negativity increased for the remaining 
institutions each time one of the centers was omitted. However, there 
were quite different increases in agreement related to the agreement 
of all five center (73%). Agreement of 3/4 or 4/4 centers ranged 
between 77% and 87% depending on which of the five analysing 
centers was omitted (Figure 5). 
Agreement on dobutamine stress tests submitted by single eel/tel's. 
In order to analyse whether dobutamine echo stress tests submitted 
by one institution were better interpretable and thus resulted in higher 
agreement than those of other institutions, the majority agreements 
for the 30 dobutamine echo tests submitted by each of the five 
institutions were analysed separately. Majority agreement on the 30 
dobutamine echo stress tests submitted by single institutions ranged 
from 70% to 80%, indicating similar interpretability of stress 
echocardiograms (Figure 6). 
Agreement dependil/g on ill/age quality. Image quality had a 
significant effect on the overall agreement on presence or absence of 
inducible wall motion abnormalities. In the 13 patients whom 
dobutamine stress echo tests were recorded with highest image quality 
(grade A, allowing good delineation of all left ventricular wall 
segments) agreement on the presence or absence of inducible wall 
motion abnormalities was 100% on a 4/5 or 5/5 basis. However, for 
the 14 patients with the lowest image quality (grade E) agreement 
was only 43% significantly less than for those having the highest 
images qllality (p=0.003) (Figure 7). 
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Figure 5 - Majority interinstitutional agreement on a three of four or four of four 
basis for positivity or negativity of dobutamine stress echo cardiographic results 
when one instution is omitted from the analisy. 
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Figure 6 - Majority interinstitutional agreement on dobutamine stress 
echocardiographic test results (n = 30) submitted by each institution, 
While none of the patients were excluded from the full analysis 
due to poor image quality, if patients with E-qualily images were omit-
ted, the interinstitutional agreement increased to 77%. 
Agreelllellt related to the illlages recordillg systelll. Agreement on 
a 4/5 or 5/5 basis for those 82 dobutamine echo-stress tests recorded 
on video-tape format was 71 %. 
This was similar to the 76% agreement in 68 studies recorded on 
video-tape after digital image processing. 
Image Quality 
A • c o e 
Image A B C D E' 
Quality 
Agreement 100% 83% 74% 55% 43% 
Number of 13 47 35 41 14 
patients 
Figure 7 - Majority interinstitutional agreement by assessment image quality of 
dobulamine stress echocardiograms, 
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Discussion 
Variability ill test illterpretatioll. Interobserver variability is a well 
known problem in cardiology and almost all diagnostic methods have 
been examined for inter and intraobserver agreement. 
A surprisingly low level of interobserver agreement has been re-
ported for interpretation of resting 12-lead ECG. 
In a study of20 physicians who were asked to intelpret 100 ECGs 
as normal showing an old myocardial infarction or showing non spe-
cific abnormalities, Segall et al. (5) found 70% or more of the readers 
agree on only 77% of the studics. A similar intcrobserver difference 
has been reported in the frequency of "abnormal" exercise ECG 
diagnosis (6). Blackburn (7) asked 14 readers from 7 institutions to 
interpret 38 exercise ECG tests as normal, abnormal or borderline 
and found that abnormality was identify in 5-58% of studies. The 
results of imaging studies are also prone to interobserver variability. 
At wood et al. (8) assessed the agreement of four experienced readers 
in the interpretation of 100 thallium perfusion images. The 
interobserver agreement for a majority of observers (three or four of 
four observers) from the same institutions was found to be 75% for 
an abnormal and 68% for a normal interpretation. A striking 
interobserver variability has been reported in the interpretation of 
coronary stenosis severity and left ventricular function evaluation at 
coronary angiography. Zir et al. (9) found that in only 13 of20 coronary 
angiograms (65%) did all 4 experienced coronary angiographer (from 
the same institution) concur regarding the significance of stenosis 
(defined as c 50% diameter luminal narrowing). De Rouen et al (10) 
et a!. reported a 31 % overall disagreemcnt between the assessment of 
single readers and those of an expert panel on the classification of a 
coronary vessel as c 70% stenotic. For left ventriculograms, the 
average percent disagreement in interpretation of wall motion between 
observers dividing the ventricle into five segments was 42%. The 
agreement on left ventricular contraction grade assessment was found 
to be only fair, with an average coefficient of agreement (kappa) of 
0.34 among II readers (10). 
Like most techniques in medicine, dobutamine stress 
echocardiography requires observer intl'''pretation and is thus subjec-
tivc to same extent. Several groups have reported their interobserver 
variabilities to both evaluate the degree of consistency in the 
interpretation of stress echocardiograms and to measure for 
interpretations validity. Sawada et al. (I) reported agreement between 
two observers of the same institution on the presence or absence of a 
stress-induced abnormality in 91 % of cases, and Beleslin et al. (13) 
reported an interobserver agreement between two observers of 93%. 
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A high degree of correlation between wall motion score indexes 
evaluated by two different observers has also been reported before as 
well as after dynamic stress during exercise echocardiography (II). 
However, the evaluation of wall motion score as a global measurement 
does not allow a statement on agreement of specific left ventricular 
segments, and has only limited value for assessment of specific 
regions. Moreover, these studies of interobserver variability have 
focused on observers from the same institution with all observers 
frequently participating in joint stress echo reading sessions. 
Sources of'illtelVbserver variabilif)'. The reasons for interobserver 
. . 
variability in stress echocardiography may be classified into three 
broad categories: I) normal regional variability of left ventricular 
function in response to dobutamine stress; 2) variability of image 
quality; 3) variability of stress echocardiography hardware, in 
particular image storage on video tape or in digitized format; and 4) 
observer variability. The normal human left ventricular functional 
response to dobutamine stress is characterized by substantial regional 
variability whithin each patient, as shown by studies with cine-
computer tomography (14), magnetic resonance imaging (15) and 
two-dimensional echocardiography (16). This hetcrogeneity of left 
ventricular wall thickening can be magnified by dobutamine infusion 
even in subjects without coronary artery disease, and there may be 
ambiguity with respect to differentiating this normal variation from 
the presence of disease. 
To obtain a high degree of interobserver agreement, multiple views 
are necessary to visualise all segments of the left ventricle with high 
quality images. 
Competence of the observer in the interpretation of stress 
echocardiograms is essential to reach high accuracy and thus a high 
interobserver agreement. This has been stressed by Picano et al. (17), 
who found accuracy in the interpretation of stress echocardiograms 
to be significantly higher for echocardiographers with a high level of 
experience with stress echocardiography. However, For a high 
interobserver agreement, there also needs to be homogeneity in' the 
classification of a wall motion as being normal, hypokinetic, akinetic 
or dyskinetic. This applies especially to the classification of 
hypokinetic wall motion which may ranges from slight to severe and 
were the cut-off from what is considered normal may vary between 
observers and institutions. Mild hypokinesia may be viewed as normal 
clinical variability at one institution and be considered pathologic at 
another. 
Sigllificallce of this study. To our knowledge, the present study is 
the first to analyse interobserver agreement among experienced stress 
echocardiographers from different institutions. There was consider-
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able discrepancy between centers in their evaluation of dobutamine 
stress echocardiograms. 
The number of studies evaluated as positive ranged from 38 to 
102 between the five centers. This is reflected by an average coefficient 
of agreement (kappa) of 0.37 which is only fair. The fact that one 
center found significantly higher rates of dobutamine 
echocardiographic positivity than others indicates a systematic dif-
ference in reading criteria, implying different "threshold" at different 
places to classify stress echocardiographic results as positive or 
negative. This stresses the necessity to further refine and unify read-
ing criteria. . 
Interobserver agreement was significantly influenced by 
echocardiographic images quality, with higher agreement in patients 
with high image quality then in those with limited image quality. 
Although no patients was excluded due to low echo image quality 
improvement in interobserver image agreement could have been 
obtained by excluding the 10% of patients with lowest image quality. 
These findings suggest that it is reasonable to exclude patients from 
stress echocardiography if image quality is insufficient to visualize 
all left ventricular segments. 
Segmental agreement was found to be highest for the anterobasal 
and lowest for the inferobasal region. This might be due to the lower 
endocardial borderdefinilion in the inferobasal region in many patients 
and reduced wall thickening present at baseline compared with other 
left ventricular segments. Reduced accuracy in the detection of 
inducible wall motion abnormalities for this area has been reported 
previously (18). 
Although we did not show better concordance on the basis of digi-
tized image loops compared with videotaped recordings, the present 
study design may have placed the digital approach at a disadvantage, 
because recording digitized data on video-tape is associated with a 
slight decrement in image resolution, and this approach limits the 
ability to use stop-frame images, which facilitate interpretation. 
Although digitized cine loop displays are desirable to simplify analysis, 
the place of digital image processing for dobutamine echocardiography 
is unresolved, with data supporting (19) as well as disproving (20) 
improvement in accuracy by application of this technique. 
Ideally, compatibility of different digitizing systems would permit 
digitized images to be readable by all systems independent of the 
system acquiring the images. Furthermore, it is desirable that the digi-
tized segment of the original echocardiogragic screen displays the 
left ventricle with maximal spatial resolution. 
The problem of considerable interobserver variability has been 
reduced for other imaging techniques. Computer-assisted quantitative 
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coronary angiography has diminished variability in interpretation of 
coronary angiograms. The agreement in interpretation of planar 
thallium-201 imaging as having ischemia or no ischemia could be 
increased from kappa value of 0.36 without standardization on inter-
pretation to 0.71 with standardization of display and quantification 
(21). Similar improvements should be the goal with stress 
echocardiography. In the future, improved image quality allowing 
better endocardial border definition, possibly obtainable by left heart 
contrast echocardiography or computer algorithms to evaluate wall 
motion abnormalities, may diminish the subjective nature of 
interpretation and reduce the interobserver variability. 
Limitatiolls of the study. Quantitative coronary angiography was 
not performed in the present study. However, this was not thought to 
be inadequate because the main purpose of the study was to determine 
agreement in interpretation of stress echocardiograms, and the issue 
of correlation between dobutamine stress echocardiography and 
angiography has been repeatedly analyzed in previous studies. 
In the present study, data acquisition as well as equipment were 
heterogeneous, with videotaped recordings in 82 patients and digital 
image storage in 68 patients. Video tapes were used as the final uniform 
media because different image acquisition and display system were 
implemented at the different centers. Furthermore, in 32 patients only 
apical views were available for evaluation. 
No standardardization of stress echocardiographic reading criteria 
was defined. These criteria were clearly heterogeneous between 
centers, with aggressive, liberal "overreaders" as well as conserva-
tive "underreaders". We did nothing to prevent these disparate read-
ing policies because the documentation of these variation was part of 
the rationale of the study. Thc results describe the current heteroge-
neity of these criteria among expert groups. 
Interinstitutional agreement was found to be dependent on the 
severity of the coronary artery disease. Thus, agreement might have 
one- or two-vessel coronary artery disease because this was the group 
with the greatest disagreement. 
Can elusions and clinical implications. A high intercenter 
agreement on the interpretation of test results is important for clinical 
decision making. The present study shows that the current 
heterogeneity in data acquisition and reading criteria between ditferent 
centers result in relatively low interinstitutional agreement in the 
interpretation of stress echocardiograms between different institutions, 
additional efforts toward standardisation and communication are 
needed. 
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CHAPTER IV 
CORRELATION OF CORONARY STENOSIS BY 
QUANTITATIVE CORONARY ARTERIOGRAPHY 
WITH EXERCISE ECHOCARDIOGRAPHY* 
Several studies have been addressed to assess the value of exercise 
echocardiography to predict the presence of "significant" coronary 
artery disease (1-7). However, a standardized definition of the gold 
standard for "significant" coronary artery obstruction is lacking. The 
classification of coronary artery disease in the literature on stress 
echocardiography is mostly semiquantitative by visual assessment 
(1,2,5-7) and in the few reports with a quantitative assessment of 
coronary angiography different angiographic parameters and different 
cut-off values for each parameter were considered (8- 10). To contribute 
to clarify this issue, we studied with exercise echocardiography and 
quantitative coronary arteriography a selected population with no 
previous myocardial infarction, normal electrocardiogram and 
echocardiogram at rest, and a proximal single site single vessel 
coronary obstruction from mild to severe. The specific aim of the 
study was to assess the value of the obstruction severity to predict a 
positive exercise stress test, where the end points of angina, ST 
segment depression and new wall motion abnormalities were 
separately analyzed. 
The study population consisted of 34 patients (27 men, 7 women, . 
mean age 59± II years, range 32-78) who performed exercise 
echocardiography at our Institution. Inclusion criteria were: I) no 
previous myocardial infarction or previous cardiac surgery; 2) nor-
mal wall motion at baseline echocardiogram; 3) normal electrocar-
diogram at rest; 4) coronary stenosis limited to one major artery at 
coronary arteriography performed within one week of exercise 
echocardiography. Patients with unstable angina were excluded. Rea-
sons to perform exercise echocardiography were the evaluation of 
chest pain in 26 patients, while the other 8 were part of an ongoing 
study on restenosis after percutaneous transluminal coronary 
angioplasty which included coronary arteriography at 6-month fol-
'" Salustri A, Arnese lvi, Boersma E, Cornel JH, Baptista A, Ten Cale FJ, de Fcijter, Roelandl 
JRTC, Fioretti PM. Am J Cardiol 1995; 75:287-290. 
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low up. All the anti anginal medications, including betablockers, were 
withdrawn before the exercise test. 
Symptom limited upright bicycle ergometry was performed with 
stepwise increments of 20 Watts each minute. Electrocardiogram was 
continuously monitored (lead II, V2, V5) and 12-lead electrocardio-
gram was recorded at rest and every minute throughout the test. Cuff 
blood pressure was measured at rest and every 2 minutes. The 
electrocardiographic complexes were analysed by a computer-assisted 
system (Cal'diovit CSG/l2, Schiller), and a horizontal or downsloping 
ST segment depression;:: I mm occurring 80 msec aftcr the J point 
was considered as ischemic. 
Two-dimensional echocardiograms were performed with a com-
mercially available wide angle phased array imaging system equipped 
with either a 2.5 or 3.5 MHz transducer. Images of standard views 
were obtained at rest and immediately after exercise with the patients 
lying in the same left lateral decubitus. The last post-exercise images 
were acquired within 90 seconds from the termination of exercise 
test. Both rest and stress images were digitized on-line and stored for 
subsequent analysis on cineloop display. 
All echocardiograms were analysed and a consensus was achieved 
by two observers without knowledge of clinical data, exercise 
electrocardiographic and angiographic results. Left ventricular wall 
Illotion was evaluated on a 16-segment, 4-grade scale model. The 
development of wall motion abnormality after stress was considered 
as an ischemic response. The location of wall motion abnormalities 
was related to the different coronary arteries as previously described 
by Broderick et al (II). The low level of inter- and intraobserver 
variability obtained in our lahoratory for the interpretation of exercise 
echocardiography has been previously reported (12). 
All the patients underwent coronary arteriography with the Judkins 
technique. Coronary arteriograms were reviewed using the Cardio-
vascular Angiography Analysis System (Pie Medical, The Nether-
lands) with authmatic luminal edges detection. This system has been 
described and validated earlier (13). All measurements were performed 
in end-diastolic frames with optimal vessel opacification. 
Data are expressed as mean ± standard deviation. The unpaired 
Student's t test was used to compare percent diameter stenosis and 
minimal lumen diameter in patients with and without a positive exer-
cise echocardiogram. Receiver Operator Characteristic curves analy-
sis was used to display the sensitivity and specificity of the percent 
diameter stenosis and the minimal lumen diameter during the whole 
range of measurements for the prediction of an ischemic response 
during exercise stress test. From these curves, the optimal cut-off was 
chosen as the point of interception between sensitivity and specificity 
of each angiographic variable. 
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The mean peak heart rate and the double product were 148±23 bl 
min and 28066±5480, respectively. Angina occurred in 8, ST seg-
ment depression in 16, and new wall motion abnormalities in 14 pa-
tients. The location of wall motion abnormalities was always consist-
ent with the site of the coronary obstruction. Twenty-seven patients 
reached the 85% of the maximal age and sex predicted heart rate. In 
the 3 patients with a negative exercise echocardiogram who did not 
reach the 85% of maximal age and sex predicted heart rate, the test 
was interrupted for ST segment depression in 2 and angina in I. 
Seventeen patients had 11 lesion of the left anterior descending 
artery, 5 had a left circumflex disease and 12 a right coronary disease. 
The distribution of the lesions severities in the entire population is 
displayed in figure I. Significant differences between patients with 
positive and negative exercise echocardiography were found for both 
quantitative angiographic measures (62% vs 41 %, p<O.OOOI, and 0.88 
vs 1.51 mm, p<O.OOO I). 
Numb.r of patient. 
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Figure 1 • Distribution of coronary lesion severities in the study group evaluated by 
percent diameter stenosis (DSt) (A) and minimal lumen diameter (MLD) (B). 
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Sensitivity and specificity of the individual values of percent di-
ameter stenosis and the minimal lumen diameter for the correct clas-
sification of patients with and without exercise induced ischemia is 
depicted in figure 2 and 3. The "best" cut-off point for predicting 
lVall motion abnormalities during exercise (defined as the value of 
diameter stenosis at the cross-point of sensitivity-specificity curves) 
was 52% (figure 2A). yielding a sensitivity and specificity of74%. In 
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the diagnistic accuracy of percent diameter stenosis for the different markes of myocardial 
ischemia during bicycle ergometry. WMA = new wail motion abnormalilies. 
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figure 2B, the Receiver Operator Characteristic curves of angina, ST 
segment and wall motion abnormalities are separately represented. 
Since the sensitivity/specificity curve for wall motion abnormalities 
is the highest, the severity of the percent diameter stenosis is better 
related to the mechanical ischemic marker from echocardiography 
than angina and ST depression. 
In figure 3, the merit of minimal lumen diameter is displayed in 
the same way, confirming the superiority of wall motion abnormalities, 
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Figure 3 - A, percent correct classilication of presence (sensitivity) 0 absence 
(specificity) of exercise-induced wall motion abnormalities as a funclion of the whole 
spectrum of minimal lumen diameter (MLD). S, receiver-operator characteristic 
curves for comparison of the diagnostic accuracy of minimal lumen diameter for the 
different markes of myocardial ischemia during bicycle exercise. WMA = new wall 
motion abnormalities. 
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in comparison to angina and ST segment depression. Tbe "best" cut-
off jJoint for tbe prediction of wall motion abnormalities was 1.13 
mm (sensitivity and specificity of 83%). 
The predictive values of minimallulllen diameter and the percent 
diameter stenosis for new wall motion abnormalities were similar, 
since the areas below tbe respective Receiver Operator Cbaracteristic 
curves were not statistically different (8864 vs 9121). 
Our study includes a well defined group of patients with single 
vessel disease, a proximal single site obstruction, a wide range of 
stenosis severity (from 21 to 100%), with a balanced prevalence of 
exercise induced wall motion abnormalities. Furtbermore, we avoided 
the confounding effect of wall motion abnormalities at rest, abnormal 
baseline electrocardiogram, and P-blocker therapy. The main findings 
of the present study can be summarized as follows: 
I. in patients with mild to severe obstruction of a single vessel, a 
minilllallumen diameter of 1.13 nlln and a percent diameter stenosis 
of 52% arc the cut-offs which best differenciate patients with and 
without new wall motion abnormalities on post-exercise 
echocardiogram; 
2. sensiti vilies and speci ficities of these cut -off points are similar, 
suggesting that minimal lumen diameter and percent diameter stenosis 
have similar predictive accuracy for exercise induced wall motion 
abnormalities; 
3. the severity of coronary obstruction is poorly related to ST-
segment depression and angina during exercise. 
From tbe curves displayed in figures 2A and 3A we selected the 
cross-point of sensiti vity and specificity curves as tbe "optimal" cut-
off. However, using another decision rule (as for instance an utility 
function wbere sensitive test would be more appropriate) different 
cut-off points can be defined and tbe corresponding sensitivity/ 
specificity values derived. This allows tbe immediate evaluation of 
reciprocal cbanges of sensitivity and specificity values over the whole 
range of cut-off values. 
Quantitative analysis of coronary arteriography has been correlated 
to exercise echocardiography by Sheikb et al (9) and Agati et al (10). 
The results of the study from Sheikh et al (9) (wbo evaluated 34 
patients, 18 of which bad an ischemic response on echocardiogram) 
indicate that tbe positivity of exercise echocardiogram is directly 
related to tbe severily of the coronary obstruction. However, the value 
of exercise induced angina and ST segment changes was not compared 
to new wall motion abnormalities. The optimal cut-off points of 
quantitative coronary angiography were not calculated directly by tbe 
authors. From the raw data of all the individual patients, we generated 
sensitivity-specificity curves for percent diameter stenosis and minimal 
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lumen diameter, yielding relative cut-off points of 53% and 1.2 mm, 
similar to our study. The sensitivity/specificity values at their cross-
point were 94 and 85% respectively. 
The data from Agati et al (10) apparently differ from ours, since 
they found that exercise echocardiography could bcst differenciate 
patients with a more severe coronary obstruction, by a diameter 
stenosis;?: 85% and a minimal lumen diameter:; 0.7 mm. This dis-
crepancy is probably due to the different study group (only few pa-
tients at the lower end of the range of lesion severity), different type 
of exercise test (supine bicycle with imaging at peak stress), and 
different criteria for the positivity of the echocardiogram based on 
the quantitative assessment of segmental area shortening. 
The comparison of the present findings with those from a previous 
study on dobutamine stress echocardiography (14) is interesting. In 
that study, the "best" cut-otT for the obstruction severity was defined 
as the point of maximal sum of sensitivity and specificity, when the 
sensitivity was equal or greater than the specificity, yielding a value 
of 52% for diameter stenosis and 1.07 nll11 for minimal lumen diameter. 
Using the same approach as in the present study (the point of 
interception), the angiographic cut-off values were 54% (sensitivity 
and specificity 78%) and 1.0 mm (sensitivity and specificity 76%), 
respectively. These rcsults are very consistent with those found in the 
present study with post-exercise echocardiography. They strongly 
suggest that high dose dobutamine-atropine stress echocardiography, 
an exercise simulating but not physiologic test, performs equally well 
for determining the functional consequences of coronary obstructions 
in the major epicardial coronary vessels. 
In conclusions, the severity of a coronary lesion evaluated by quan-
titative coronary arteriography can predict an ischemic response on 
exercise testing. Among the different ischemic markers, wall motion 
abnormalities are beller predicted than S-T segment changes or angina. 
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CHAPTER V 
QUANTITATIVE ANGIOGRAPHIC MEASUREMENTS 
OF ISOLATED LEFT ANTERIOR DESCENDING 
CORONARY ARTERY STENOSIS: CORRELATION 
WITH EXERCISE ECHO CARDIOGRAPHY AND 
99m-Tc MIBI SPECT* 
Abstract 
Obiectives. The aim of this study was to assess the value of 
quantitative coronary arteriography to predict an ischemic response 
at exercise echocardiography and MIBI single photon emission 
computed tomography (SPECT) in patients with single vessel disease 
of the left anterior descending (LAD) coronary artery. 
Background. The relation between the severity of coronary stenosis 
and the ischemic response of exercise echocardiography and peli'usion 
scintigraphy in patients with single vessel LAD disease is not well 
established, 
Methods. Thirty-one patients without previous myocardial 
infarction and with isolated stenosis of different degree in the proximal 
or mid portion of LAD were studied. Quantitative arteriographic 
analysis was used for measurements of percent diameter stenosis (DS) 
and minimal lumen diameter (MLD). Exercise induced wall motion 
abnormalities by echocardiography and transient perfusion defects 
by MIBI SPECT were considered as a positive response. The analysis 
of sensitivity/specificity curves and Receiver Operator Characteristic 
curves was applied to establish the diagnostic power of quantitative 
coronary arteriography (DS and MLD) to predict an ischemic response 
at exercise echocardiography and MIBI SPECT. 
Results, The "best" angiographic cut-off values to predict a positive 
exercise echocardiography and scintigraphy were similar (DS of 52% 
and MLD of 1.121l1m for echocardiography; DS of 49% and MLD of 
1.20 mm for SPECT). However, the sensitivity/specificity at cross 
point was slightly higher (even if not statistically significant) for 
echocardiography than SPECT, both for DS (81 % vs 67%) and MLD 
(81 % vs 74%), suggesting a closer relation of quantitative coronary 
* Arnese M, Salustri A, Fioretti PM, Cornel JH, Boersma E, Reijs AEtvl, de Peyter Pl, 
Roelandl JRTC. J Am Coli Cardial 1995;25.1486-91. 
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arteriography with the outcome of echocardiographic than 
scintigraphic exercise testing. 
COIle/usions. The functional significance of a proximal/mid LAD 
coronary artery stenosis measured with quantitative coronary 
arteriography is slightly better related to echocardiographic than 
scintigraphic markers of exercise induced myocardial ischemia. 
Introduction 
Anatomic information derived from arteriography is not always 
predictive of the physiologic significance of a coronary stenosis (I). 
Several noninvasive techniques have been proposed to assess the 
functional significance of a coronary stenosis detected by contrast 
arteriography. Exercise testing in conjunction with echocardiography 
(2-4) or perfusion scintigraphy (5,6) has been extensively used for 
the evaluation of patients with suspected or known coronary artery 
disease and data available on the comparative value of the two methods 
in the same population demonstrate that they have similar diagnostic 
accuracy (7-12). However, in these previous studies coronary 
arteriography was not quantitatively evaluated, and the confounding 
effects of previous myocardial infarction and abnormal wall motion 
at rest were not always avoided. 
Accordingly, we wanted to investigate which quantitative 
angiographic parameter best correlates with exercise-induced wall 
motion abnormalities and with transient perfusion defects. For this 
aim, a selected population with proximal or mid left anterior 
descending (LAD) coronary artery stenosis and no previous myocardial 
infarction was studied and Receiver Operator Characteristic (ROC) 
curves analysis was used as an objective method for determining the 
power of quantitative angiographic parameters for the prediction of 
an abnormal exercise echocardiogram and SPECT. 
Methods 
We selected 31 consecutive patients (23 males, mean age 57±11 
years, range 32 to 78) referred for the evaluation of chest pain or 
enrolled in follow-up studies after percutaneous coronary angioplasty 
who fulfilled the following inclusion criteria: I) proximal or mid LAD 
coronary artery stenosis at arteriography judged from mild to severe 
by visual assessment; 2) no history of previous myocardial infarction; 
3) simultaneous exercise echocardiography and MIBI SPECT 
performed within 2 weeks from coronary arteriography; 4) normal 
wall motion and perfusion at rest. Patients with unstable angina were 
excluded. 
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Exercise testing procedure. Symptom-limited upright bicycle 
ergometry was performed with stepwise increments of 20 Watts each 
minute. Electrocardiogram (ECG) was continuously monitored (lead 
II, V2, VS) and l2-lead ECG was recorded at rest and every minute 
throughout the test. Cuff blood pressure was measured at rest and 
every two minutes. The ECG was analysed by a computer-assisted 
system (Cardiovit CSG/ 12, Schiller), and a horizontal or downsloping 
ST segment depression> I mm occurring 80 msec after the J point 
was considered as ischemic. 
Exercise echacan/iography. Two-dimensional echocardiograms 
were performed with a wide-angle phased-array system equipped with 
either a 2.S or 3.S MHz transducer. Resting images were acquired in 
the standard views (parasternal long- and short-axis, apical 4- and 2-
chamber), with the patients in the left lateral decubitus. Post-exercise 
images were obtained immediately after the termination of exercise 
testing, with the patients lying in the same rest position. The first 
stress images were always acquired within I minute from the 
termination of exercise. . 
Both rest and stress images were recorded on video tape, digitized 
on-line and stored for subsequent analysis. 
Analysis a/exercise echocardiagraphy. Rest and exercise digitized 
two-dimensional images were reviewed on a side-by-side cine-loop 
display and video tape. Images were interpreted by two experienced 
investigators who were blinded to the patient's clinical data, exercise 
ECG and angiographic results. Agreement between the two observers 
was required for the classification of the wall motion abnormalities. 
In case of disagreement, the opinion of a third investigator was binding. 
For purpose of analysis, left ventricular wall motion was evaluated 
on a 16-segment model, each segment being scored using a 4-point 
scale, where I =normal wall motion and thickening, 2=hypokinesis, 
3=akinesis (absence of systolic wall motion and thickening), and 
4=dyskinesis (systolic outward wall motion with thinning). An 
ischemic response was defined as an exercise-induced wall motion 
abnormality. The low level of inter- and intra-observer variability 
obtained in our laboratory for the interpretation of exercise 
echocardiography has been previously reported (8). The location of 
the wall motion abnormal ities was correlated with coronary arterial 
distribution by using the methodology described by Segar et al (13). 
Exercise MIBI SPEeT. About one minute before the termination 
of the exercise stress test, 370 MBg of 99-m technetium MIBI were 
injected in an antecubital vein through a previously inserted cannula. 
Stress SPECT images were acquired one hour after injection. A resting 
MmI SPECT was performed on a separate day, one hour after a new 
injection of the same dose of radiotracer. 
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Al1alysis (if SPECr For each patient, six short-axis slices and 3 
vertical long-axis slices were displayed and analysed. As previously 
described (14), the left ventricle was divided in 47 segments and each 
segment was scored on a 4-point scale (from 1= normalt04= "absence" 
of uptake). The visual analysis was performed by two observers with 
the assistance of the circumferential profile analysis of the short-axis 
slices. The apical portion was assessed only visually on the vertical 
and horizontal long-axis slices. An ischemic response was based on 
the presence of transient perfusion defect. 
Quantitative cOl'On(ll), arteriography. All 35 mm films were 
analyzed using the Cardiovascular Angiography Analysis System II 
(CAAS II, Pie Medical, the Netherlands). The automated edge 
detection of the system has been validated and described elsewhere 
(15). A region of interest of 512x512 pixels was selected and digitized 
using a high-fidelity charge coupled device camera. The luminal edges 
were detected on the basis of a weighted sum of the first and second 
derivative function of the brightness profile of each scan line 
perpendicular to the vessel centerline. The vessel diameter function 
was determined by computing the shortest distance between the right 
and left contours. Calibration of these measurements to absolute values 
was achieved by using the catheter tip as a scaling device. A computer 
derived estimation of the original arterial dimension at the site of 
obstruction was used to calcu late the interpolated reference diameter. 
This technique is based on a computer-derived estimation of the 
original values over the analyzed region. The calcu lation is based on 
a first degree polynomial computed through the diameter values of 
the proximal and distal portions of the arterial segment followed by a 
translation to the 80th centile level. All measurements were performed 
from end-diastolic frames with optimal vessel opacification. 
Statistical llnalysis. All continuous variables are expressed as 
mean ± SO. The agreement between echocardiography and SPECT 
was defined as the percentage of concordant diagnosis and it was 
also assessed by calculating the kappa (k) value and the corresponding 
95% confidence intervals (C.r.). Receiver Operator Characteristic 
curves analysis was used as an objective method for determining the 
power of the angiographic parameters (OS, MLD) for the prediction 
of an abnormal exercise echocardiography and SPECT. The sensitivity 
and specificity were plotted against the whole range of measurements 
of a specific parameter for determining the "best" cut-off point. The 
best cut-off point was defined as the intersection of the sensitivity/ 
specificity curves. The sensitivity/specificity values at these cut-off 
points are reported as percent with the corresponding 95% c.r. 
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ECHO 
+ 
+ 13 6 
MIBI 
3 9 
Agreement 70% 
kappa = 0.42 
Figure 1 - Two-by-two table for the agreement of an ischemic response by exercise 
echocardiography (ECHO) and MISI SPECT. 
+ = positive response; . = negative response. 
Results 
Exercise lestillg resliits. The mean maximal heart rate was 145 
beats/min (range 120-190). The 85% of the maximal age-predicted heart 
rate was not reached in 8 patients. In 4 cases the exercise was stopped 
because of chest pain, and in the other 4 for fatigue (in 3 of these last 4, 
echocardiography was positive). During the exercise test, angina 
occurred in 9 patients and ST segment depression (horizontal or 
downsloping> I mm) in 14. 
Exercise ecllOcardiography. New wall motion abnormalities were 
detected on post exercise echocardiogram in 16 patients. The site of 
wall motion abnormalities was always consistent with the territory of 
LAD. 
Exercise SPECT reslllls_ Transient perfusion defects were present, 
all in the distribution territory of the LAD, in 19 patients. The 
agreement between echocardiography and SPECT for the diagnosis 
of myocardial ischemia is represented in figure 1 (22/31 =70%, kappa 
value = 0.42, 95% c.r. 0.10-0.74). Of the 9 patients with discordant 
responses, 6 had positive SPECT and negative echocardiograms. The 
median DS and MLD in these 6 patients were 35% (range 30-53%) 
and 1.89 mm (range 1.12-2.26 mm), respectively_ 
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Qualltitative arteriography alld exercise-illduced myocardial 
ischemia. Quantitative coronary arteriography revealed a mean percent 
DS of 52± 19 (range 30% to 100% - 2 patients with total occlusion). 
The DS was <50% in 14 patients, 50 to 70% in 13, and >70% in 4. 
The 111ean MLD was 1.20±0.58 111111 (range 0 to 2.26 nUll). Faint 
collaterals were visible in the 2 patients with occluded artery. 
Sensitivity and specificity of the individual values ofDS ancl MLD 
for the correct classification of patients with and without exercise-
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Figure 2 - Percentage correct classification of presence (sensitivity) or absence 
(specificity) of exercise induced wall motion abnormalities as a function of cut-off 
points over the whole spectrum of percent diameter stenosis (panel A) and minimal 
lumen diameter (panel 8). 
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induced myocardial ischemia are depicted in figure 2 (panel A and B) 
for echocardiography and in figure 3 (panel A and B) for SPECT. 
From these figures it can be observed that the "best" cut-off point of 
DS (dcfined as the value at the cross-point of sensitivity and specificity 
curves) for predicting a positive response during exercise was similar 
for echocardiography and SPECT (52% vs 49%, respectivcly). 
However, the sensitivity/specificity cross-point was slightly higher 
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Figure 3 • Percentage correct classification of presence (sensitivity) or absence 
(specificity) of transient perfusion defects as a function of cut· off points over the 
whole spectrum of percent diameter stenois (panel A) and minimal lumen diameter 
(panel 8). 
61 
% sen s itivity . 
100 
~~~g _________ R ________ \ 
, 
, 
, 
, 
, 
80 '------, ----- X- Echo 
60 
40 
20 
o 
o 20 40 60 80 
% specificity 
% sensitivity 
100 - - -- -- -- - - -- -- - - -- - - -- - --, 
, 
, 
, 
, 
80 \ 
, 
, 
,- -, 
, 
60 : 
, 
100 
,- -, 
, 
40 
20 
o 
o 20 40 60 80 100 
% specificity 
-X-MISI SPECT 
x -Echo 
X-MISI SPECT 
Figure 4 - Receiver Operator Characteristic curves comparison of the diagnostic 
accuracy of percent diameter stenosis (panel A) and minimal lumen diameter (panel 
B) lor the prediction of wall motion abnormalities and transient perfusion defects 
during bicycle ergometry. 
For percent diameter stenosis, the ares below the ROC curves (expressed as percent 
of the maximal theoretical area, and 95% confidence intervals) are 95 (89-100) for 
echocardiography and 74 (57-91) for SPECT. For minimal lumen diameter, the 
corresponding values are 93 (84-100) and 73 (55-90), respectively. 
X-Echo = exercise echocardiography; X-MIBI SPECT = exercise SPECT. 
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for echocardiography than SPECT (81 %, 95% C.I 54-96, vs 67%, 
95% c.l. 43-87). Similar results were found considering the MLD, 
including a similar "optimal" cut-off (1.12 n1l11 vs 1.20 mm) and a 
trend suggesting a slightly higher sensitivity/specificity cross-point 
for exercise echocardiography (81 %, 95% C.I. 54-96, vs 74%, 95% 
c.l. 48-90). 
In figure 4, the ROC curves of quantitative coronary arteriography 
for the prediction of wall motion abnormalities and perfusion defects 
are separately represented. There is a clear trend showing that the 
areas below the ROC curves for the prediction of new wall motion 
abnormalities were larger compared to those for the prediction of 
transient perfusion defects. This observation suggests that these 
angiographic parameters are better related to the mechanical than to 
the perfusion marker of ischemia. 
The accuracy of DS and MLD for new wall motion abnormalities 
was similar, since the areas below the respective ROC curves were 
not statistically different (93% vs 95%). 
Discussion 
Although coronary artelY disease comprises a continuous spectrum 
of obstruction severities, the diagnostic accuracy of noninvasive tests 
mostly relies on one arbitrary ungiographic cut-off value (0 define 
"significant" disease. This "fuzzy" decision implies that some stenoses 
which are physiologically non significant may be included in the 
definition of the presence of disease, and also that some physiologically 
significant stenoses may be classified as non significant. Clearly, this 
is a crucial issue since one of the most important determinants of the 
sensitivity and specificity of noninvasive tests for the diagnosis of 
coronary artery disease is the definition of the angiographic reference 
(which parameter and which cut-off value for each parameter). In 
addition, many reports do not rely on quantitative angiographic 
assessment of coronary stenoses, which can be a major drawback of 
any study aiming at assessing the accuracy of any test for the diagnosis 
of coronary artery disease (1,16). 
The present study. The aim of the present study was to assess the 
value of quantitative coronary arteriography to predict an ischemic 
response at exercise echocardiography and MIDI SPECT in a selected 
group of patients without previous myocardial infarction and isolated 
discrete mild to severe lesion in the proximal or mid-portion of the 
LAD coronary artery. To address this problem, quantitative 
measurements of the coronary stenoses were performed by quantitative 
coronary angiography, and the functional end-point of the study was 
the ischemic response on symptom limited exercise echocardiography 
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and MlBI SPECT, which were simultaneously applied in all patients. 
To assess the relationship between coronary stenosis and exercise 
induced ischemia over the whole range of obstruction severity, the 
ROC and the sensitivity/specificity curves from the percent DS and 
MLD were analyzed. This approach allows the identification of the 
most efficient angiographic cut-off values for predicting an ischemic 
response on stress echocardiography and SPECT. At this aim, we 
used an utility function where sensitivity and specificity are considered 
equally appropriate. 
This study provides new information, since the few previous 
comparative studies between exercise echocardiography and perfusion 
scintigraphy (7-12) were confounded by the inclusion of patients with 
previous myocardial infarction or multi vessel coronary disease. 
Further, no study included a homogeneous group with single vessel 
LAD disease, the functional significance of different degrees of 
stenoses severity was not explored, and in some studies the quantitative 
assessment of coronary angiograms was not appropriate. 
The main findings of this study can be summarized as follows: 
I) the best angiographic cut-off values from DS and MLD to 
predict an ischemic response by exercise echocardiography and MlBI 
SPECT are similar; 2) the accuracy of DS and MLD to predict the 
functional outcome of exercise stress testing is similar; 3) quantitative 
coronary arteriographic measurements are slightly better related to 
echocardiographic than to scintigraphic results. 
The "best" allgiographic variables alld cw-oH vailles. The 
diagnostic accuracy of DS ancl MLD was similar for the prediction of 
both exercise echocardiography and MIDI SPECT. This is in contrast 
to previous studies suggesting that MLD is a better parameter to 
characterize the functional significance of coronary stenoses (17). This 
difference maybe related to the patients selection. For instance, Wilson 
et al (18) found that, consistently with our results, DS is a functionally 
meaningful variable in patients with discrete single site coronary artelY 
narrowing. It is likely that MLD is superior to DS for the functional 
assessment of the coronary obstruction in patients with a diffuse 
disease, which may be undetected or underestimated by measuring 
only the relative diameters differences (17,19). Consistent with our 
findings, recent data by Uren et al in paticnts with single vessel disease 
and normilileft ventricular function have shown that myocardial blood 
flow during adenosine or dipyridamole induced hyperemia is equally 
well correlated with DS and MLD (inverse correlation with the percent 
of DS and direct correlation with the MLD) (20). 
In the present study, the cut-off values which optimally separated 
patients with a normal from those with an ischemic response during 
exercise were defined as those corresponding to the cross-point of 
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the sensitivity/specificity curves (figures 2 and 3). They were 52% 
for DS and 1.12 mm for MLD, using the echocardiographic end-point. 
They were similar when MIBI SPECT was applied (49% and 1.20 
mm, respectively). These results are in agreement with the cut-off 
values found applying a similar statistical approach, but utilizing 
different stress or imaging modalities like exercise ECG (21) or 
dobutamine echocardiography (22) as functional end-point. 
Exercise echocardiography versus MIBI SPEeT. An important 
finding of the present study is that the results of exercise 
echocardiography are predicted by quantitative coronmy mteriography 
at least as well as those of MIBI SPECT. This can be concluded by 
the inspection of the ROC and the sensitivity/specificity curves. From 
the analysis of the ROC curves, the sensitivity and specificity for the 
prediction of a positive exercise echocardiogram are slightly higher 
than those for the prediction of a positive MIBI SPECT during the 
whole range of measurements of both DS and MLD (figure 4). This 
higher sensitivity and specificity of coronary angiography for the 
prediction of echocardiographic results is confirmed by the sensitivity/ 
specificity curves (figures 2 and 3). The inspection of these curves 
allows the assessment of the sensitivity and specificity over the whole 
range of DS and MLD, and the cross-point represents the cut-off of 
the angiographic variables with the "optimal" sensitivity and 
specificity. In this specific case, it clearly appears that, while the values 
of both DS and MLD at the cross-point were similar for exercise 
echocardiography and MIBI SPECT, the sensitivity-specificity values 
at the cross point were slightly lower for MIBI SPECT than for 
echocardiography, implying a less strict relationship of coronary 
arteriographic measurements with scintigraphy than with 
echocardiography. 
Several factors may explain the discrepancies between exercise 
echocardiography and MIBI SPECT. Both imaging methods have 
limitations and pitfalls. Perfusion SPECT may lack an optimal 
diagnostic accuracy for a variety of technical reasons, as soft tissue 
attenuation, overlying abdominal viscera, ventricular hypertrophy, 
cardiac rotation, patients motion (23). Acquisition of 
echocardiographic stress images is strongly operator dependent, and 
with the post-exercise acquisition some mild transient ischemia may 
be missed (24). Furthermore, SPECT perfusion imaging detects not 
only true myocardial ischemia but also malperfusion, which results 
in detection of stenosis of mild/moderate degree. This has been 
underscored in in recent observations by Uren et al in humans (20), 
who found a decline of the coronary vasodilator reserve during 
adenosine or dypiridamole induced hyperemia for moderate degree 
of coronary stenosis, starting from 40%, and an exaustion of coronary 
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reserve for stenoses greater than 80%. It is uncertain to establish which 
of these factors intrinsic to the two methods was of importance in our 
series. However, the results of the present study suggest that the "grey 
zone" for the prediction of exercise induced myocardial ischemia from 
quantitative coronary angiography is smaller for echocardiography 
compared to perfusion scintigraphy. 
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CHAPTER VI 
QUANTITATIVE CORONARY ANGIOGRAPHY IN 
THE ESTIMATION OF THE FUNCTIONAL 
SIGNIFICANCE OF A CORONARY STENOSIS. 
CORRELATIONS WITH DOBUTAMINE-ATROPINE 
STRESS TEST" 
Abstract 
Objectives: The purpose of this study was to determine the 
predictive value of quantitative coronary angiography in the 
assessment of the functional significance of coronary stenosis as 
judged from the development of left ventricular wall motion 
abnormalities during dobutamine-atropine stress echocardiography. 
Background: Coronary angiography is the reference method for 
assessment of the accuracy of nOll-invasive diagnostic imaging 
techniques to detect the presence of a significant coronary stenosis. 
However, use of arbitrary cut-off criteria for the interpretation of 
angiographic data may considerably influence the true diagnostic 
accuracy of the technique investigated. 
Methods: Thirty four patients without previous myocardial 
infarction and with single coronary stenosis were studied with both 
quantitative angiography and dobutamine-atropine stress 
echocardiography. Two different techniques of quantitative 
angiographic analysis, edge detection and videodensitometry, were 
used for measurement of minimal lumen diameter, percent diameter 
and percent area stenosis. Two-dimensional echocardiographic images 
were collected during incremental doses of intravenous dobutamine 
and later analyzed using a 16 segment left ventricular model. 
Angiographic cut-off criteria were derived from receiver-operating 
curves to define functional significance of coronary stenosis based 
on dobutamine-atropine stress echo. 
Results: The angiographic cut-off values with the best predictive 
value for the development of left ventricular wall motion abnormalities 
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during dobutamine-atropine stress echocardiography were a minimal 
lumen diameter of 1.07 nUll, a percent diameter stenosis of 52 %, and 
percent area stenosis 01'75 %. Minimal lumen diameter was found to 
have the best predictive value of a positive dobutamine stress test 
(odds ratio 51, sensitivity 94% and specificity 75%). 
COl/elusiol/s: Automated quantitative angiographic measurements 
of minimal luminal diameter is a practical and useful index for 
determining both the anatomical and the functional significance of a 
coronary stenosis and a value of 1.07 nun is the best predictor of a 
positive dobutamine stress test. 
Introduction 
Establishing the functional significance of a coronary stenosis 
detected by contrast angiography is a clinical challenge especially in 
the case of intermediate stenotic lesions. The traditional criteria for 
detennining the presence of functionally significant disease, a 50 % 
reduction in lumen diameter by visual estimation, suffers from 
considerable inter- and intraobserver variability (1-3), making this 
criterion unreliable in the estimation of the functional impact of lumen 
obstructions (3). It is in the range of mild to moderate stenoses (30-60 
% diameter stenosis) that the discrepancy between visual estimates 
and objecti ve measurements of lumen dimensions is most marked (4, 
5). Computerised quantitative coronary angiography reduces the latter 
source of errol' and provides objective measurements of lumen 
dimensions, but the physiological significance of a given coronary 
stenosis remains unclear. Because of the use of arbitrary cut -off criteria 
in previous studies addressing this problem, and in which coronary 
angiographic estimates of severity were compared with other imaging, 
objective indices are lacking. 
Recently, dobutamine stress echocardiography has been introduced 
as a safe and reproducible technique for the diagnosis of coronary 
mtery disease (6-13). Several studies have indicated a good correlation 
between the development of wall motion abnormalities during stress 
echocardiography and the severity of a coronary stenosis (6-15). 
However, these studies have limitations because either visual 
interpretation of the angiogram was performed (6,7,14) or arbitrary 
cut-otf points (13) for quantitative angiographic data were used. 
The goal of this study was to investigate which quantitative 
angiographic parameters of stenosis severity best correlates with the 
dcvelopment of ischemia-induced wall motion abnormalities during 
dobutamine-atropine stress echocardiography. Angiographic cut-off 
criteria were derived from receivcr-operating curves to obtain objective 
criteria for assessment of functional significance of stenosis severity. 
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Methods 
SlIIdy Patiellts. The study patients included 34 consecutive patients 
referred from the catheterization laboratory, with a single coronary 
stenosis judged to have 330% diameter stenosis by visual assessment. 
The coronary angiogram was performed within 2 weeks prior to the 
performance of dobutamine-atropine stress echocardiography. The 
stenosis was located in the left anterior descending coronary artery in 
26 patients, left circumflex coronary artery in 3 patients, and right 
coronary artery in 5 patients. Mean age was 61.3 ± 12.6 years (range 
32 to 79). There were 21 (62%) men and 13 (38%) women. Patients 
with unstable angina, previous myocardial infarction, and left bundle 
branch block were excluded. Patients were under treatment with 
antianginal medication, consisting of heta-blocking agents (24 
patients) either alone or in combination with nitrates and/or calcium-
channel blocking agents, which was not discontinued prior to the study. 
Dahl/tamine-atropille Stress Test. The protocol used at the 
Thoraxcenter in the performance of dobutamine-atropine stress 
echocardiography has heen described in detail previously (16). Briefly, 
two dimensional precordial echocardiography was performed at rest 
and during incremental doses of dobutamine. After a baseline 12-
lead electrocardiogram, dobutamine was infused through an 
antecubital vein starting at a dose of I 0 ~Ig/Kg/min for 3 minutes, and 
increasing by I 0 ~Ig/Kg/min every 3 minutes to a maximum of 40 pg/ 
Kg/min (stage 4); this was continued for 6 minutes in the absence of 
an ischemic response. In patients not achieving 85% of maximal 
predicted heart rate, atropine (0.25 mg) was given intravenously at 
the end of stage 4, and repeated to a maxinlllm of 1 mg with the 
continuation of dobutamine for a further 5 minutes if necessary to 
achieve the above mentioned target heart rate. The infusion of 
dobutamine was stopped if the patient developed marked new wall 
motion abnormalities, ST segment depression of>0.2mV 80 ms after 
the J point, ST segment elevation, typical angina, significant 
arrhythmias, a decrease in systolic blood pressure> 40 mmHg from 
resting level, 01' any complication considered to be related to the stress 
test. 
Standard apical and parasternal views were recorded in a closed 
cineloop in a quad-screen format, facilitating the comparison of rest 
and stress images, on super-VHS videotape. During the analysis of 
the images, the left ventricle was divided into 16 segments (17), each 
segment being scored using a 4 point scale: 1 = normal wall motions 
and thickening; 2= hypokinesia; 3= akinesis (absence of systolic wall 
motion and thickening); 4= dyskinesis (systolic outward wall motion 
with thinning). 
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Images were reviewed by two experienced investigators who were 
unaware of the clinical and' angiographic data. Agreement between 
the two observers was required for the classification of the wall motion 
abnormalities. In cases of disagreement the opinion of a third 
invcstigator was considered. An ischemic response was defined as a 
stress-induced new wall motion abnormality or a worsening of a wall 
motion abnormality at rcst. 
The location of the wall motion abnormalities was correlated with 
coronary arterial distribution by using the same methodology as 
described by Segar ct al (13), after a modification of the schemc of 
Bourdillon et al (17). The apical lateral and apical inferior segments 
were considered to be areas of overlap. The apical lateral scgment 
was considered to be a part of the left anterior descending coronary 
artery territories in association with additional septal or anterior wall 
motion abnormalities. The same segment was considered to be part 
of the Icft circumflex coronary artery distribution in association with 
posterior or posterolateral wall motion abnormalities. The apical 
inferior segment was relatcd to the right coronary artery system if 
there were additional inferior wall motion abnormalities and to the 
left anterior descending region in the presence of anterior or 
antcroseptal wall motion abnormalities. 
QUllntitative Coronar)' Angiography. All 35 nlln films were 
analyzed using the Cardiovascular Angiography Analysis System II 
(CAAS II, Pie Medical, The Netherlands). The automated edge 
detection and videodensitometric techniques of this system have been 
validated and described in detail elsewhere (18-22). All measurements 
were performed from end-diastolic frames with optimal vessel 
opacification. 
Edge detection. A region of interest of 512X512 pixels was selected 
and digitised using a high-fidelity charge coupled device (CCD) 
videocamera. The luminal edges were detected on the basis of a 
weightcd sum of the first and second derivative function of the 
brightness profile of each scanline perpendicular to the vessel 
centerline. The vessel diameter function was determined by computing 
the shortest distance between the right and left contours. Calibration 
of these measurements to absolute values was achieved by using the 
catheter tip as a scal ing device. A computer derived estimation of the 
original arterial dimension at the site of obstruction was used to 
calculate the interpolated reference diameter. This technique is based 
on a computer-derived estimation of the original valucs over the 
analyzed region. The calculation is based on a first degree polynomial 
computed through the diameter values of the proximal and distal 
portions of the artcrial segment followed by a translation to the 80th 
centile level. 
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Videodensitometry. Densitometry is based on the approximate 
linear regression that exists between the optical density of a contrast 
enhanced lumen and its absolute dimensions. In order to follow this 
approach, the brightness of each scanline perpendicular to the vessel 
centerline was transformed into an absorption profile using a simple 
logarithmic transfer function to correct for the Lambert-Beer law. The 
background contribution was estimated by computing the linear 
rcgression line through the background pixels located left and right 
of the detected luminal contours. By subtracting this background 
portion from the absorption profile of the vessel a net cross-sectional 
absorption profile was calculated. A cross-sectional area function of 
the analyzed segment was obtained by repeating this process with all 
scan-lines. An interpolated reference area was calculated from the 
reference diameter assuming a circular cross section. The cross-
sectional area at the narrowest point was identified and expressed in 
mm2. 
Data aI/a lysis. All continuous variables were expressed as mean 
± SD. The two-tailed Student's t test was used for analysis of 
continuous data. The chi-square test and Fisher's exact test were used 
to compare differences between proportions. The independent 
correlation of the angiographic parameters to the percentage of the 
maximal age-predicted heart rate was determined by logistic regression 
analysis. Angiographic variables were entered as categorical variables 
by use of their respective cut-off values. These values were achieved 
by determining for each variable the point of the maximal sum of 
sensitivity and specificity, when the sensitivity is equal to or greater 
than the specificity. Furthermore, receiver operator characteristics 
(ROC) curve analysis as an objective method for determining the value 
of the various angiographic parameters in the prediction of an abnormal 
dobutamine stress test was applied. This technique is independent of 
definitions of cut-off values. The sensitivity (true positives) is plotted 
against one minus specificity (true negatives) during the whole range 
of measurements of a specific parameter. Odds ratio and 95 % 
confidence intervals, were calculated, for the comparison of the rela-
tive predictive power of the best cut-off value of each angiographically 
determined variable. A p value of < 0.05 was considered statistically 
significant. The statistical package used was SAS, release 6.04, North 
Carolina, USA. 
72 
Results 
Results of Do!Jllfalllille-atropille Stress Test. Dobutamine-atropine 
stress echocardiography was positive in IS patients. There were no 
significant differences in age, gender, or the affected coronary artery 
between patients with a positive (group I) or negative (group 2) test. 
Beta-blockers were part of the antianginal therapy in 24 (70%) patients. 
Of these, 10 patients (4%) developed a positive dobutamine stress 
test compared with 14 (58%) with a negative test (ns). 
Table I summarises the results of the dobutamine-atropine stress 
test. The percentage of the maximal age-predicted heart rate achieved 
was noted to be significantly higher (S2±14) in group I than in group 
2 (69±17) (p<0.05) and in patients without beta-blocker therapy (S7±9 
versus 72± 17; P < 0.05). Atropine was added in 15 patients. (12 were 
on beta-blocker therapy). However, since the presence and severity 
of the disease is the main determinant of a positive test, the 
achievement of the target hemt rate was not found by logistic regression 
analysis to be an independent predictor of a positive stress test. In 
figure I, the evolution of the heart rate during the test is shown. 
Although the maximal heart rate when atropine was added was higher, 
it did not change the sensitivity of the test. It was also evident, that 
patients taking beta-blockers frequently need atropine at the end of 
the test in order to achieve the target heart rate. During the test, angi-
na occurred in II patients (32%) with equal distribution in the two 
groups (6 patients in group I, and 5 in group 2, p = ns). An ischemic 
electrocardiographic response during stress testing occurred in S 
patients (24%) and again there were no significant ditJerences between 
the two groups (5 patients in group I, and 3 patients in group 2, p = 
ns). 
% Maximal heart rate 
Stress angina 
Ischemic ST segment deviation 
Atropine 
Group I 
(n = 18) 
82 ± 14 
6 (18%) 
5 (15%) 
8 (53%) 
Group 2 
(n = 16) 
69 ± 17' 
5 (15%) 
3 (9%) 
7 (47%) 
'p < 0.05. Data presented are mean value ± SD or number(%) of patients. 
Table 1 - Results 01 Dobutamine Strees Test in Study Groups 1 and 2. 
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Figure 1 " Evolution of heart rate (HR) during dobutamine infusion and atropine 
administration. Clearly seen is the steep increase in heart rate with the addition of 
atropine, although the difference in maximal heart rate between patients who did 
and did not receive atropine was not statistically significant. 
Results of Qualltitative Allgiography. For the entire population, 
quantitative coronary angiography rcvealed a mean percent diameter 
stenosis of 56±20% (range II % to 100% - 4 patients with total 
occlusion), a mean percentage area stenosis of 74±20% (range 24% 
to 100%). a mean minimal lumen diameter of 1.0 I ±0.59 mm (range 0 
to 2.84 mm) and a mean reference diameter of 2.41 ±0.52 mm (range 
1.64 to 4.07 mm). 
Figure 2 shows the relationship between the sensitivity and 
specificity of the dobutamine-atropine stress test and their receiver 
operator characteristics curves for each of the angiographic indices, 
as a function of stenosis severity. For clinical purposes, a cut point is 
often selected to permit computation of sensitivity and specificity, 
parameters that are widely employed and understood in the medical 
literature (23). There are two commonly used schemes for selecting 
cut points in this setting. The first involves the choice of a convenient 
but arbitrary point, such as 50% diameter stenosis. The second uses 
the intersect of the sensitivity and specificity curves as the cut point 
(24). In the present study an alternative approach was used based on 
receiver operator characteristics curves. We selected the point at which 
the sum of the sensitivity and specificity, when the sensitivity is equal 
to or greater than the specificity reaches a maximum. As this point 
takes into account the shape of the two curves near the point of 
interception (figure 2) it was hoped that this technique will provide 
better diagnostic accuracy. As an example in figure 2, if we select the 
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Figure 2 - Relation between the sensitivity and specilicity of the dobutamine-atropine 
stress test and the receiver-operator curves for each of the angiographic indexes 
as a function of stenosis severity. Left, Variation in sensitivity (solid circles) and 
specificity (open circles) are presented as a function of cutoff points forthe different 
quantitative agiographic variables. Right, Corresponding receiver-operator curves 
for the angiographic variables. 
interception of the sensitivity and specificity curves, the sum will be 
159 points (sensitivity 78 + specificity 81). Using our approach, the 
sum of the sensitivity and specificity will be 169 (sensitivity 94 + 
specificity 75). 
All the quantitative angiographic parameters revealed a high 
sensitivity (ranging from 82-94 %) for the identification of ischemia 
- induced wall motion abnormalities. While all the angiographic 
variables had the same specificity (75 %), minimal lumen diameter 
had the highest sensitivity (94 %). Because patients with normal 
coronaries were not included in the study, the specificity value is 
probably underestimated. 
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Table 2, summarizes the relationship of different cut-off points to 
the outcome of the stress test. Minimal lumen diameter has a predictive 
value which is considerably larger (odds ratio 51), than the commonly 
used parameters of relative obstruction (odds ratio of 15 and 23 for 
percent diameter and percent area stenosis respectively). 
Positive Negative 
Angiographic Predictive Predictive 
Cutoff Values Sensitivity Specificity Value Value Odds Ratio 
MLD $1.07 mOl 94 (84-100) 7l (l4-%) 81 92 II (4-1,929) 
A Sle "2:.75% 88 (73-100) 7l (l4-%1 79 86 23 (2-242) 
D SIc "2:.52% 83 (66-100) 7l (l4-%) 79 80 Il (2-123) 
Numbers in parentheses are 95% confidence intervals. A Sle ::: area stenosis; D Sle '" djameter stenosis; 
MLD'" minimaJlumen diameter. 
Table 2 - Quantitative Angiographic Results According to Cutofi Values. 
Discussion 
Doblilamillc Slress EciIocardiograpiIy. The usc of dobutamine 
stress echocardiography in the assessment of myocardial ischemia 
offers advantages over the traditional nuclear techniques, including 
lower cost, less time consuming, no radiation exposure and greater 
availability, which justify its growing application in clinical practice 
(6-10,12,13). Because wall motion abnormalities are an early and 
specific indicator of myocardial ischemia, dobutamine stress 
echocardiography is potentially superior to stress scintigraphy, since, 
particularly in patients with mild to moderate stenoses, transient 
perfusion defects result from a maldistribution of coronary flow, and 
do not necessarily reflect "true" myocardial ischemia. In addition, 
SPECT myocardial scintigraphy is associated with a lower specificity 
when compared with dobutamine stress echocardiography in patients 
with single coronary stenosis (25-26). 
In the study population the incidence of chest pain and ischemic 
electrocardiographic response during dobutamine echocardiography 
was low (32% and 24% respectively) and without relation to the 
outcome of the echo stress test. This is not surprising, since also in 
previous works the sensitivity and specificity of stress induced ECG 
changes in single vessel disease were relatively low (27-30). The 
finding of a significant higher heart rate in patients who developed 
wall motion abnormalities during dobutamine stress echo underlines 
the importance of chronotropism as an additional mechanism to 
increase inotropism to induce ischemia. This is in agreement with 
previous experimental and clinical data (16,31,32). 
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Previous Studies. In previous studies, quantitative angiographic 
measurements of stenosis severity correlated well with the outcome 
of stress echocardiography (13, 15). In a population of 25 patients 
with single vessel disease, Ryan et al (14), using the criteria of more 
than 50% visually determined percent diameter stenosis, found a 
sensitivity of 76% of exercise echocardiography. Sheikh et al (15), 
studying 34 patients with single vessel obstruction, reported that all 
patients with more than 75 % diameter stenosis by visual assessment 
developed wall motion abnormalities during exercise 
echocardiography. However, only 50 % of the same patients had an 
abnormal test if the angiographic cut -off criterion was lowered to 50 
% diameter stenosis. In a subgroup of 30 patients with normal left 
ventricular function at rest and single or multi vessel disease, Segar et 
al (13) described a high sensitivity (90 %) of dobutamine stress test 
to detect significant coronary disease using a diameter stenosis of 
more than 50% by quantitative angiography. Several authors 
(8, I 0,12,16) using the same approach reported a wide variation of 
the sensitivity values for the detection of significant lumen reduction. 
All these studies, however, relied on arbitrary cut-off points for the 
determination of a significant stenosis, and few evaluated (13,15) 
absolute parameters of luminal obstruction. The high sensitivity and 
specificity noted for minimal lumen diameter in our study (94% and 
75 % respectively), although using a different approach, are in 
accordance with Segar et al (13) who reported a high sensitivity of 
the dobutamine stress test in the identification of coronary stenoses 
using a cut-off criterion of 1.0 mm for minimal lumen diameter, 
although in this study an attempt to determine the best cut-off point 
was not reported. 
Relative versus Absolute Measurelllellts of Corollary Stellosis. It 
is known that in the setting of diffuse coronary disease relative 
parameters of luminal narrowing may underestimate the functional 
impact of stenosis severity (33-35). In this study, only patients with 
single discrete stenosis were included, therefore it is of greater 
significance that minimal lumen diameter was found to be the best 
predictor of an abnormal stress test. However, even in the presence of 
focal disease, angiographically normal segments used in the 
determination of the relative measures of luminal obstruction are 
frequently involved in the atherosclerotic process as reported in several 
intracoronary echo cardiographic studies (36,37). Therefore, absolute 
dimensions may be a better indicator of the physiological importance 
of coronary stenoses in medium to large arteries. Our finding that a 
minimal lumen diameter of less than or equal to 1.07 mm is the best 
parameter for the prediction of ischemia-induced wall motion 
abnormalities, supports this hypothesis. In this regard, data derived 
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from the MERCATOR study (38) revealed that patients with a minimal 
lumen diameter less than 1.1 mm at the follow-up had a higher 
OCClllTence of subsequent clinical events. Although it has been reported 
that the sensitivity of a visually determined diameter stenosis of more 
than 50 and less than 70 % is low for the occurrence of new wall 
motion abnormalities during stress echocardiography (15), the finding 
in our study of a cut-off point of 52 % for the diameter stenosis is in 
agreement with previous experimental work showing a decline in 
coronary flow reserve at this level (39), and confirms that for this 
range of obstructions, visual assessment overestimates quantitative 
measurements (4,5). 
Edge Detectioll versus Videodellsitollletry ill Allgiographic 
Allalys;s. Serruys et al (40) and Wijns et al (41), reported that a 
videodensitometrically determined area of obstruction> 80 % 
constituted a physiologically significant obstruction as assessed by 
exercise - redistribution thallium scintigraphy, and these data concord 
with our criteria of 75 % reduction in cross sectional area for the 
prediction of ischemia-induced wall motion abnormalities. 
Videodensitometrical determination of percent area obstruction is 
theoretically independent of the geometrical shape of the luminal 
obstruction, having the potential to overcome limitations related to 
edge detection techniques, when using a single projection. Because 
in our study an average of two projections was used to determine the 
different angiographic parameters, and because situations where the 
occurrence of a complex luminal shape were not included in the 
analysis (eg: post-angioplasty, unstable angina), there was no clear 
advantage of the densitometric determined percent area stenosis over 
the percent diameter stenosis. 
COllclusiolls. Quantitative angiography provides an objective 
assessment of the functional significance of coronary stenoses as 
determined by dobutamine stress echocardiography. Although relati-
ve measurements of lumen obstruction are predictive of an abnormal 
stress echocardiogram, minimal lumen diameter appears to be the 
optimal parameter in the determination of the physiological 
significance of coronary stenoses in medium to large arteries. 
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CHAPTER VII 
IMPROVED IDENTIFICATION OF CORONARY 
ARTERY DISEASE IN PATIENTS WITH COMPLETE 
LEFT BUNDLE BRANCH BLOCK BY USE OF 
DOBUTAMINE STRESS ECHOCARDIOGRAPHY; A 
COMPARISON WITH MYOCARDIAL PERFUSION 
SINGLE PHOTON EMISSION COMPUTED 
TOMOGRAPHY * 
Abstract 
Objectives: This study was conducted to compare the efficacy of 
dobutamine stress echocardiography with that of perfusion 
tomography for the non-invasive identification of coronary artery 
disease in patients with left bundle branch block. 
B{/ckgrollnd: False positive perfusion defects are common in the 
territory of the left anterior descending coronary artery in patients 
with len bundle branch block. Preliminary data have suggested that 
dobutamine stress echocardiography may provide an accurate means 
of identifying coronary disease in these patients. However. these 
techniques have not been compared in the same patients with len 
bundle branch block. 
Methods: Twenty-four patients with complete left bundle branch 
block were studied prospectively with dobutamine stress 
echocardiography and single-photon emission computed tomography. 
Eleven patients had a previous myocardial infarction. The presence 
of coronary artery disease (> 50 % coronary stenoses at coronary 
angiography) was comparcd with the presence of fixed or reversible 
perfusion defects, and with resting or dobutamine-induced 
abnormalities of wall thickening. For each test, the left anterior 
coronary artery territory was compared with the circumflex and/or 
right coronary artery . 
• Mairesse G, lvfarwick TH, Arnese ivl, Valloverschelde LJ, Cornel JH, Detry Ji'vfR, i'vlelin 
lA. Fioretti PM. Am 1 Cardinl 1995;76:321-325 
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Results: Significant coronary artery disease was found in the cir-
cumflex andlor right coronary artery in 13 patients, II (85 %) were 
identified both by perfusion imaging and dobutamine 
echocardiography. In the II patients without circumflex andlor right 
coronary artery disease, scintigraphy was positive in 4 (specificity: 
64 %), and dobutamine echo cardiography in 3 (specificity: 73 %, P = 
NS). Significant coronary artery disease was found in the left anterior 
descending coronary artery in 12 patients, all (100 %) were identified 
by perfusion imaging and 10 (83 %, P = NS) by dobutamine 
echocardiography. In the 12 patients without left anterior descending 
coronary artery disease, scintigraphy was also positive in all 
(specificity: 0 %), and dobutamine echocardiography in only I 
(specificity: 92 %, P < 0.0 I). Their diagnostic accuracy was 50 % and 
87 % (p < 0.05) respectively. This low specificity of perfusion 
tomography was partially corrected by restricting the diagnosis of 
coronary disease to those patients with partially reversible defects or 
with an associated apical defect to indicate left anterior descending 
coronary artery disease. 
Conclusions: Dobutamine stress echocardiography, using wall 
thickening impairment to define coronary artery disease, is more spe-
cific and accurate than conventional perfusion tomography for the 
non-invasive identification of coronary artery disease in the left 
anterior descending artery of patients with left bundle branch block. 
Introduction 
Left bundle branch block is known to be a strong predictor of 
cardiovascular mortality, especially when associated with coronary 
artery disease (1-3). However, the ability of non-invasive tests to di-
agnose coronary artery disease in these patients has been disappoint-
ing. Exercise-induced changes in the electrocardiogram are non 
diagnostic in the presence of left bundle branch block (4). Exercise 
perfusion scintigraphy has been proposed as an alternative method, 
but several studies have reported false positive anteroseptal and septal 
perfusion defects, despite an angiographically normal left anterior 
descending coronary artery (5-11). This phenomenon is thought to be 
related to asynchronous septal contraction due to the left bundle branch 
block. 
Dobutamine stress echocardiography has been widely accepted 
as a safe, sensitive and specific technique for detecting coronary artery 
disease and for identifying disease in individual coronary arteries (12-
14). Two-dimensional echocardiography is able to recognize the 
typical asynchronous septal contraction due to the left bundle branch 
block (15,16), despite which myocardial thickening is preserved in 
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the absence of coronary artery disease (17). Preliminary data (18) 
have indicated that stress echocardiography, using wall thickening 
impairment to identify coronary artery disease could be the 
investigation of choice for the non-invasive identification of coro-
nary artery disease in patients with complete left bundle branch block. 
The present study thus compared the accuracy of dobutamine stress 
two-dimensional echocardiography with that of single photon cmission 
computed tomography for the detection of left anterior descending 
coronary artery disease in paticnts with left bundle branch block, and 
further evaluated the diagnostic accuracy of dobutamine stress 
echocardiography in the other vascular territories. 
Methods 
Patiellt Populatioll. Twenty-four patients with permanent 
complete left bundle branch block were studied with dobutamine strcss 
two-dimensional echocardiography, perfusion tomography and 
coronary arteriography in our two institutions between July 1991 and 
January 1994. There were 18 men and 6 women of mean age 61 ± 9 
years (range from 31 to 75 years). Angiograms were reviewed by 
experienced observers who were unaware of the dobutamine results. 
Coronary stenosis were quantitated visually and coronary artery 
disease was defined by > 50 % luminal diameter stenosis of a major 
epicardial coronary segment. 
Patients were separated into 2 groups, according to the presence 
or absence of previous history of myocardial infarction. 
- Group I comprised 13 patients without myocardial infarction 
studicd for the diagnosis of coronary artery disease. Their pre-test 
disease probability, calculated for each patient based on age, gender, 
and symptoms (19), was 50 ± 33 %. Significant coronary artery disease 
was present in 5 patients, 2 patients had single left anterior descending 
artery disease, 2 patients had two vessel disease, and one patient had 
three vessel disease. 
- Group II comprised II patients with a previous history of 
myocardial infarction. All but one of them had significant coronary 
stenoses. Five had two vessel disease, and the remaining 5 had three 
vessel disease. 
Dobutalllillc stres.\'. The dobutamine stress test was performed 
using a standard protocol. Before starting the test, the clinical history 
was recorded, a resting electrocardiogram and cchocardiogram were 
performed, and intravenous access was secured. Dobutamine was 
infused in 3 minute dose increments of 5, 10, 20, 30, and 40 flg/kg/ 
min. In 7 patients, an additional increase of rate-pressure product was 
84 
obtained by repetitive injections of 0.25 mg of atropine, up to a maxi· 
mum dose of I mg (20). Blood pressure and a three channel ECG 
were monitored throughout the test. Endpoints were achievement of 
maximal dose, severe angina, or the development of intolerable side· 
effects, including a significant drop of systolic blood pressure, or life· 
threatening arrhythmias. The isotope was injected intravenously one 
to two minutes before completion of the stress. If severe angina 
nccessitated early termination of the test, dobutamine was continued 
at a lower dose for one minute after the isotope was injectcd. 
Pe/fllsioll Scilltigraphy. A dose of 20 mCi of technetium 99m 
methoxy isobutyl isonitrile (MIBI) was injected in21 patients. Stress 
perfusion scintigraphy was performed I to 2 hours later, and rest 
imaging was performed on another day. In 3 patients [17,19,20], 2 
mCi of Thallium·20 I was used instead of MIBI. In these patients, 
stress perfusion imaging was begun within 10 minutes after the end 
of the stress, and rest imaging was performed 4 hours later, 30 minutes 
after the reinjection of I mCi of thai I ium·20 I. Single photon emission 
computcd tomography was acquired over 180 degrees, using large 
field, single crystal cameras (General Electric 400 ACIT, or Siemens 
Orbiter) and either high resolution collimator (n = II), or low·cnergy 
all purpose collimator (n = 13). Transaxial images were obtained by 
back·projection and reconstructed into short·axis, and vertical and 
horizontal long axis views. 
Perfusion scintigrams were interpreted by the consensus of 3 ex· 
perienced observers unaware of the clinical, echocardiographic, and 
angiographic data. Vascular territories were ascribed to scintigraphic 
imaging by the conventional mcthod (21). Each short axis view was 
di vided into 6 segments. The left anterior descending coronary artcry 
territory was represented by the anterior segments and the upper and 
lower septum. The right coronary artery was assigned the inferior 
segments and the basal part or the lower septum, and the left circumflex 
artery, the posterior and lateral segments. The vertical and horizontal 
long axis views were only used to characterize the apex, which was 
assigned to the left anterior descending coronary artery. Three different 
approaches were used to identify coronary artery disease. 
· MetllOd A (collvelltiollal approach): Coronary artery disease was 
identified by any perfusion defect. . 
· Method B ("reversible" approach): Perfusion defects had to be 
at least partially reversible at rest to evoke a diagnosis of coronary 
artery disease. Fixed perfusion defects were considered as non·cliag· 
nostic. 
· Method C ("apical" approach): According to the new method 
suggested by Matzer (8), left anterior descending coronary artery dis· 
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ease was considered present only when the apex of the left ventricle 
was abnormal, irrespective of the reversible or irreversible nature of 
the defect. 
Stress echocanliograpily. Two-dimensional echocardiographic 
images were acquired in parasternal long and short axis, and apical 4 
and2 chamber views. These were recorded on tape and digitized on-
line at baseline, low and high dobutamine doses, and after the addition 
of atropine. Images were interpreted for the presence of coronary artery 
disease by the consensus of 3 experienced observers, blinded to all 
clinical, scintigraphic, and angiographic data. A normal response was 
defined by an enhancement of wall thickening with stress. Heteroge-
neity of septal contraction was not regarded as a possible marker of 
coronary artery disease. An ischemic response was identified by stress-
induced wall thickening impairment, including failure to improve wall 
thickening relative to hyperkinetic response to maximal stress. 
Infarction was characterized by failure of wall thickening associated 
with akinesis or dyskinesis at rest. 
Regional function was interpreted in 16 myocardial segments: 
septal, lateral, inferior, and anterior at the apex, and these segments 
as well as anteroseptal and posterior segments at the base and mid-
papillary muscle level. These were combined to reflect vascular terri-
tories using thc same segmentation as that employed for perfusion 
scintigraphy. Thus, the same assumptions were made about the coro-
nary artery distribution. 
Statistical allalysis. The sensitivity, specificity, accuracy, positive 
and negative predicti ve values of dobutamine stress perfusion 
tomography and echocardiography were obtained in the usual fashion. 
For each test, the left anterior descending coronary artery was 
compared with the left circumflex and/or right coronary arteries. The 
results of each test are compared using the Mc Nemar test for paired 
data. To avoid limitations due to the normal approximations rule for 
proportions (22), we used the Youden index to compare individual 
patients. The Youden Index, which is not influenced by prevalence, 
was calculated using the formula: 
Youden Index = Sensitivity + Specificity - 100. 
Continuous variables are expressed as mean ± one standard de-
viation, and compared with a paired t-test. 
Results 
Dobl/tall/ille stress respollse. During the dobutamine test, heart 
rate increased from 74 ± 14 to 129 ± 22 bpm (p < 0.001), systolic 
blood pressure increased from 133 ± 25 to 145 ± 31 mmHg (p < 
0.0 I), and the rate-pressure product from 10,157 ± 3,447 to 18,784 ± 
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4,966 bpm.mmHg (p < 0.00 I). Chest pain occurred in 9 patients (6 of 
whom had coronary artery disease), and was of sufficient severity to 
provoke premature termination of the test in4. Prediction of coronary 
artery disease based on dobulamine-induced chest pain alone gave a 
sensitivity of 37 %, a specificity of 67 %, an overall accuracy of 46 
%, and a You den Index of 4. 
Detection (~t'eoron(l/)' a rte I)' disease in the le,ti anteriur descending 
coron(/l)' artel), territO/)'. Left anterior descending coronary artery 
disease was identified in 12 patients. Septal perfusion defects were 
present in all 24 patients. Thus, using the conventional method A, 
sensitivity was 100 %, specificity was 0 %, and accuracy was 50 %. 
In 9 patients with and in I patient without left anterior descending 
artery disease, this defect was found to be at least partially reversible. 
Using thc "reversible" approach B, sensitivity was 7S %, specificity 
was 92 % (p < 0.00 I vs A), and accuracy was 83 % (p < 0.00 I vs A). 
There was an associated apical defect in II patients with and in 6 
patients without left anterior descending artery disease. Thc "apical" 
approach C gave a sensitivity of92 %, a specificity of 50 %, and an 
overall accuracy 01'71 %. 
At stress echocardiography, 10 patients with left anterior descend-
ing coronary artery had dobut<l1nine-induced wall thickening impair-
ment, while a false positive response was noted in I patient. Thus, 
sensitivity was 83 %, specificity was 92 % (p < 0.01 vs A), and 
accuracy was 87 % (p < 0.05 vs A). The positive predictive value was 
91 %, and the negative predictive value was 85 %. A comparison 
between these 4 methods is provided in figure I, and individual data 
are provided in table I. 
Detectiun o/curonary artery disease in the I~ft eirellll!flex and lor 
right corunary artery territory. Significant coronary stenoses were 
found in the left circumflex and/or right coronary artery territory in 
13 patients. Any type of perfusion defects were present in II of these, 
but also in 4 of the II patients without left circumflex and/or right 
coronary disease. Using the cOHventional approach A, scnsitivity was 
85 %, specificity was 64 %, and accuracy was 75 %. Only I of these 
tme positive, and2 of the false positive defects were partially reversible 
on the resting scan. For the "reversible" approach B, sensitivity was 8 
% (p < 0.0 I vs A), specificity was 82 %, and accuracy was 42 % (p < 
0.05 vs A). 
At dobutamine echocardiography, II patients with left circumJ'lex 
and/or right coronary artery disease had corresponding wall thicken-
ing impairment, while false positive responses were noted in 3 pa-
tients. Sensitivity was 85 % (p < 0.0 I vs B), specificity was 73 %, and 
accuracy was 79 % (p < 0.05 vs B). The positive predictive value was 
79 %, and the negative predictive value was 80 %. A comparison 
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LAO LCX/RCA 
PC MI 
An SPECT SPECT SPECT 20E An SPECT SPECT 20E 
A B C A B 
I 0 0 + 0 0 0 0 0 0 0 
2 0 0 + 0 0 0 0 0 0 0 
3 0 0 + 0 0 0 0 0 0 + 
4 0 0 + 0 0 0 0 0 0 0 
5 0 0 + 0 0 0 0 0 0 0 
6 0 0 + 0 + 0 0 0 0 0 
7 0 0 + 0 + 0 0 + 0 0 
8 0 0 + 0 0 0 0 0 0 0 
9 0 + + + + 0 0 + + 0 
10 0 + t 0 + + 0 t 0 + 
11 0 + + t + + + 0 0 0 
12 0 0 + 0 t 0 + + 0 + 
13 0 + + + + + + 0 0 + 
14 + 0 + 0 + t + + 0 + 
15 + 0 + + + + 0 + + + 
16 + t + + 0 0 + + 0 t 
17 + t t t + t + t + + 
18 + 0 t 0 t 0 + + 0 + 
19 t t + + t + + t· 0 + 
20 + t + + + + + + 0 + 
21 t + t 0 t t + t 0 + 
22 t + t 0 t + t t 0 0 
23 t t t + + + t + 0 + 
24 + + t + + + t + 0 + 
Table 1 • Individual palient data. 
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100 *** 
Sensitivily Specificily 
** 
Accuracy 
ElSPECT A 
DSPECT B 
~SPECTC 
111112D Echo 
Figure 1 - Comparision belween Tc99m-MIBI lomography, and slress 
echocardiography for Ihe localisalion of coronary arlery disease in Ihe left anlerior 
descending coronary artery. 
SPECT A, B, and C represenl Ihe Ihree scintigraphic crileria (see lexl); 2D Echo, 
slress echocardiography. 
*'*, p < 0.001; H, < 0.01; *, < 0.05 versus A. 
between the accuracy of stress echocardiography and the two 
scintigraphic approaches in the right and circumflex artery 
distributions is shown in figure 2. 
** ** 
85 85 
Sensitivity Specificily 
* 
Accuracy 
* 
OSPECTA 
OSPECTB 
112D Echo 
Figure 2 - Comparison belween Tc99m-MIBI lomography, and slress 
echo cardiography for Ihe localisalion of coronary arlery disease in Ihe left circumflex 
andlor righl coronary arlery. 
SPECT A, and B represenllhe Iwo scinligraphic criteria (see lexl); 2D Echo, slress 
echocardiography. 
**, p < 0.01; *, < 0.05 versus B. 89 
Idemit/catioll of corollary artery disease ill illdividllal patiellts. 
GI'OUp I: In the 8 patients without coronary artery disease, 
specificity was 0 % for the scintigraphic approach A, 75 % for the 
approach B, 100 % for the approach C, and 87 % for dobutamine 
echocardiography. In the 5 patients with coronary artery disease, but 
without myocardial infarction, sensitivity was 100 % for the conven-
tional scintigraphic approach A, 100 % for the "reversible" approach 
B, 60 % for the "apical" approach C, and 80 % for dobutamine 
echocardiography. Accuracy was 38 %, 84 %, 84 %, and 84 % 
respectively. The Youden indices were 0, 75, 60, and 71. 
GI'OUp II: One patient [15] with a history of previous myocardial 
infarction had no significant coronary artery stenosis and evoked false 
positive responses using all techniques. In the remaining 10 patients 
with significant coronary artery disease, all had some kind of perfusion 
defect, and it was partially reversible in at least one of the vascular 
territories in 6 of them. Sensitivity was 100 %, 60 % and 100 % for 
the scintigraphic approaches A, B, and C. All of these patients also 
showed stress-induced wall thickening impairment, giving a sensitivity 
of 100 % for dobutamine cchocardiography. 
Group I + II: When data of patients with and without history of 
previous myocardial infarction are combined, the accuracy of the 
scintigraphic approaches A, B, and C, and that of dobutamine 
echocardiography were respectively 67 %, 92 %, 75 %, and 92 %. 
The Youden indices were 0,75,62, and 81 respectively. 
Discussion 
These data confirm the lack of accuracy of conventional myocardial 
perfusion tomography for the non-invasive identification of coronary 
artery disease in patients with left bundle branch block. This is mainly 
explained by the poor specificity of pelfusion defects in the left anterior 
descending coronary artery territory. The specificity of scintigraphy 
was enhanced by restricting the diagnosis of coronary disease to those 
patients with partially reversible defects, or an associated apical defect 
to indicate left anterior descending coronary artery disease. 
Dobutamine echocardiography, using the presence of impaired wall 
thickening to define coronary artery disease, has significantly superior 
accuracy for the localization of coronary artery disease in different 
vascular territories. In individual patients however, stress 
echocardiography and the two alternative scintigraphic approaches 
had comparable accuracy. 
COllvelltiollal scilltigraphic results. False positive perfusion 
defects have been reported repeatedly in patients with left bundle 
branch block and no coronary artery disease (5-11). The present study, 
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reporting a 100 % incidence of septal defects on the post -stress scan, 
irrespective of the coronary anatomy thus confirm these previous 
observations. Various mechanisms have been proposed to explain these 
false positive myocardial perfusion defects. First, a reduction of 
myocardial blood flow within the intraventricular septum was 
observed during rapid pacing and artificial induction of left bundle 
branch blocks in dogs (6). While the underlying pathophysiology is 
controversial (23), this reduction of perfusion is thought to reflect an 
increased systolic and reduced diastolic time in the septum due to the 
conduction defect. Other causes of false positive perfusion defects 
includc partial volume effects, camera field nonuniformity, patient 
motion during imaging, 01' an incorrect definition of the long axis of 
the left ventricle. Finally, we can not exclude a possible role of 
microvascular insufficiency, myocardial cell dysfunction (24) or septal 
fibrosis (25) which have been sometimes observed in patients with 
complete left bundle branch block. 
In the present study, perfusion scintigraphy was performed using 
computed tomography. This approach is now well established as be-
ing superior to planar imaging for the detection and sizing of perfusion 
defects (26), and this superiority is mainly due to the higher image 
contrast resolution and improved definition of individual vascular 
territories afforded by tomography. The 0 % specificity found in the 
left anterior descending coronary artery territory contrasts with a few 
studies using planar imaging and reporting a lesser incidence of septal 
defects (11,27). However, recent studies using computed tomography 
have reportcd comparable results. DePuey, using exercise thallium-
201 in 10 patients without left anterior descending coronary artery 
disease reported a 90 % false positive rate in the corresponding 
vascular territory (7). This high incidence of false positive perfusion 
defects with exercise thallium-20 1 perfusion tomography was 
confirmed by Burns (9) in 70 % of patients by visual analysis, and in 
80 % by quantitative analysis; and by Matzer, who demonstrated, 
using the conventional visual approach, a 86 % false positive rate for 
left anterior descending coronary disease (8). 
Altel'llative scilltigraphic criteria. In the present study, we also 
evaluated the diagnostic accuracy of reversible perfusion defects for 
the diagnosis and localisation of coronary artery disease (Method B). 
In the left anterior descending coronary artery territory, all but one 
false positive septal perfusion defects were found to be fixed, while 3 
true positive defects were partially reversible. Accuracy thus 
significantly increased in comparison with the conventional analysis. 
However, in the left circumflex and/or right coronary artery territory, 
despite the low incidence of false positive defects, only one true 
positive perfusion defect \Vas found to be partially reversible. 
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Obviously is this related to the high proportion of patients with 
previous myocardial infarction included into this study. However, why 
this high propOltion of true positive fixed defects was not observed in 
the left anterior descending coronary artery remains elusive. 
To avoid isolated septal defects as possible source of false positive 
tests, Matzer required the apex to be abnormal to indicate left ante-
rior descending coronary artery disease (Method C). In that study, 
specificity improved from 14 % to 79 % (p < 0.001) by visual analy-
sis and from 14 % to 64 % (p < 0.01) by quantitative analysis (8). We 
tested this method in the present study and confirmed an improved 
specificity from 0 % to 50 % in the 12 patients without left anterior 
descending coronary artelY disease. Accuracy also increased from 50% 
to 71 % compared with the conventional approach. However, this 
improvement failed to reach statistical significance. 
The present results thus suggest that, in the presence of a known 
left bundle branch block, alternative scintigraphic interpretations 
should be used in the left anterior descending coronary artery terri-
tory; but that the conventional approach should still be prcferred in 
other vascular territories. 
Echocardiogmphic assessment. Septal wall motion abnormalities, 
with delayed contraction of the left side of the septum and the left 
ventricular free wall are well known in patients with left bundle branch 
block (15,16). However, myocardial thickening is supposed to remain 
normal or nearly normal in the absence of coronary artelY disease (17). 
Exercise-induced wall motion abnormalities were previously evaluated 
using gated radionuclide ventriculography in patients with permanent 
or rate-dependent left bundle branch block (28,29). These studies have 
confirmed that the ability to increase ejection fraction was impaired in 
these patients, even in the absence of coronary artery disease. 
. The present study specifically evaluated the diagnostic value of 
stress-induced wall thickening abnormalities using dobutamine 
echocardiography in patients with left bundle branch block. Using 
this criterion, both left anterior descending and left circumflex andlor 
right coronary artery disease were identified with adequate sensitiv-
ity and specificity. On a patient-based analysis, the diagnostic accu-
racy of dobutamine echocardiography was superior to that of the 
conventional scintigraphic approach: 84 % vs 38 % in patients without 
previous myocardial infarction, and 92 % vs 67 % when patients with 
previous myocardial infarction were included. However, it was 
comparable with that of the two alternative scintigraphic approaches 
(B and C). This last finding thus indicate that, despite inadequate 
localisation of coronary stenoses, patients with and without coronary 
artery disease were similarly recognised as such, either by dobutamine 
echocardiography, or by the two alternative scintigraphic approaches. 
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Use of dabulamine siress. Dobutamine stress echocardiography 
has been extensively validated as a sensitive and specific method for 
the non-invasive diagnosis and identification of coronary artery disease 
(12-14). In patients able to exercise, however, the exercise stress 
echocardiography is known to be of superior diagnostic accuracy (30). 
In the present study, we preferred dobutamine to exercise for two 
reasons: first, DePuey reported more marked septal perfusion 
abnormal ities in patients achieving very high peak heart rates (> 170 
bpm) during exercise (7), which are infrequent with dobutamine (31). 
Second, superior echocardiographic images are required to allow wall 
thickcning instead of wall Illotion assessment, and image quality is 
casier to obtain during pharmacological testing than during exercise 
assessment. This possible benefit of pharmacological stress was indeed 
already suggested by Pellika (32) for dobutamine echocardiography, 
and by Burns (10) for dipyridamole thallium-20 I perfusion 
tomography. 
Study limitaliolls. Inclusion of patients with previous myocardial 
infarction into the present study could appear as a possible study 
limitation. However, both imaging modalities were tested in the same 
patients, and the main issue of this study was not only to establish the 
diagnostic accuracy of dobutamine echocardiography, but more to 
compare it with that of perfusion tomography. The same limitations 
thus similarly affected both imaging techniques. Moreover, 
dobutamine echocardiography was similarly more accurate than 
conventional perfusion tomography for the non-invasive diagnosis 
of coronary artery disease in the 13 patients with a pretest probability 
of disease of 50 ± 33 % (Group I) and in the entire population (Group 
I + II). A second possible study limitation is the use of two different 
isotopes for the scintigraphic assessment. Thalliul11-201 is indeed sup-
posed to produce more fixed defects at 4 hour imaging due to late 
redistribution. However, only 3 of the 24 patients were studied with 
thallium-20 I and in all three cases, left anterior descending coronary 
artery perfusion defects were found to be at least partially reversible. 
Conclusions 
The present study is the first one, to our knowledge, to specifically 
evaluate the diagnostic accuracy of dobutamine stress 
echocardiography in patients with left bundle branch block, and to 
compare it with three different scintigraphic approaches. In these pa-
tients, conventional scintigraphic interpretation produces a prohibi-
tive proportion of fase positive perfusion defects in the left anterior 
descending coronary artery territory, and should be replaced by 
altcrnative approaches requiring partially reversible defects or an 
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associated apical defect to indicate left anterior descending coronary 
artery disease. With dobutamine stress two-dimensional 
echocardiography, specificity and accuracy were significantly supe-
rior to conventional myocardial perfusion tomography regarding the 
left anterior descending coronary artery disease, and equivalent 
regarding other vascular territories. Thus, dobutaminc stress two-
dimensional echocardiography, using wall thickening abnormalities 
to define ischemia, appears to be an ideal non-invasive test for the 
identification of coronary artery disease in patients with complete 
left bundle branch block. 
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CHAPTER VIII 
AKINESIS BECOMING DYSKINESES DURING HIGH 
DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY: 
A MARKER OF MYOCARDIAL ISCHEMIA OR A 
MECHANICAL PHENOMENON? * 
There is increasing evidence that dobutamine stress 
echocardiography is a potentially useful clinical tool for assessing 
the functional severity of coronary disease and myocardial viability 
(1-8). Therefore the idea has arisen that dobutamine stress 
echocardiography provides the unique opportunity to assess, with a 
single, easily repeatible, non-expensive and widely available method 
both residual ischemia and viability (5). Since that time several studies, 
incuding some from our group (9-12), confirmed a fair agreement 
between stress echocardiography with different stress modalities and 
perfusion scintigraphy for the diagnosis of myocardial ischemia. The 
specific aim of the present study was to distinguish whether the 
pathophysiological mechanism of an equivocal stress 
echocardiocardiographic finding, that of an akinetic segment at rest 
becoming dyskinetic during peak dobutamine test was due to ischemia 
or was a nonischemic mechanical event. This is a particularly 
important clinical topic because a correct identification of viable and 
jeopardized myocardium is crucial for the proper selection of coronary 
revascularization in patients with left ventricular dysfunction. To 
explore this, 20 patients with this pattern were studied with a 
simultaneous 2-stage (low and high dose) dobutamine stress echo 
and perfusion single-photon emission computed tomography (SPECT) 
imaging. 
The study group consisted of 20 patients (15 men and 5 women; 
mean age 58, range 24-80), out of 560 consecutive patients referred 
for dobutamine stress echocardiography for the diagnosis or functional 
assessment of coronary disease. All these patients had a previous old 
myocardial infarction and a regional akinesis on resting echo becoming 
clearly dyskinetic during a high dose dobutamine-atropine test. At 
'" Arnese M, Fioretti P., Cornel JI-I, Postmu-Tjoa, Reijs AEM, Roelandt JRTC. Am J Cardial 
1994; 73:896-899 
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the time of the study the patients were off beta-blockers. All patients 
were studied by simultaneous echocardiography and technetium-99m 
isonitrile (n=16) or thallium-201 SPECT (n=4) during dobutamine-
atropine infusion. 
The test was performed as previously described (3,8,12). Brietly, 
a 2 dimensional echocardiogram was recorded at baseline, llsing a 
commercially available wide-angle phased array system (Esaote 
biomedica SIM 7000 CFM or Vingmed CFM 800). The following 
views were obtained for subsequent analysis: apical four-three-two 
and five chamber views. The left ventricle was divided into 14 
segments and each segment was scored using a 4 point scale: 1= 
normal wall motion and thickening; 2= hypokinesia; 3= akinesis 
(absence of systolic wall motion and thickening); 4= dyskinesis 
(systolic outward wall motion with thinning). 
Following a previously described protocol (3), dobutamine was 
infused through an antecubital vein cannula starting at the dose of 10 
~tg/kg/minute, increasing by I 0 ~tg/kg every 3 minutes up to a 
maximum of 40 ~tglkg/minute, which was continued for 6 minutes. 
In patients without side effects, myocardial ischemia or 85% of age 
predicted maximal heart rate, atropine (up Img i.v.) was added. A 2-
dimensional echocardiogram was continuously monitored and 
recorded on videotape for the last minute of each stage and 
continuollsly after atropine administration. The images were digitized 
and displayed side by side on a quad-screen, for comparison of rest 
and stress images. To analyze wall motion, the images recorded on 
videotape were subsequently reviewed at various playback speeds as 
well. Echocardiographic images were analyzed by 2 independent 
observers, blinded to the clinical data of the indi vidual patient. 
Dobutamine stress echocardiography was considered "positive" when 
a new wall motion abnormality or a worsening of abnormal wall 
motion (inward motion and/or thickening) appcared in one or more 
segments at peak stress. 
99m-technetium isonitrile (370 MBq) or 20 [-thallium (80 MBq) 
were injected intravenously I minute before the termination of the 
stress test. Post-stress SPECT imaging were acquired one hour after 
technetium and within 10 minutes after thallium injection respectively. 
A resting technetium-99m isonitrile SPECT was repeated on a sepa-
rate day, while a 4 hour redistribution thallium imaging was repeated 
after a reinjection of 40 MBq. For each patient, six short axis slices 
and 3 vertical long axis slices were displayed and analyzed. As 
previously described (10,12), the left ventricle was divided in 47 
segments and each segment was scored with a 4 point scale (from 
[=normal up to 4= "absence" of uptake). The visual analysis was 
pelformed by two observers with the assistance of the circumpherential 
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profile analysis of the short axis slices. The apical p0l1ion was assessed 
only visually. 
Three different responses were defined: normal, "ischemia" 
(transient peli'usion defects), and "infarction" (fixed perfusion defect). 
The severity of ischemia and infarction was graded as mild, moderate 
and scvcre. 
The demographic and clinical data and also the results of 
simultancous dobutamine stress echo and perfusion SPECT imaging 
in thc 20 patients are summarized in table I. 
In all patients there was an agreemcnt between the site of the 
akinetic region on resting echocardiogram and of perfusion defects 
on the resting or redistribution SPECT images. Also the 
electrocardiographic site of the infarction was in all cases consistent 
with the imaging results. 
The dobutamine stress test was uncomplicated in all cases. The 
highest dose was 40 ~tg/kg/min in 18 patients (with atropine added in 
10 cases). The target heart rate was achieved in 10 patients. In 6 patients 
the target heart rate was not achieved despite the full dose of 
dobutamine and atropine, and in 4 the test was stopped because of I) 
hypotension (I) or 2) electrocardiographic changes (3). Chest pain 
occurred in 3 patients, ST segment depression in 4 and ST segment 
elevation in 5. 
By definition, all patients developed a worsening of the akinetic 
region (which became dyskinetic) while new wall motion 
abnormalities remote to the akinesia became apparent in 8 cases. The 
wall motion of the akinetic segment which became dyskinetic at peak 
stress did not improve at low dose dobutamine. In contrast, the wall 
motion of the control left ventricular regions improved in all cases, as 
a confirmation of the adequacy of low dose dobutamine for improving 
the contractility of normal myocardium. Myocardial scintigraphy 
showed a severe "fixed" perfusion defect in all the akinetic regions 
becoming dyskinetic at peak stress, consistent with a lack of 
scintigraphic markers of ischemia in those regions. 
Dobutamine stress echocardiography is a rapidly emerging 
noninvasive technique for asseSsing patients with coronary artery 
disease. However, more study is required for the pathophysiological 
interpretation of some specific stress echocardiographic patterns. In 
this regard, myocardial perfusion scintigraphy, performed 
simultaneously with stress echocardiography provides a unique 
opportunity for the validation of stress echocardiographic findings 
(9-12). 
The classical marker of myocardial ischemia by stress 
echocardiography is the appearance of new wall motion abnormalities 
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"" 
Age 
(yr) Side 
Patient & Sex ECG Dobutamine Atropine Max HR MaxBP Dyskinesis SPEer ChP sr Effects 
1 24F Sept 40 + 160 105/50 Apic Apic 0 1 0 
2 42F Ant 40 0 145 155/105 Sept-apic Apic 0 1 0 
3 44M Inl 40 + 148 150/80 Int Post 0 = PVCs 
4 44M Ant 40 0 150 140170 Apic Apic 0 j PVCs 
5 47M Ant 30 0 • 134 120/60 Apil; Apic + 1 0 
6 51M Ant 40 + 120 120/75 Apii~ Apic 0 = 0 
7 54M Int 40 + 118 120/80 Int Post 0 = 0 
8 57M Ant 40 + 141 120/60 Apil; Apic 0 = 0 
9 58M Ant 40 + 95 90/50 Apif; Apic 0 = vrs 
10 61M Int 40 0 90 80/60 Int Post 0 = Hypo 
11 63F In! 40 + 108 140/75 Int Post 0 = 0 I 
12 64M Inf 40 + 140 145/75 Inf Post 0 = 0 
13 65M Sept 40 0 150 110/70 Sept-apic Apic + j 0 
14 65M Ant 30 0 150 150170 Sept Sept + j 0 
15 66M Ant 40 0 138 150/80 Apic Apic 0 j AF 
16 66M Ant 40 0 133 130/70 Apic Apic 0 = 0 
17 67F Ant 40 0 120 140170 Ant Ant 0 1 0 
18 68F Int 40 + 110 170/90 Int Post 0 = VTns 
19 73M Sept 40 0 133 175/85 Apic Apic 0 1 0 
20 80M Int 40 + 135 120/60 Int Post. 0 = AF 
Ar: "" atria~ fibrillation; Ant =- anterior; Aplc "" 3pical; ehP _ chest pain during test; Dobutamine "" maxima) dObutamine dose (~g/kg/min): Dyskinesia ~ site of dyskinesia on 
echOcardlography; ECG = electrocardiographic site of Infarcti.on; Hypo = hypotension: Inf = inferior; Max BP =- blood pressure at maximal stress (mmHg); Max HR "" maximal heart 
rate (beats/min); Post::: postertor: PVCs :: premature ventriCular complexes: Sept = septum; SPEeT = Site of fixed defect on Single-photon emiSSion computed tomography; ST "" 
electrocardiographic changes; VTs = sustained ventricular tachycardia; VTns ;: .nonsusta1ned ventricular tachycardia. 
- - - - - -
Table 1 - Demographic, Electrocardiographic, Echocardiographic and SCintigraphic Results 
at peak stress while an improvement of wall motion (including wall 
thickening) of a severely hypokinetic or akinetic segment during low 
dose dobutamine is considered a marker of residual viable myocardium 
(5,6). Thereforc, the evaluation of dobutamine stress echocardiography 
in two phases, at low and high doses, allows a more complete and 
comprehellsive evaluation particularly in patients with left ventricular 
dysfunction, who represent an increasing proportion of patients in 
our daily practice. 
The interprctation of stress echocardiography for the detection of 
myocardial ischemia is easiest in patients with normal or moderate 
hypokinesia on the resting echo, but is increasingly difficult in patients 
with previous myocardial infarction and severe hypokinesia or akinesia 
at rest. The main question in these cases is if the worsening of akinesis, 
becoming dyskinesis during stress, represents myocardial ischemia 
or is mainly a mechanical phenomenon due to a systolic outward 
bulging secondary to a hyperdynamic contraction of the remaining 
myocardium. The concepts of stunned and hibernating myocardium, 
which may be viable but not contractile at rest (5,6), make this an 
important issue. 
The main finding of our study, in which we used a simultaneous 
perfusion scintigraphy as standard for comparison with stress echo, 
is that the scintigraphic equivalent of an akinetic segment becoming 
dyskinetic during peak stress, without an improvement of wall 
thickening during low-dose dobutamine is that of a severe and "fixed" 
perfusion defect, consistent with the presence of an infarcted tissue 
without significant ischemia in that territory. Ifwe accept the perfusion 
scintigraphy as an adequate "gold standard" for the diagnosis of 
myocardial ischemia, these data suggest that the assessment of 
dobutamine stress echocardiography in two stages is useful to clarify 
this stress echocardiographic pattern. 
We acknowledge that this study would be more complete if we 
had included patients in whom an improvement of wall thickening 
occurred during low dose dobutamine, to assess the frequency of stress 
induced ischemia in these patiellts:' Another potential limitation of 
the study is that the radiotracer us~d Wa~ clifferent:in different patients, 
since technitium-99m isonitril~ Ivas'tised in 16 patients and'thallium 
in 4 cases. It is very unlikely that the conclusions of the study were 
influenced by this methodological problem, since in previous studies 
little disagrcement has been found between stresslrest technetium-
99m isonitrile and thallium studies, for the detection of myocardial 
ischemia (13). ' . , 
In summary, by a combined dobutamine stress echo and perfusion 
scintigraphy we conclude that in the event of no improvement of wall 
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thickening at low-dose dobutamine, the echocardiographic pattern of 
an akinetic segment at rest becoming dyskinetic during peak stress 
does not represent myocardial ischemia and is probably related to a 
mechanical phenomenon due to a hypercontraction of the surrounding 
myocardium. 
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CHAPTER IX 
POTENTIAL AND LIMITATIONS OF Tc-99m 
SESTAMIBI SCINTIGRAP-HY FOR THE DIAGNOSIS 
OF MYOCARDIAL VIABILITY * 
Summary 
Sestamibi is a Tc labeled radiotracer particularly suitable for 
myocardial perfusion studies, providing similar information to 
thallium scintigraphy for the diagnosis of coronary artery disease, but 
having the advantage of better imaging properties due to a higher 
energy properties than thallium. This is particular relevant when 
SPECT imaging is considered. The role os sestamibi for the diagnosis 
of coronary artery disease is well accepted, while it is controversial 
for the assessment of myocardial viability. The myocardial uptake of 
sestamibi is partially passively related to the myocardial flow, but it 
also related to the metabolic cellular activity, being proportional to 
the electrochemical gradient generated at cell membrane level. 
Clinical studies reported by others and results from our own 
institution will be described both in the setting of a recent myocardial 
infarction (myocardial stunning) and of long standing left ventricular 
dysfunction (hibernating' myocardium) concordantly suggest that 
sestamibi underestimates myocardial viability, compared to the 
accepted standards of thallium (rest-redistribution or stress-reinjection 
protocols), IS-F FOG PET and also in the prediction of left ventricular 
functional recovery after revascularisation. However, the data 
available, particularly after revascularisation, are very limited. 
Furthermore, according to new promising results, the role of sestamibi 
in the setting of myocardial viability has potential for improvement, 
if the resting injection will be performed during nitrates. It is also 
foreseen that the combined use of sestamibi perfusion/wall motion 
scan (first pass and/or gated perfusion studies) and the developement 
of new softwares for attenuation correction might improve the results 
in the setting of myocardial viability. 
* Cornel JH., Arncsc M., Forster T" Postma-Tjoa, Reijs AEM, Fioretti PM, Herz 1994; 
19:19-27. 
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Introductiom 
Sestamibi is a Tc labeled myocardial perfusion agent, providing 
similar information to thallium scintigraphy for the diagnosis of 
coronary artery disease 15, but having the advantage of having better 
imaging properties than thallium, particularly when SPECT imaging 
is considered 16. The major draw-back of thalliunl for imaging are its 
low X-ray energy (68 to 80 keY) and its long physical half life (73 
hours). In contrast, the X-ray energy of sestamibi is higher (141 ke V) 
and its physical halflife shorter (6 hours). An othcrdiffcrencc betwcen 
thallium and sestamibi is the lower first pass extraction of sestamibi 
(40% vs 80%), which is compensated by the slow myocardial clearance 
of sestamibi (16,32). This last property allows the decoupling between 
the injection of the tracer and imaging, which can be advantageous in 
several clinical conditions, like acute myocardial infarction or unstable 
angina. 
While use of sestamibi for myocardial perfusion is well accepted, its 
role for assessing myocardial viability is still controversial (3,7, 16). 
Properties of sestamibi and experimental results, 
Sestamibi is a positively charged technetium complcx, surrounded 
by 6 isonitrile groups (16). Its tissue uptake is parallel to myocardial 
flow, with the exception of high flows, at which thallium uptake is 
better (21, 30). However, the uptake of sestamibi at cellular level is 
also proportional to the electrochemical gradient generated at cell 
membrane level (26). Therefore, the uptake myocardial uptake of 
sestamibi, being dependant on coronary flow and cell membrane 
integrity (IS) reflects myocardial perfusion and also, in some way 
myocardial viability. 
On the basis of these experiments, it seems expcctable that 
sestamibi would be comparable to thallium for the detection of viable, 
stunned myocardium, in which the myocardial perfusion has been 
restored after the ischemic episode. In contrast, thallium, due to its 
properties of redistributing seems more suitable than sestamibi in the 
setting of hibernating myocardium, due to the chronic low-flow (3). 
In this condition, a resting sestamibi scan are expected to show a 
perfusion defect, possibly undercstimating the presence of viable 
myocardium. However, we should remember that it is very likely that 
in the clinical setting stunned and hibernating myocardium coexist 
and constitute a dynamic condition. Therefore a distinction between 
stunning and hibernating is more theoretical than real in the patients 
that we daily deal with. 
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Clinical applications of sestamibi for the study of viability in 
patients with acute or recent myocardial infarction. 
Due to its unique physical properties, sestamibi allows an 
uncoupling between the injection of the tracer and imaging, allowing 
to acquire the images up to a few hours after the injection which still 
will reasonably reflect the perfusion conditions at the moment of the 
injection. This has been shown to be particularly interesting in the 
setting of patients with evolving infarction, in which serial resting 
perfusion studies have been done in the acute phase, before 
thrombolysis, and a few days later (12,28,34). In this way, measuring 
the recovery of perfusion, some information on the extent of 
myocardial salvage could be obtained. Importantly, it has been shown 
that this approach has the potential to assess not only the initial risk 
zone, but also the success of reperfusion, in terms of recanalisation 
(34) and the spontaneous recovery of left ventricular regional wall 
motion at one month after the acute phase (28). These data strongly 
indicate that sestamibi does not simply provide information on 
myocardial perfusion, but also on myocardial viability. 
In line with these observations, Gibbons and co (13) have used 
sestamibi for assessing myocardial salvage in a trial comparing im-
mediate primary angioplasty with the administration of an intravenous 
thrombolyic agent followed by a conservative approach. Although 
sestamibi SPECT imaging during the first few days after acute 
myocardial infarction is a very attractive method, it has been suggested 
that it may be a not ideal one for assessing myocardial viability in this 
setting, since a considerable amount of hibernating myocardium can 
be present at hospital discharge and sestamibi has been shown to 
underestimates the extent of hibernating myocardium (27). 
Also, the optimal timing for assessing myocardial perfusion andl 
or viability after a recent infarction is not settled. Pellikka an co (23) 
have demonstrated in 25 consecutive patients treated with 
thrombolysis that there is a sustained improvement ofsestamibi uptake 
by an additional 10% from 18-48 hours to 6-14 days after the acute 
phase. An example of a spontaneous improvement of sestamibi uptake 
from the second to the 21 th day after an acute myocardial infarction 
treated with thrombolysis who came to our observation, is reported 
in figure 1. This example shows how myocardial "viability" could be 
underestimated if the perfusion study is performed "early" after the 
acute event. 
More recently, still unpublished data by Marcassa and co (17) , 
based on a study in 52 patients, show that the uptake of sestamibi 
may spontaneously improve even in a later stage, from 6 weeks to 6 
104 
\ 
Figure 1a 
Figure 1 b - (apical shari axis, day 2) 
Figure 1 c - (Apical short axis, day 21) 
Figure 1 a to 1 c - Spontaneous improvement of sestamibi uptake from the early (two 
days) to a later (21 days) stage after an acute anterior infarction treated with thrombolysis. 
In a) the serial changes in apical short axis and vertical long axis slices are shown. It is 
obvious that a spontaneous substantial improvement of myocardial perfusion took place 
in the infarcted area (anterolatera!).ln b) and c) the same short axis slices are depicted, 
combined whit the correspondent circumpherential prolile analysis, showing a decrease 
of the area below the normal limits (from 1560 to 629 units), consistent with the reduction 
of the 'perfusion defect on visual assessment. 
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months after an acute myocardial infarction. This study, in which 
quantitative analysis was applied, found an improvement of the extent 
of sestamibi uptake by 21 % on average during this time span. This 
improvement was accompanied by a parallel improvement of left 
ventricular ejection fraction. 
As far as we are aware of, there arc no head to head comparisons 
between sestamibi and thallium scintigraphy in patients with recent 
myocardial infarction for assessing residual viability. Therefore, we 
extended our previous observations in 21 consecutive patients with a 
recent (7 -10 days) Q-myocardial infarction (9) who were studied with 
sequential resting SPECT sestamibi and rest-4 hour redistribution 201-
Thallium SPECT. Eleven patients had an anterior infarction. The aim 
of this study was to compare the extent and the severity of the perfusion 
defect with the 2 different tracers. Our hypothesis was that, if thallium 
uptake reflected myocardial viability better more sestamibi, the 
thallium defects would be smaller compared to the sestamibi defects. 
We performed a quantitative assessment of the perfusion defects 
by circumferential profile analysis of 6 standardized short axis slices, 
compared to the results in normal subjects. The profiles were defined 
within the automatically detected endo and epicardial boundaries. The 
normal limits were separately defined for sestamibi and thallium as 
within 2 standard deviations of the mean values of normal subjects. 
The perfusion defects were calculated by summing the areas in the 6 
short axis slices which were below the lower limit of the normal 
subjects. 
The results, summarized in table I and in figures I ad 2 e 3, indi-
cate that indeed the severity of sestamibi defect was systematically 
larger compared to that of thallium, independent of the location of 
the infarction. This suggest that the thallium is a more proper tracer 
for viability in the setting of recent myocardial infarction, while 
sestamibi is more related to myocardial perfusion and underestimates 
viability. 
Sestamibi at rest 
Thallium rest, post-injection 
Thallium, four hour redistribution 
2977 ± 1904* 
1896 ± 1169 
1820 ± 1211 
Table 1 - Severity of perfusion defects (unitless, mean ± SO) of sestamibi and resting 
Thallium (posHnJection and four hour redistribution) SPECT in 21 patients with a recent 
Q·myocardial infarction. 
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Figure 2 - Scalier diagram comparing the quantitative anatysis of the perfusion defect 
from (rest)-four-hour redistribution thallium and resting sestamibi SPECT imaging in 21 
patients with a recent myocardial infarction. The dolled line is the regression line and 
the continuous line is the identity line. Although there is a reasonable correlation between 
the two methods, the sestamibi deiect was systematically larger than the thallium defect. 
Figure 3a 
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Figure 3b 
Figure 3a and 3b - Matched apical short-axis slices of thallium rest-four-hour 
redistribution SPECT (a) and sestamibi SPECT (b) in a patient with a recent (ten days) 
large anterior infarction. As by visual assessment, and by analysis of the circumferential 
profiles, the smallest perfusion defect was observed on Ihe delayed Ihallium imaging, 
while the largesl was presenl on seslamibi imaging. 
Clinical applications of sestamibi for assessing myocardial 
viability in patients with coronary artery disease and chronic left 
ventricular dysfullction. 
Some recent studies have been addressed recently in a direct or 
indirect way to assess the merit of sestamibi in the selling of chronic 
left ventricular dysfunction, where a correct identification of the 
distribution of scarred, stunned and hibernating myocardium may be 
crucial for a proper indication to revascularization procedures. 
There are 2 kind of data available: the first are comparative studies 
between sestamibi and other "standard" viability tracers, like thallium 
(5, 8, 33) or F-IS FDG PET (1,2,) the second kind is that of studies 
using the improvement of left ventricular wall motion after 
revascularization as a standard for viability (IS, 19,20). 
Comparison between sestalllibi and thalliulII. The 2 tracers have 
been compared by different authors using different protocols and all 
studies have very similar conclusions, that sestamibi overestimates 
necrosis compared to thallium. 
Cuocolo and co (5) compared exercise-redistribution-reinjection 
thallium with exercise-rest sestamibi (2 day protocol) planar imaging 
in 20 patients with proven coronary disease and left ventricular 
dysfunction (average ejection fraction of 30%). These authors found 
122 regions with irreversible thallium defects at redistribution. 57/ 
122 of these regions (47%) had a filling-in after thallium reinjection. 
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In contrast, only 22/122 regions had a reversible defect on exercise-
rest sestamibi. 
Dondi and co (8) and Taylor and co (33) compared exercise-rest 
sestamibi SPECT with rest-redistribution thallium (3) hour (8) and 
(24) hour (33) in patients with left ventricular dysfunction, and they 
also found a greater incidence of reversible thallium defects with 
thallium compared to stress-rest sestamibi. In particular, Taylor and 
co (33) found that in 167 sestamibi severe fixed defects, 87(57%) 
showed a late (24 hour) thallium redistribution, suggesting the presence 
of viable myocardium undetected by sestamibi. 
In order to compare the size of the perfusion defect with thallium 
and sestamibi, we have recently studied 26 patients with chronic left 
ventricular dysfunction with sequential high dose dobutamine (up to 
40 ~lg/kg/min)-reinjection thallium (10) and resting sestamibi SPECT 
imaging (unpublished data). The SPECT imaging were quantitatively 
analyzed, as described in the previous section of the present article. 
Similarly to the comparative study in patients with a recent infarction, 
the resting sestamibi defects were significantly larger than the thallium 
reinjection defects (3777 ± 1599 vs 2541 ± 1,274, p<0.05) (figure 4). 
This reinforces the concept that resting sestanlibi may underestimate 
the extent of residual myocardial viabil ity. 
8000 III 
6000 l1li l1li .' 
~ III ~ III •• 
ro 
iii III ~. ~ 4000 III 
l1li.' 
2000 III n = 26 
iii 
0 
0 2000 4000 6000 8000 
TI (dobutaminel-reinjection 
Figure 4 - Scatter diagram for comparison between the severily of perfusion defect 
from resling sestamibi and (dobulamine)-reinjeclion Ihallium SPEeT in 26 palienls with 
an old myocardial infarction. The continuous line represents the identily line and the 
dotted line the regression line. The data show a reasonable correlalion between the two 
melhods, wilh a systematic overestimation of the perfusion defect by seslamibi. 
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Different protocols have been nsed in the previous studies for 
comparison, however it has been recently been demonstrated that only 
trivial differences for assessing viability are present between stress-
redistribution-reinjection and rest-redistribution thallium protocols (6). 
Therefore it likely that the concordant results of all the different studies 
are consistent with similar conclusions. 
Comparisoll betweell JS-F FDG PET alld sestamibi. Recently 
Altehoefer and co published a study comparing resting sestamibi 
SPECT with 18-F FDG PET for assessing viability in 46 patients 
with chronic coronary artery disease and regional wall motion 
abnormalities (I), and recently extended his observations to a larger 
group of III patients (2). The important findings of these authors 
(figure 5) is that in a substantial proportion of patients with a "seve-
re" (> 50%) sestamibi uptake defect there was an FDG uptake, marker, 
of the presence of viability. It is concluded by the authors that FDG 
uptake provides additional informations potentially useful for clinical 
decisions in patients with severe sestamibi uptake defects who are 
considered for revascularization procedures. 
These data are in agreement with the comparative data with 
thallium previously discussed. 
100 o PET viable o PET non-viable 
,--
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a 
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-
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< 30 31 - 40 41 - 50 51 - 60 61 -70 > 70 
MI81 uptake 1%1 
Figure 5" Results of the comparison between resting sestamibi and 18-F FDG PET in 
111 patients with chronic coronary artery disease and wall motion abnormalities at 
rest, from Allehoefer et al. [21. From the data it clearly appears that the sestamibi uptake 
underestimates the extent of viable myocardium (especially between 31 and 70% of 
sestamibi uptake defects), when 18-F FDG PET is considered the "golden standard". 
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COlllparisOIl betweell stress echocardiography alld sestalllibi. 
Stress echocardiography is emerging as a new, potentially useful tool 
for assessing myocardial viability, particularly in the setting of stunned 
myocardium in patients with recent myocardial infarction (22, 24, 
25, 29). However, few data on the value of stress echo are available 
in hibernating myocardium (4) or comparing stress echo to sestamibi 
(18). 
Therefore, we found of interest to briefly describe our comparati-
ve results (unpublished data) for assessing myocardial viability 
between simultaneous high-dose dobutamine-rest sestamibi SPECT 
and low-dose dobutamine echocardiography in 83 consecutive patients 
with an old myocardial infarction. 
The criteria for assessing echo viability in dyssynergic regions 
was an improvement of wall thickening, by visual inspection, during 
the infusion of a low-dose dobutamine (5 or, if no change was 
observed, 10 ~tg/kg/min during steps of 3 minutes). The criteria for 
defining sestamibi viability were the presence of a normal perfusion, 
of a (partially)transient or fixed but moderate defect during high-dose 
dobutamine (up to 40 ~tg/kg/min)-rest sestamibi SPECT imaging. The 
severity of the defects were assessed visually and with the assistence 
of a circumferential profiles analysis of the short axis slices. The 
agreement between echo and sestamibi viability was assessed in six 
matched left ventricular regions. 
The results on the agreement between echo and sestamibi are 
reported in table 2 and in figure 6. As we can see the agreement was 
on average poor, since sestamibi detected more frequently regions 
with viable tissue compared with low-dose dobutamine echo. The 
discrepancy was greatest in the 68 akinetic regions, of which 37 (54%) 
were sestamibi viable but only 13 (19%) were echo viable. Since we 
do not have the results on wall motion changes after revascularization 
in these patients, it is impossible to say which is the clinical relevance 
of these results. However these data would suggest that low-dose 
dobutamine echo underestimates the presence of hibernating 
myocardium. Clearly, more research is needed at this regard, since 
the data available so far arc not sufficient being based on very small 
series of patients (4). 
SII/dies with sestalllibi before alld after CO/'OlIaJ)' reva.l'cu{arizatioll. 
The number of studies to assess the value of sestamibi to predict the 
improvement of regional wall motion after revascualrization is very 
limited (18, 19, 20, 29). The results of the studies using resting 
sestamibi (18, 19, 20) indicate, although in small number of patients, 
that sestamibi has a relatively poor predictive value. In particular, 
Maublant and co (20) have observed that in 9 segments with a severe 
sestamibi defect wall motion improved after revascularization in (8). 
I II 
Echo No of LV 
segmets 
Normal WM 328 
Hypokinesis + 73 
Akinesis + 13 
Hypokinesis - 29 
Akinesis - 55 
MIBI 
viable 
325 
67 
10 
24 
27 
MlBI 
non viable 
,3 : 
6 
3 
5 ~ 
28 
+ = improvement of wall thickening during lOW-dose uobutaminc; 
- = no improvement of wall thickening during low-Jose dobutamine; 
WM :::: wall mol ion. 
Table 2 - Regional agreement for viabilily belween seslamibi (high dose dobulamine-
resl) and lOW-dose echocardiography, in 83 patienls (six regions for each palienl) wilh 
myocardial infarction. 1-,.,. 
, 
Figure 6 - Two by Iwo table comparing Ihe 
agreement between echo and sestamibi 
viability in dyssynergic (hypo or akinetic) 
regions on resting echocardiogram. The 
kappa value of 0.29 indicates a significant 
disagreemenl belween Ihe two methods. In 
parlicular, il appears Ihat seslamibi detected 
more viable regions tham low-dose 
dobutamine echo. 
Echo viability 
+ 
MISI {~J[J 
viability I::-l~. 
-LJL.J 
Agreement 65% 
kappa 0 0.29 
Marzullo and co (18, 19) studied 14 patients before and II weeks 
after PTCA with resting sestHmibi, rest-redistribution thallium and 
low-dose dobutaminc. These authors also found that ther was a trend 
indicating that sestamibi had lower sensitivity and specificity 
compared to delayed thallium imaging. 
In contrast, encouraging results for sestamibi in the same setting 
(before and after revascularization) were found if the resting injection 
of sestamibi was performed during the infusion of nitrates (29). In 
this way, in a study based on 20 patients, the results of sestamibi were 
comparable to those of rest -redistrihution thallium. This approach, is 
particularly interesting and consistent with previous work by Galli 
and co with sestamibi (11) and by Zuo-Xiang and co (35) with thallium 
reinjection SPECT. 
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Conclusion 
99m Tc sestamibi is a very valuable myocardial tracer for perfusion 
studies, but from the data so far available it seems less suitable than 
thallium for assessing myocardial viability, since it tends to 
overestimate the extent of myocardial necrosis and/or fibrosis. 
However, also because of its superior imaging properties, the value 
of sestamibi for myocardial viability should be further investigated. 
The potential improvements could be achieved in different ways: with 
the systematic administration of nitrates before the resting injection, 
repeating a delayed imaging (a small delayed redistribution has been 
described (32), combining perfusion and wall motion studies (first 
pass and/or gated imaging). Finally, the new methods for attenuation 
conection with transmission scan 14 will certainly reduce the artifacts, 
particularly the the false perfusion defects in the left ventricular 
posterior wall. 
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CHAPTER X 
PREDICTION OF IMPROVEMENT OF REGIONAL 
LEFT VENTRICULAR FUNCTION AFTER 
SURGICAL REVASCULARIZATlON: A COMPARI· 
SON OF LOW-DOSE DOBUTAMINE ECHOCARDIO-
GRAPHY WITH 201-TL SPECT* 
Abstract 
Backgroulld. Although both Thallium-20 I (TL) scintigraphy and 
low-dose dobutamine echocardiography (LODE) have been proposed 
as cffective methods for the assessmcnt of myocardial viability, their 
relative efficacies arc unknown. The aim of the present study was to 
compare the two imaging techniques in the prediction of improvement 
of regional left ventricular function after surgical revascularization. 
Methods. Thirty-eight patients with severe chronic left ventricular 
(LV) dysfunction (ejection fraction less than or equal to 40%, one or 
more akinetic (Ak) or severely hypokinetic (SH) segment on resting 
eehocardiogram) who underwent uncomplicated coronary artery 
bypass surgery were studied with simultaneous dobutamine stress 
echoeardiography and post-stress reinjection TL single photon 
emission computcd tomography (SPECT) before surgery. The Ak or 
SH segmcnts were considered viable by LODE when wall thickening 
improved during the infusion of 1 0 ~lg/kg/min of dobutamine. 
Scintigraphic definition of viability was the presence of normal TL 
uptake, totally reversible defcct, partially reversible defect or 
moderately severe fixed defect. The postoperative improvement of 
dyssynergic segments was determined by a rest echocardiogram three 
months after surgery. 
Results. Out of 608 left ventricular segments, 169 were classified 
as Ak and 51 as SH on resting preoperative echocardiogral1l. Of these, 
170 were successfully revascularized. Wall motion during LODE 
improved in 33 severely dyssynergic segments and was more frequent 
in SH than in Ak segments (19/44 vs 14/126, p < 0.0001). Viability 
. Arnesc ivl, Cornel JH, Salustri A, Manl APWM, Elhcndy A, Reijs AEi'vl, Ten Cale Fl, 
KC<llle D, Balk AHtvUvl, JRTC Roclandt, Fioretti P~\'f. Circulation 1995;91:2748-2752. 
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was detected by TL SPECTcriteria in 103 SH or Ak segments. Thirty-
two out of the 33 segments LODE responder were judged viable on 
TL SPECT, while TL viability was detected also in 71/137 segments 
LODE non responders. The sensitivity and the specificity for the 
prediction of postoperative improvement of segmental walimotion 
were 74% (95% c.l. 67%-81 %) and 95% (92%-98%) by LODE, 89% 
(84%-94%) and48% (40%-56%) by TL SPECT respectively. Positive 
predictiw value of LODE was higher than that of TL SPECT (85%, 
c.r. 80%-90%, vs 33%, c.r. 26%-40%). 
Thirty-six patients had angina before and only one had angina 
three months after revascularization. High-dose dobutamine 
echocardiography demonstrated significant reduction of stress induced 
ischemia (new of worsening of pre-existing walimotion abnormali-
ties) after surgery (from 163 to 23 left ventricular segments). 
COllelusiolls. In patients with severe chronic LV dysfunction, 
LODE is a good predictor of the improvement of dyssynergic seg-
ments after revascularization. Because TL SPECT overestimates the 
probability of postoperative improvement of dyssynergic segments, 
LODE should be the preferred imaging technique for pre-operative 
assessment of these patients. 
Introduction 
Coronary artery bypass grafting can improve regional and global 
ventricular performance and the functional status of patients with 
chronic left ventricular dysfunction (I). The concepts of stunned and 
hibernating myocardium have been advocated to explain such 
improvement (2,3). Reliable pre-operative prediction of patients in 
whom regional and/or global left ventricular dysfunction wili improve 
after revascularization would present several clinical advantages. 
These potential advantages would include a) the appropriate referral 
for cardiac surgery of patients who are currently considered to be 
unsuitable for revascularization, b) the referral of patients for 
revascularization who would at present only be considered for car-
diac transplantation, and c) the avoidance of cardiac surgery in pa-
tients in whom revascularization would result in no functional ben-
efit (but would only carry significant risk of perioperative morbidity 
and mortality). 
Both TL SPECT (2-5) and, more recently, low-dose dobutamine 
echocardiography (LODE) have been proposed as effective techniques 
for the evaluation of myocardial viability (6-11). While LODE is more 
widely available, it is unknown whether its efficacy and reliability 
equals that of TL SPECT which is more established in this role (2-5). 
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To determine the relative merits of the two imaging techniques, 
we compared TL SPECT and LDDE in the prediction of functional 
recovery in 38 patients with left ventricular dysfunction undergoing 
coronary artery bypass surgery. Post-operati ve resting 
echocardiography at three months was used to determine left ven-
tricular improvement. 
Methods 
Stlldy jJojJlllatioll. Fourty-three patients with stable left ventricular 
dysfunction undergoing coronary artery bypass surgery fulfilled the 
study inclusion criteria: 
- ejection fraction of £ 40% on contrast ventriculography; 
- history of previous (> 3 months old) myocardial infarction; 
- one or more akinetic (Ak) or severely hypokinetic (SH) segments 
on pre-operative resting echocardiography (16-segment left ventricular 
model); 
- absence of recent episodes of unstable angina; 
- absence of significant (> 50%) left main stem stenosis; 
- absence of (hemodynamically) significant valvular disease. 
Five patients were withdrawn from the study on account of peri-
operative myocardial infarction (3 patients), resection of all 
dyssynergic segments (I patient), inability to graft any of the Ak of 
SH segments (I patient). Thirty-eight patients were finally included 
in the study. The mean age of the patients was 59 years (range 36-73) 
and 26 were male. All patients were symptomatic, 36 had angina 
pectoris and 20 had dyspnea on effort. Mean angiographic left 
ventricular ejection fraction was 31 % (range 18-40%). Single vessel 
disease, defined as diameter stenosis of a major coronary artery> 
50%, was present in three patients, 16 patients had two vessel dis-
ease, and 19 patients had three-vessel disease. Four patients had 
undergone previous coronmy artelY bypass surgely. Four patients were 
on beta-blockers during the preoperative diagnostic work-up. 
Doblltalllille stress echocardiograpily. The dobutamine stress test 
was performed as follows. A two-dimensional transthoracic 
echocardiogram in standard views and a 12-lead electrocardiogram 
(ECG) were recorded at rest. Dobutamine was infused through an 
antecubital vein at doses of 5 and 10 Ilg/kg/min, for 3 minutes at each 
dose. Subsequently, other 3 steps from 20 to 40 ftg/Kg/min (3 minutes 
each) were added. Finally, atropine (up to I mg) was injected in the 
negative cases where 85% of the maximal heart rate rate was not 
reached (12). Echocardiogram was monitored during the test, and the 
last minute of each stage was recorded on video tape. The 
echocardiographic images were also digitized (on optical disk -
liS 
Vingmed CFM 800, or on floppy disk - Esaote Biomedica SIM 7000) 
and displayed side by side in quad-screen format to facilitate the 
comparison of rest and dobutamine images with subsequent post-
operative images. A 3-lead ECG was monitored continuously and a 
12-lead ECG was recorded every minute. Blood pressure was 
mcasured by sphygmomanometer at each 3 minute stage. 
Posl-opemlive echocardiogmpily. To assess the functional 
outcome of the dyssynergic segments, resting two-dimensional 
echocardiograms were obtained in all patients 3 months after cardiac 
surgery. In addition, high-dose dobutamine/atropine stress 
echocardiography was obtained in 32 patients. 
Allalysis of pre- alld posl-opemlive eciloc({l'diograllls. The 
interpretation of echocardiograms was performed by two experienced 
observers, blinded to the clinical, angiographic and previous 
echocardiographie results of the individual patients. In a subset of II 
patients (176 segments) the inter- and intra-observer variability of 
the classification of resting wall motion and the response to LODE 
was assessed as well. The assessment was based on both the digitized 
images displayed in a quad-screen format and by reviewing the images 
recorded on the video tape. The assessment was semi-quantitative, 
and a 16-segment model (13) was used. The wall motion, including 
wall thickening, of every segment was scored with a 5-point scoring 
system, where I =normal wall motion and thickening, 2=moderately 
hypokinetic, 3=severely kypokinetic, 4=akinetic, and 5=dyskinetic. 
We defined a segment as severely hypokinetic in the presence of 
minimal wall thickening with a limited inward motion of < 2 mm; as 
akinetic in the absence of systolic wall motion and thickening and 
also, whenever possible, confirmed by M-mode tracing; as dyskinetic 
in the presence of systolic outward wall motion with thinning. 
Wall thickening was primarily utilized for the classification of 
wall motion, preventing the problem of post-operative paradoxical 
septal motion. Additionally, in order to reduce the confounding effect 
of tethering from adjacent segments, segmental wall thickening was 
analyscd frame by frame during the first half of systole. Myocardial 
viability was judged to be present in a dyssynergic (either Ak or SH) 
segment when wall motion improved during the infusion of low-dose 
dobutamine by at least one point of the scoring system. Thus, a severe 
hypokinesis becoming moderately hypokinetic or systolic myocardial 
thickening becoming apparent in a previously akinetic segment were 
considered as markers of viability. Myocardial ischemia was judged 
to be present in case of worsening~ I of the segmental score. Akinetic 
and dyskinetic segments were not evaluated for this purpose. 
Follow-up echocarciiograms were compared with the 
corresponding pre-operative resting images. For each segment, 
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improvement of function was defined as a decrease of one or more 
grades. Moreover, we utilized the pre- and post- operative wall motion 
score index (WMSI) to evaluate the effect of revascularization on 
global LV function. WMSI was defined as the sum of the degrees of 
each segment divided by the total number of segments analysed. 
71wllilllll SPEer illlaging: Briefly, as previously described (14-
16) TL (2mCi) was injected intravenously I minute before the 
termination of the infusion of high-dose dobutamine (up to 40 mcg/ 
kg/min, with the addition of atropine if there were no signs of ischemia 
and if the 85% of the maximal heart rate was not reached). The 
acquisition of the post-stress SPECT imaging was started within 10 
minutes after the interruption of the dobutamine infusion. All images 
were acquired by a Siemens Gammasonics single-head Rota Camera 
(Orbiter; Siemens Corp., Iselin, N.J.) and a low energy, all purpose 
collimator. Thirty-two projections were obtained, from left posterior 
oblique to right anterior oblique, with an acquisition time of 45 seconds 
for each projection. A Gamma II computer system was used to process 
the tomographic data. Four hours after the stress imaging, a second 
acquisition was performed 20 minutes following the reinjection of I 
mCi ofTL. 
As previously described (15,16), the interpretation of the images 
was based on 6 short axis slices, 3 longitudinal and 3 transverse long 
axis slices (both stress and post-reinjection). The analysis was 
performed visually with the assistance of quantitative measurement 
(circumferential profiles). The same 16-segment model used for in-
terpretation of the echocardiograms was applied for the interpreta-
tion of the SPECT images. Scintigraphic images from the short axis 
and the long axis views were matched with the echocardiographic 
images. Each defect was classified as fixed, partially reversible, or 
totally reversible. A myocardial segment was considered as non-vi-
able in the presence of a severe irreversible defect. A defect was clas-
sified as severe if the TL uptake of a segment was less than 50% of 
the uptake of the "normal" segments on the quantitative circumferen-
tial profile analysis and if it was consistent with a severe visually 
assessed defect. Scintigraphic definition of viability was based on the 
presence of normal TL uptake, totally reversible defect, partially 
reversible defect, or moderately severe fixed defect. 
Statistical analysis. Continuous data are expressed as mean ± 
standard deviation. Univariate analysis for categorial variables was 
pelformed using the chi-square test with Yate's correction. Differences 
were considered significant if the null hypothesis could be rejected at 
the 0.05 probability level. Sensitivity, specificity and positive and 
negative predictive values were based upon their standard definitions 
and are reported with the corresponding 95% confidence intervals 
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(c'l.). The inter- and intra-observer variability of regional wall motion 
pattern was assessed as % agreement and kappa value. 
Results 
Pre-operative data. Out of a total number of 608 left ventricular 
segments, 169 were classified as Ak and 51 as SH. Fourty-three Ak 
segments were excluded from the postoperative evaluation on account 
of aneurysmectomy (n=41), or because they were not grafted (n=2). 
Out of the 51 SH segments, 7 were excluded from the post-operative 
evaluation on account of aneurysmectomy (n=3) or because they were 
not graftable (n=4). 
Low-Dose Dobutallline EchocanliographY. Only 14 out of the 
126 Ak segments which could be successfully rcvascularized, showed 
the presence of wall thickening during low-dose dobutamine on 
preoperative echocardiogram. These 14 Ak segments were detected 
in 8 patients. 
Wall thickening improved during the infusion of dobutamine in 
19 of the 44 SH segments. These 19 segments were present in 9 pa-
tients. Thus, viability was detected more frequently in severely 
hypokinetic than in akinetic segments (p<O.OOO I). 
The inter- and intra-observer concordance of resting wall motion 
analysis were 84% (kappa 0.79) and 87% (kappa 0.82) respectively. 
The inter- and the intra-observer concordance of the response of wall 
motion during LDDE were excellent as well by 92% (kappa 0.84) 
and 94% (kappa 0.86) respectively. 
High-dose dobutallline echocardiography. At peak stress, new or 
worsening of pre-existing wall motion abnormalities were detected 
in 163 out of 576 segments, in 32 out of the 36 patients. Angina during 
the test occurred in 28 patients. 
ThalliulII SPEeT. TL SPECT imaging indicated the presence of 
viable myocardium in 49!112 Ak regions not responding and in 141 
14 Ak regions responding to dobutamine, in 22125 SH regions not 
responding and in 18/19 SH regions responding to dobutamine (Table 
I). From these data it is clear that TL SPECT indicates viable 
myocardium more frequently than LDDE (p<O.OO I). Figure I displays 
the distribution of perfusion patterns by TL SPECT according to the 
different LDDE results. 
Postoperative clinical and echocardiographic data. At 3 months 
post-operatively, only one patient had angina and 10 patients still 
complained of dyspnea on effort. 
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LODE patterns Thallium viability Postoperative 
improvement 
Ak - 112 49 g' 
Ak + 14 14 13 
SH - 25 22 1 
SH + 19 18 15 
Abbreviations: Ak: akinetic segments; LODE low-dose dobutamine 
echocardiography; SH: severely hypokinetic segments; + /- = improvement/no 
improvement of wall motion during low-dose dobutamine infusion. 
Table 1 - Relationship between preoperative dobutamine echocardio9raphic results, 
viability on thallium SPECT and postoperative outcome of wall motion in severely 
dyssynergic segments. 
IlIIprovelllel// of regiol/o/lVal/lllo/iol/. Resting echocardiograms 
at three months post-operative follow-up revealed an improvement 
of wall motion in 38 (22%) of the 170 dyssynergic segments, The 
improvement was found in 22 (17%) out of the 126 Ak segments (to 
SH in 6 segments, to moderate hypokinesis in 13 segments, to normal 
in 3 segments) and in 16 (36%) out of the 44 SH segments (to normal 
in 8 segments, and to moderate hypokinesis in 8 segments) (p=O.02). 
Reduction of dobutamine induced myocardial ischemia. 
Out of 32 patients who underwent a high dose dobutamine stress 
test during follow-up, three had angina at peak stress. New or wors-
ened wall motion abnormalities lVere detected in 10 patients, and in 
23 out of 512 left ventricular segments. 
Predic/iol/ o.f regiol/a/ illlprovelllel/t. Post-operative improvement 
occurred in 28 of the 33 segments which improved during LDDE and 
in only 10 of 137 segments which did not improve (Table I). Of the 
segrnentsjudged to be viable by LDDE, a postoperative improvement 
occurred in 79% of SH and in 93% of Ak segments. 
Thallium-20 I SPECT detected the presence of viable myocardium 
in 32 of the 33 matched segments considered viable by LDDE. De-
spite the frequent indication of viability by TL SPECT in the Ak seg-
ments unresponsive to dobutamine (44%), improvement after sur-
gery was found in only 8% of these segments. Similarly, wall thick-
ening improved after revascularization in only I of the 25 SH regions 
unresponsive to dobutamine, despite signs of viability by TL SPECT 
in 22 of these 25 segments. Table II shows the predictive accury with 
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Figure 1 -Distribution 01 dobutamineiatropine·reinjection thallium·201 SPEeT pertusion 
patterns in 4 predefined lOW-dose dobutamine echocardiographic patterns. 
Abbreviations: Ak = akinetic segment; SH = severel hypokinetic segment;· = non·viabte; 
+ = viable; fixed = fixed perfusion delect; reversible = reversible perfusion delect. 
95% confidence intervals of the two methods for the post-operative 
improvement of SH and of AK segments. 
Globall~li ventricular/unction. The WMSI revealed that there 
were no significant differences before and after coronary artery bypass 
surgery, neither in the subset in whom myocardial viability was 
predicted by LDDE (13 patients) (2.6 ± 0.5 vs 2.4 ± 0.4) nor in the 
entire study population (2.3 ± 0.5 vs 2.3 ± 0.5). 
Coronary angiography. A routine coronary angiogram 
independent of the recurrence of symtollls was undertaken in 14 
patients at 3 months follow-up. Sustained patency of the grafts to the 
Ak or SH segments was demonstrated in all of these patients. 
DisclIssion 
The functional assessment of hibernating myocardium and the pres-
ence of viability is clinically challenging (3) and of paramount impor-
tance for the selection of the 1110st appropriate treatment for individual 
patients with chronic severe left ventricular dysfunction (I). 
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We prospectively studied a group of patients with severe chronic 
left ventricular dysfunction candidate for surgical revascularization 
in order I) to assess the prevalence of regional improvement of Akf 
SH segments after surgical revascularization, and 2) to evaluate the 
role of LODE and TL SPECT for predicting such improvement. In 
addition, the reversibility of stress induced myocardial ischemia was 
also assessed by clinical judgement and high-dose dobutamine stress 
test. 
In this series of patients, improvemcnt of regional function after 
revascularization was found in 22% of Ak/SH segments. This value 
is lower than in other series (7,9-10), and might be related to the 
selection of patients with scverely impaired LV function in a tertial 
referral ccnter with an ongoing heart transplant program. 
We have demonstrated that pre-operative LODE is both a sensitive 
(28 out of33 segments) as well as specific (127 out of 137 segemcnts) 
predictor of post-operative outcome of regional myocardial function. 
The pattern of improvement of wall thickening in severely dyssynergic 
regions during the infusion of low dose dobutamine was found to bc a 
reliable predictor of functional recovery of wall motion after successful 
and uncomplicated surgical revascularization, with a positive predictive 
value of 85% (C.r. 80-90), while the pattern of Ak or SH unresponsive 
to low-dose dobutamine is indicative of non-viable tissue and offers a 
negative predictive value of 93% (C.I 89-97). 
Thallium SPECT (matched for echocardiographic segements) in-
clicated the presence of viable myocardium more frequently than 
LODE (103/170 vs 33/170). However, this imaging technique ap-
pears less suitable than LODE to predict the post-operative improve-
ment of regional wall motion in patients with severe LV dysfunction. 
In particular, the high prevalence of viability detected pre-operatively 
Method Sensitivity Specificity PPV NPV 
LODE, % 74 95 85 93 
95% C.I. 67 - 81 92 - 98 80-90 89 - 97 
TL, % 89 48 33 94 
95%C.1. 84 - 94 40 - 56 26 - 40 90-98 
Abbreviations: C.I. = confidence Intervals; LODE: low-dose dobutamlne 
echocardlography; NPV: negative predictive value; PPV: positive predictive value; 
TL: Thallium SPECT 
Table 2 - Diagnostic accuracy with 95% confidence intervals of low-dose dobutamine 
echocardiography and high-dose dobutamine-reinjection Thallium-201 SPECT for the 
prediction 01 postoperative improvement of wall motion in severely dyssynergic segments. 
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at TL SPECT and the low prevalence of post-operative functional 
improvement result in a 101V specificity and in a low positive predictive 
value (table II). 
Overestimation of myocardial viability by perfusion scintigraphy 
may relate to several factors. Firstly, scintigraphy may detect islands 
of jeopardized vital myocardial cells of inadequate size to revert left 
ventricular dysfunction despite successful revascularization. Secondly, 
tethering by scar tissue may restrict the improvemcnt in wall motion 
of adjacent viable segments. Thirdly, functional recovery may not 
have completed by three months (so called "embalmed myocardium") 
(17). Finally, since subendocardial layers playa major role in wall 
motion, a necrosis limited to the subendocardiummay result in severe 
dyssynergy despite the presence of viable myocardium in the 
subepicardial layers (18). 
In our study group, there lVas no significant post-operative im-
provement of global left ventricular function, however bypass sur-
gely alleviated myocardial ischemia, since the number of patients with 
angina and the extent of stress induced ischemia was greatly reduced. 
This is consistent with the high post-operative patency rate of bypass 
coronary grafts, and confirmed the usefulness of dobutamine stress 
echocardiography for the assessment of stress induced myocardial 
ischemia aftcr coronary revasculnrization (12). 
Previous studies. While several studies have addressed the role 
of dobutamine echocardiography for the assessment of left ventricular 
functional recovery in patients with recent myocardial infarction (6-
8,11,19), few data are available on its predictive value for post-
revascularization functional improvement (9, I 0). In two previous 
studies on post-revascularization recovery, Marzullo et al (9) and 
Cigarroa et al (10) reported a higher incidence of wall thickening 
during low-dose dobutamine in AK regions (47% and 39% respec-
tively, compared to II % in our study). This discrepancy may relate to 
different methodologies (absence of sub classification for SH seg-
ments in their studies) and patient selection (inclusion in our study of 
patients with more severe and more longstanding ventricular 
dysfunction where stunned myocardium is less likely to be present). 
Considering the value of LODE to predict the post-operative functional 
outcome, our findings are in agreement with the two previous reports. 
Study Iimitaliol/s. The number of viable Ak and SH segments 
identified in our study was limited despite our analysis of a total of 
608 segments both pre- and post-coronary bypass surgery. This, 
however, reflects our stringent inclusion criteria and our strict method 
of analysis (panel review with simultaneous, quad-screen format). 
Secondly, we arbitrnrely timed the outcome of dyssynergic seg-
ments 3 months after surgical revascularization. However, it cannot 
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be excluded that functional improvement can also occur later. Finally, 
this study was focused on the post-operative phase of regional wall 
motion. We are aware that the improvement in a limited area of 
myocardium can be clinically not relevant on global LV function. 
However, this was not the primary aim of the study. 
Conclusion 
Our observations in the setting of severe chronic left ventriculair 
dysfunction indicate that 
I) wall thickening during low-dose dobutamine in akinetic seg-
ments is unfrequent, 2) responsiveness of akinetic and severe 
hypokinetic segments to low-dose dobutamine is both a specific and 
sensitive predictor of post -revascularization functional improvement, 
and 3) compared to LDDE, TL SPECT has an equivalent sensitivity 
for the prediction of post-operative myocardial functional 
improvement but a lower specificity. Thus, LDDE should be the 
preferred imaging technique for predicting the functional outcome of 
patients with severe left ventricular dysfunction under consideration 
for coronary artery bypass surgery. 
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CHAPTER XI 
IMPROVED CARDIAC RISK STRATIFICATION IN MAJOR 
VASCULAR SURGERY WITH DOBUTAMINE-ATROPINE 
STRESS ECHOCARDIOGRAPHY* 
Abstract 
Objectives. To optimize preoperative cardiac risk stratification in 
a large group of consecuti ve vascular surgery candidates by combin-
ing clinical risk assessment and semi-quantitative dobutamine-atro-
pine stress echocardiography. 
Backgroulld: Dobutamine-atropine stress echocardiography has 
been used for the prediction of perioperative cardiac risk in small 
group of patients scheduled for elective major vascular surgery, based 
on the presencc or absence of stress-induced regional left ventricular 
wall motion abnormalities. 
Methods: Clinical risk assessment and dobutamine-atropine stress 
echocardiography were performed in 300 consecutive patients pre-
senting for major vascular surgery. The extent and severity of stress 
wall motion abnormalities and the heart rate at which they OCCUlTed, 
in addition to the presence of wall motion abnormalities at rest were 
assessed. 
Results. The absence of clinical risk factors (angina, diabetes, Q 
waves on ECG, symptomatic ventricular tachyarrhythmia's, age >70 
years) identified a low-risk group of 100 patients with one-percent 
cardiac event rate (unstable angina). Dobutamine-atropine stress 
echocardiography was positive in 72 patients. Twenty-seven 
perioperative cardiac events (5 cardiac deaths, 12 nonfatal infarctions 
and unstable angina pectoris in 10) occurred, all in patients with a 
positive stress test (positive predictive value 38%, negative predictive 
value 100%). The semi-quantitative assessment of the extent and 
severity of ischemia did not provide additional prognostic information 
in patients with a positive test. In contrast, the heart rate at which 
ischemia occurred defined a high-risk group with a low ischemic 
threshold [38 patients with 20 events (53%)] and an intermediate-
risk group with a high ischemic threshold [34 patients, 7 events (21 % )] . 
• Poldennans D, Arnese M, Fioretti PM, Salustri A, Boersma E, Thompson fR, Roeland! 
H<TC, van Urk H. J Am Call Cardiol 1995;26:648-53 
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All 5 patients with a fatal outcome and 8 of 12 with nonfatal myocardial 
infarction were in the high-risk group with a low ischemic threshold. 
/11 cOllclusioll: Clinical variables identify a 1/3 of patients having 
a very low-risk of peri operative complications of vascular surgery in 
whom further testing is redundant. In all other candidates, dobutamine-
atropine stress echocardiography is a powerful tool which defines an 
intermediate-risk population, and a small very high-risk group. Risk 
stratification with a combination of clinical assessment and 
pharmacological stress echocardiography has the potential to facilitate 
clinical decision-making, and contains resources. 
Introduction 
Perioperative cardiac complications are a leading cause of mor-
bidity and mortality in patients undergoing major vascular surgery( 1-
4). For example, elective resection of an abdominal aortic aneurysm 
is associated with an operative mortality rate of 3-10 %(2), with 
approximately 50% of deaths being cardiac in origin. Effective 
preoperative risk stratification has the potential to facilitate decision-
making by enabling patients and physicians to better assess the risk-
benefit ratio of proposed surgical procedures. Furthermore, 
unequivocal definition of a low-risk group would permit expeditious 
and cost-effectivc surgical management of those patients. 
Several techniques for preoperative cardiac risk assessment have 
been advocated. These include clinical evaluation(5-7), exercise 
electrocardiography(8), ambulatory electrocardiography(9, I 0), 
radionuclide ventriculography( II), and dipyridamole-thallium 
scintigraphy(l2-14). Of these, dipyridamole-thallium myocardial 
perfusion scintigraphy has been most widely advocated. However, 
recent studies have found that dipyridamole-thallium scintigraphy to 
have poor predictive power and suggest that its routine use may not 
have been justified( 15). 
More recently, pharmacologic stress echocardiography with 
dobutamine or dipyridamole has been proposed as an alternative to 
dipyridamole-thallium scintigraphy for risk assessment in vascular 
surgery candidates( 16-21). This technique uses transthoracic 
echo cardiography to detect ischemic left ventricular wall motion ab-
normalities induced by pharmacologic stress. Preliminary studies 
suggest that stress echocardiography is a safe(22) and sensitive tech-
nique for predicting perioperative cardiac events, which has excel-
lent negative predictive power(16-21). However, these previous 
studies had limitations. First, most studies did not enrol patients con-
secutively, so a referral bias may have been present. Second, clini-
cians caring for the patients usually had access to test results, and this 
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may have altered management. In some studies, apparently high-risk 
patients underwent coronary angiography and/or myocardial 
rcvascularisation prior to vascular surgery. Third, relatively small 
number of paticnts were studied. Finally, test result were classified 
simply as positivc or negative, without including information about 
the extent and severity of inducible ischemia, or the threshold heart 
rate at which ischemia developed. This later defect might explain the 
relatively low positive predictive power of stress echocardiography 
in some studies(l6, 17). We attempted to overcome this limitations 
by evaluating the predictive power of dobutamine-atropine stress 
echocardiography in a large group of consecutive patients, while 
blinding clinicians to test results. We also attempted to improve the 
predictive power of the test by employing a quantitative approach 
which utilizes more of the information available from the test. This 
work represents an extension of our previous consecutive 136 
patients(21 ). 
Methods 
Patient characteristics: Three-hundred-and-two consecutive pa-
tients schcduled for elective major vascular surgery were studied dur-
ing a three-year period from 1991 to 1994. All patients were judged 
not suitable to be assessed by exercise testing. A detailed history, 
physical examination and 12-lead electrocardiogram (ECG) were 
performed and Detsky's modification of Goldman cardiac risk index 
was calculated for each subject. Using the method of Eagle et al( 13), 
the number of clinical risk factors (angina, diabetes requiring drug 
therapy, age> 70 years, Q wave on ECG and history of ventricular 
ectopic activity requiring treatment) present in each subject were 
counted. Minimal additional preoperative testing or therapy was 
undertaken. Three patients underwent dipyridamole-thallium 
myocardial scintigraphy and none had coronary angiography or 
prophylactic myocardial revascularisation before surgery. 
Dahl/fallline-atropine stress fest: The study protocol was approved 
by the Hospital Ethics Committee and all patients gave informed con-
sent. In each subject, a resting two-dimensional echocardiographic 
examination including standard apical and parasternal views of the 
left ventricle was performed and recorded on video tape. A resting 
12-lead electrocardiogram was also obtained. Dobutamine was 
administered intravenollsly with an infusion pump, starting at I 0 ~tg/ 
kg/min for 3 minutes (stage I). The infusion rate was increased by 10 
~tg/kg/min every 3 minutes to a maximum of 40 ~tg/kg/min (stage 
IV), and continued for 6 minutes. If signs and symptoms of ischemia 
were absent during stage IV, atropine was given to patients who did 
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not reach their age-corrected target heart rate [(220-age) X 0.85 in 
men, and (200-age) X 0.85 in women]. Atropine was administered iv 
in 0.25 mg increments, to a maximum of I mg, while the dobutamine 
infusion was continued. During the test, the 12-lead ECG was 
monitored continuously and recorded each minute. Blood pressure 
was measured noninvasively (Accutorr A I, Datascope Corp., Paramus 
NY, USA) at rest and at each stage of the protocol. The two-
dimensional echocardiogram was monitored continuously and 
recorded on video tape during the last minute of each stage. A quad-
screen video display, for side-by-side comparison of resting and stress 
images, was used during the last 150 examinations (Vingmed CFM 
800, Diasonics Sonatron, Zug, Switzerland). The criteria for stopping 
the test included a decline in systolic blood pressure of more then 40 
mmHg from the resting valuc or a systolic blood pressure of less than 
100 mmHg, significant cardiac arrhythmias, severe chest pain, 
horizontal or downsloping electrocardiographic ST depression of::,0.2 
mV measured 80 ms after the J point, ST-segment elevation of ::,0.2 
mV, and severe or extensive new echocardiographic wall motion 
abnormalities. 
Off-line assessment of echocardiographic images was performed 
by two investigators who knew the doses of dobutamine and atropine 
used, but were blinded to clinical information. The left ventricular 
wall was divided into 16 segments(23) and wall motion in each was 
subjectively scored on a four point scale: 1= normal; 2= hypokinetic; 
3= akinetic and 4= dyskinetic. The test was considered positive when 
wall motion in any segment deteriorated one grade or more. Agreement 
between the two investigators was required for a test to be designated 
as positive. In the event of disagreement, a third investigator resolved 
the dispute. 
For each patient, a wall motion score index (total score divided 
by the number of assessable segments) was calculated at rest and 
during peak stress. The severity of ischemia was defined as the dif-
ference between these two values. The extent of ischemia was defined 
as the number of segments exhibiting deteriorating wall motion dur-
ing stress. The "ischemic threshold" was defined as the heart rate at 
which new echocardiographic wall-motion abnormalities occurred, 
divided by the maximal age-related heart rate [(220-age) in men, and 
(200-age) in women]. 
Allalysis ofclillical outcomes: Patients were followed throughout 
their stay in hospital. On the 1st, 3rd and 7th postoperative days se-
rum creatine kinase with MB-fraction was measured and a 12-lead 
ECG was recorded. These tests were repeated when necessary, at the 
discretion of the treating physicians. Adverse clinical outcomes 
included: I) cardiac death (based on clinical assessment, cardiac 
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isoenzymes, ECG and autopsy when available), 2) non-fatal 
myocardial infarction documented by cardiac isoenzymes (creatine 
kinase >110 Ull with MB >10%) and ECG (new Q waves >0.03 sec-
ond), 3) unstable angina consisting of typical persisting chest pain at 
rest with transient ischemic ECG changes requiring prolonged stay 
or readmission at the IC and intravenous treatment with nitrates andl 
or percutaneous transluminal angioplasty. 
Statistical allalysis: Univariate analysis was performed using the 
chi-square test with Yates' correction or Fisher's exact test for cat-
egorical variables, and Student's t test for continuous variables. 
Stepwise logistic regression models were fitted to identify independ-
ent predictors of a cardiac event. All variables from the univariate 
analysis, regardless of statistical significance, were entered into the 
multi variable analysis. The risk associated with a given variable was 
expressed as an odds ratio (OR) with corresponding 95% confidence 
intervals (CI). Differences were considered significant if the null 
hypothesis could be rejected at the 0.05 probability level. Receiver-
operator characteristics (ROC) clll'ves were used to determine the 
optimal ischemic threshold for the prediction of cardiac events. 
Results 
Patient characteristics: The subject's mean age was 67 years 
(range 22-90 years) and the majority (257/302) were male. A history 
of previous myocardial infarction was present in 93 (31 %), angina 
pectoris in 60 (20%) and diabetes mellitus (with drug therapy) in 33 
(II %) cases. 
Detsky scores of 0-15 points were present in 275 patients, 23 pa-
tients had 16-30 points and 4 patients had >30 points. Using Eagle's 
clinical risk factors( 13), 100 patients had no clinical risk factors, 179 
patients I or 2 risk markers and 21 patients had 3 or more risk factors. 
Dobiltalllille-atmpille stress echocanliography: Two patients with 
severe pulmonary disease were excluded from the study because ad-
equate echocardiographic images were not obtained. Atropine was 
administered in 10 I of 300 patients. Patients taking B-adrenergic 
blocking agents prior to the test required atropine more frequently 
(67/10 I) than those who were not (3411 0 I) (p=0.004). Test end-points 
were: target heart rate in 276 patients (92%), severe angina in 17 
(5.6%) and side effects in 7 (2.3%). The side-effects causing 
termination of the test were: ventricular fibrillation in one, paroxysmal 
atrial fibrillation in two, hypotension in one, severe hypertension (2401 
130 mmHg) in one, and chills in two patients. Cardiac arrhythmias 
all occlll'red in the recovery phase of the test, in these patients test 
results were available. In the four other patients the test was 
inconclusive, in the perioperative period no events occurred. 
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Cardiac arrhythmias developed in 15 patients (5%). These included 
sustained ventricular tachycardia in three; non sustained ventricular 
tachycardia in eight and paroxysmal atrial fibrillation in three patients. 
One patient developed ventricular fibrillation dlll'ing stage IV. This 
arrhythmia was terminated with a single countershock and the patient 
suffered no sequelae. Two patients with sustained ventricular 
tachycardia responded quickly to discontinuation of dobutamine, while 
another received Lv. metoprolol. Paroxysmal atrial fibrillation reverted 
to sinus rhythm after discontinuation of dobutamine plus 
administration of Lv. mctoprolol in two patients and i.v. digoxin to 
one. Mild hypotension (decline in systolic blood pressure of >20 
mmHg) occurred in 12 patients (4%), hypertension (systolic blood 
pressure >220 nunHg) in 3 (I %) and chills in 7 (2%). 
New wall motion abnormalities occurred in 72/300 patients, 12 
of whom had a normal wall motion at rest. Six patients had a left 
bundle branch block, making interpretation of ST-segment changes 
impossible. New ST-elevation or depression >1 mm during testing 
occurred in 68 patients and angina in 42. [n all patients new wall 
motion abnormalities preceded the occurrence of stress induced 
angina. 
Cmdiac events: Twenty-seven patients experienced cardiac events 
between days I and7. These included fatal myocardial infarction in 
5, non-fatal myocardial infarction in 12 and unstable angina in 10. 
Predictive vallie ({{clinical variables alld test: 
I) Clinical variables: The Detsky score in patients with a cardiac 
event was significantly higher than in those without events (12.0 ± 
8.1 vs 6.5 ± 5.4, p <0.0 I). Cardiac events occurred in 22/275 "Iow-
risk"patients (0- I 5 points), 4/23 "intermediate-risk" patients (16-30 
points) and 114 "high-risk" patients (>30 points). 
One cardiac event occurred among 100 patients (I %) with no clini-
cal risk factors (i.e. "low-risk) according to "Eagle's" criteria. The 
event rate was 20/181 (II %) in "intermediate-risk" patients with one 
or two risk factors and increased to 612 I «29%) in "high-risk" patients 
with more than two risk factors (p <0.00 I). 
2) Univariate analysis: a) Clinical variables: Significant univariate 
clinical predictors of perioperative events were a history of angina 
(OR 4.6, 2.0-10), previous myocardial infarction (OR 4.1, 1.8-9.2) 
and diabetes mellitus (OR 3.2, 1.3-8.4). Other clinical variables in-
cluding age, gender, history of hypertension, smoking, heart failure, 
use of anti-anginal medication and type of slll'gery (abdominal vs 
infrainguinal) lVere not predictive of perioperative events. b) 
Echocardiographic variables: Perioperative cardiac events were more 
frequent in patients with echocardiographic wall motion abnormal i-
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ties at rest (OR 3.7, /.6-8.3). All 27 patients with cardiac events had 
new wall motion abnormalities during stress. Consequently, patients 
with a positive test were more likely to have cardiac events (OR 124, 
17-934). The positive predictive value of new wall motion 
abnormalities in this study was 38% (CI 26-50). Ischemic ST-segment 
changes were less strongly correlated with perioperative events (OR 
4.9,2.2-11) and the occurrence of angina during stress was unrelated 
to outcome (OR 1.8, 0.6-4.6). 
Multivariable analysis of clinical data and stress test results re-
vealed only one independent predictor of cardiac events, new wall 
motion abnormalities (OR 124, [7-934). 
Among patients with new wall motion abnormalities, 
quantification of the extent and severity of stress induced wall motion 
abnormalities was not correlated with perioperative cardiac events 
(Table I). However, the heart rate threshold at which ischemia occurred 
provided additional prognostic information. Among patients with car-
diac events the ischemic threshold was 67% (CI 63-71) of the age-
corrected maximum heart rate, compared to 80% (CI 77-83) in pa-
tients without events (p <0.0 [). Using the ROC-curve analysis, the 
best "cut-off' point for the heart rate ischemic threshold was esti-
mated to be 70%. There were 20 postoperative cardiac events among 
38 patients in whom ischemic wall motion abnormalities developed 
at a heart rate of £70% of the age-corrected maximum heart rate 
(positive predictive power = 53%). In contrast there were 7 cardiac 
events among 34 patients with a heart rate threshold of> 70% (positive 
predictive power = 2 [%). All patients with cardiac death had ischemia 
at a low threshold (65%, CI 58-71). The characteristics of patients 
with a fatal perioperative cardiac event are presented in Table 2. 
Discllssion 
This study demonstrates the utility of dobutamine-atropine stress 
echocardiography for preoperative cardiac risk stratification in can-
didates for major vascular surgery. The test was especially effective 
for defining a low-risk group with a very low incidence of peri operative 
cardiac complications. There were no cardiac events among 228 
patients with a negative test (negative predictive power 100%, CI 98-
100%). A positive test greatly increased the likelihood of a 
perioperative cardiac event (OR [24, CI 17-934) and was the sole 
independent predictor of cardiac events. There were 27 perioperative 
cardiac complications among 72 patients with a positive stress test 
(positive predictive power= 38%, CI 26-50). 
Surprisingly, quantifying the extent and severity of stress-induced 
wall motion abnormalities did not provide additional risk stratifica-
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Table 1 ~Semiquantitative analysis of dobutamine-atropine stress test in patients w'lth a positive test (new wall motion abnormal'rtiesduring stress) 
(n = 72). 
il 
All cardiac events (n =27) Cardiac death / infarction No events (n =45) p value 
(n=l7) 
mean ± CI mean ± CI mean ± CI 
I Threshold 67 (63-71) 62 (57-67) 80 (77-83) <0.01 
2 Extent 3.3 (2.3-4.3) 3.4 (2.2-4.6) 3.6 (2.5-4.7) NS 
3 Severity 1.5 (1.4-1.7) 1.5 (1.3-1.7) 1.6 (1.4-1-8) NS 
Threshold= heart rate increment at which echocardiographic detected myocardial ischemia occurs «heart rate ischemia-heart rate rest : 
age-predicted maximal heart rate-heart rate rest)%); extent= number of ischemic segments during stress; severity= difference between 
wall motion score at peak stress and rest; CI = 95 % confidence interval; NS = not significant. 
, 
, 
w 
~ 
Table 2 - Clinical data and dobutamine stress test results on patients with perioperative cardiac death. 
-
Pt age (yrs) AP Ml days WMSI-R NWMA threshold extent severity I 
1 70 no yes 3 1.48 yes 68 4 0.24 
2 76 no yes 5 1.96 yes 63 5 0.42 
3 76 yes yes 5 1.24 yes 64 6 0.36 
4 62 no no 3 1.00 yes 62 4 0.24 
5 85 no yes 7 1.54 yes 66 4 0.18 
-------
L 
- . 
--
--_ ... _-~- ... --
-
L-... 
Pt= patient; AP= angina pectoris; MI= history of previous myocardial infarction; WMSI-R= wall motion score index at rest; NWMA= 
new wall motion abnormalities; threshold = heart rate increment at which echocardiographic detected myocardial ischemia occurs «(heart 
rate ischemia: age-predicted maximal heart rate)%); extent= number of ischemic segments; severity= difference between wall motion 
score at peak stress and rest. 
tion among patients with a positive test. However, consideration of 
the heart rate threshold at which ischemia occurred significantly en-
hallCed risk stratification. Patients with cardiac events became 
ischemic at significantly lower heart rates than those without «67%, 
CI 63-71) vs (80%, CI 77-83) of the age-corrected maximum heart 
rate). An ischemic threshold of 70% of the age-corrected maximum 
heart rate provided optimum risk stratification. This threshold defined 
a high-risk group of 38 patients with an ischemic threshold ( <70%) 
in which 20 cardiac events occurred (positive predictive value 53%). 
This high-risk group included all 5 cardiac deaths and 8 of 12 nonfatal 
infarctions (76% of "hard" cardiac events). There were only 7 events 
in an intermediate-risk group of 34 patients with new wall motion 
abnormalities at a high ischemic threshold (positive predictive value 
21 %) (Figure I). 
Our results regarding the prognostic value of the ischemic "thresh-
old" during dobutamine stress testing arc in agreement with those 
Figure 1 - Breakdown of clinical variables and dobutamine stress test results for 
perioperative outcomes as applied to this group of 300 patients. Clinical variables 
are age> 70 years, angina, diabetes requiring treatment, Q waves on 
electrocardiogram and history of ventricular ectopic activity; DSE = dobutamine-
atropine stress test; Events refers to cardiac death, nonfatal myocardial infarction 
and unstable angina pectoris; Ischemic threshold = the heart rate at whic new 
echocardiographic wall-motion abnormalites occurred, divided by the maximal age-
corrected heart rate, [(220-age) in men, and (200-age) in womenl; High-threshold = 
new echocardiographic wall-motion abnormalities occurred at > 70% of maximal 
age-corrected heart rate; Low-threshold = new echocardiographic wall-motion 
abnormalities occurred at <; 70% of maximal age-corrected heart rate. 
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reported by Cutler et al(8) using exercise electrocardiography. They 
found that cardiac complications occurred most frequenlly in patients 
who developed ischemic ST-segment depression at <75% of the 
predictedmaxil1lum age-related heart rate. 
We were surprised that quantifying the extent and severity of stress-
induced ischemia did not enhance the tive power of dobutamine-
atropine stress echocadiography. Other investigators, using 
dipyridamole-thallium myocardial scintigraphy, have demonstrated 
that the extent and severity of redistribution defects enhanced the tive 
value of this test(24). A possible explanation for these different 
findings is that malperfusion precedes ischemia during dipyridamole 
infusion and scintigraphy detects both conditions. In contrast, positivity 
of stress echocardiography is based only on the presence of ischemia. 
Thc dobutamine-atropine stress test caused three serious compli-
cations in this study (ventricular fibrillation in one and paroxysmal 
atrial fibrillation in two). There where no fatal complications. This 
confirms previous findings about the safety of the stress test(22). 
The present study has several unique features compared to previous 
publications: I) we studied a large group of consecutive patients; 2) 
test results were not used for clinical decision making; 3) a compre-
hensive analysis of stress test results, including the severity, extent 
and heart rate threshold of ischemia was applied. These features in-
crease our confidence in the reliability of our results. The findings are 
consistent with previous work, including our own. All earlier studies 
found that preoperative pharmacologic stress echocardiography has 
excellent negative tive power for perioperative cardiac events (95-
100%) (Table 3). Moreover, most early studies found the positive 
tive power to be relatively low (21-42%). The exception is the work 
of Tischler et al(20). In the only study using dipyridamole stress 
Authors Sues> Nr of pis S, Sp + py • py NT of e\'enu Events 
Tischler(20) Dipy 109 88 98 78 99 , CD, MI, UAP, 
CHF 
Lant(11) 1lOO. 
" 
100 56 21 100 4 CD, MI, UAP 
Poldermans(21) ""b. 131 100 
" 
42 100 
" 
CD, MI, UAr, 
CHF 
Lalka(18) 1lOO. 
'" " 
44 29 OS 13 CD, MI, UAP 
Eichelberger(16) ""b. 70 100 66 19 100 5 MI,UAP 
Dipy'" dipyridamole; Deb\!= dobutwllne; Nz= number; pl$= patients; Se'" sensitivity%; Sp= spedficity%; + PV", positive predictive 
value%; • PV = negative predlcti>,e value%; CO'" cardiac duth; MI= myocardial Infarction; UAP", unstable angina pKloris; CHF= 
oongHtive hean failure. 
Table 3 " Review of value of new wall motion abnormalities detected by stress 
echocardiography for preoperative risk stratification of perioperative cardiac events in 
patients scheduled for major vascular surgery. 
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echocardiography, these authors found a positive tive power of 78%. 
There are several possible explanations for this different result. First 
dipyridamole-induced ischemia might be a less sensitive but more 
specific indicator of severe coronary artery disease than caused by 
dobutamine/atropine. Consistent with this hypothesis, the sensitivity 
of dipyridamole stress echocardiography was 88% in the study of 
Tischler et ai, versus 100% in our study, and two other 
pUblications( 16, 17,21). Alternatively, methodological di fferences 
might explain the results. The study by Tischler was relatively small 
(n= 109), and there were few cardiac events (n=8). In addition, 
differences in the patient population and selection criteria may have 
been operative. These differences in study design make it impossible 
to draw definite conclusions about the relative et1'icacy of dipyridamole 
or dobutamine as pharmacologic stressors. 
Our experience shows that clinical risk assessment using Detsky's 
scoring system is too insensitive for use as a screening tool in vascu-
lar surgery candidates. In our study, 22/27 cardiac events occurred in 
patients with a relatively low Detsky score of 0-15 points. Detsky 
system is a modification of Goldman's cardiac risk index, which is 
itself a specific but relatively insensitive indicator of risk(25). 
Furthermore, the cardiac risk index was derived from a general surgical 
population undergoing a variety of surgical procedures rather than 
the relatively unique vascular surgery popUlation in this study. 
In contrast, the clinical risk factors defined by Eagle et al(l3) in a 
study of vascular surgery candidates were useful in our study group. 
There was only one cardiac event (unstable angina pectoris) among 
100 patients with none of Eagle's five clinical tors (angina, diabetes 
requiring drug therapy, age> 70 years, Q wave on ECG and history of 
ventricular ectopic activity requiring treatment). The negative tive 
power of no Eagle criteria was 99%, CI 98-100. This is consistent 
with the negative tive power of 96.9% in Eagle's study, and 96.8% 
noted by Letle et al(6). This result is not surprising, considering that 
the three univariable clinical tors of perioperative cardiac risk that we 
noted (angina, diabetes and previous myocardial infarction) are similar 
to those noted by Eagle et al. 
Based on these results, we do not recommend routine preoperative 
pharmacologic stress echocardiography in all vascular surgery candi-
dates. Patients with none of Eagle's clinical risk factors appear to 
represent a low-risk population (33% of our patients), in whom fur-
ther cardiac evaluation may be unnecessary. We recommend that the 
remaining patients (with one or more clinical risk factors) undergo 
stress echocardiography preoperatively. This test identifies another 
large low-risk population (70% of the remaining patients) with 
negative test results. Avoiding additional testing and/or expensive 
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risk-reduction strategies (e.g. coronary angiography and myocardial 
revascularisation) in these patients has the potential to conserve health-
care resources. The test also defines an intermediate risk group with a 
positive stress test but a high ischemic threshold. The optimum 
management of these patients is unclear. 
Patients with a positive pharmacologic stress test and a low 
ischemic threshold (heart rate <70% of the age-corrected maximum 
heart rate) are extremely high-risk, and the advisability of surgery 
should be carefully reconsidered. 
The optimum management of the very high-risk patient who must 
undergo major vascular surgery because of life or limb-threatening 
disease is unknown. Various risk-reduction strategies including in-
tensive perioperative monitoring and intervention(2,6,27), 
peri operative beta-adrenergic blockade with ultra-short acting beta 
blockers like esmolol(2), stress suppression with regional anaesthe-
sia and analgesia(28), and prophylactic myocardial 
revascularisation(3,27) have been proposed. However, the efficacy 
of these techniques has never been adequately investigated and their 
benefits are unproven. 
Dobutamine-atropine stress echocardiography clearly defines a 
high-risk population of patients in whom the utility of these previ-
ously untested risk-reduction strategies can be prospectively assessed. 
This may represent the most immediate application of the test. 
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CHAPTER XII 
SUSTAINED PROGNOSTIC VALUE OF DOBUTA-
MINE STRESS ECHO CARDIOGRAPHY FOR LATE 
CARDIAC EVENTS AFTER MAJOR NONCARDIAC 
VASCULAR SURGERY * 
Abstract 
Background: Late cardiac events after major noncardiac vascular 
surgery are an important cause of morbidity and mortality. We studied 
the prognostic value of perioperative dobutamine stress 
echocardiography, relative to clinical risk assessment, for predicting 
late cardiac events. 
Methods: Three hundred and sixteen patients undergoing major 
vascular surgery were studied. All paticnts underwent clinical 
evaluation for the presence of cardiac risk factors (smoking, 
hypertension, angina, diabetes, history of heart failure, previous 
infarction and age> 70 years) and dobutamine stress echocardiography. 
Left ventricular wall motion was evaluated at rest and the extent and 
severity of stress-induced new wall motion abnormalities occurred 
was noted. Patients were followed perioperatively and for 19 ± 11 
months postoperatively and the occurrence of cardiac events was 
noted. Uni- and multivariate Cox proportional-hazard regression 
models were used to identify predictors of late cardiac events. 
Results: Thirty-two cardiac events occurred (II cardiac deaths, 
11 nonfatal myocardial infarctions and 10 patients with unstable 
angina). By multivariate regression analysis the occurrence of 
extensive (2 3 segments) or limited (1-2 segments) stress-induced 
new wall abnormalities and previous infarction independently predict 
late cardiac events, elevating the risk by 6.5, 2.9 and 3.8 fold 
respectively. The severity of ischemia during stress and heart rate 
threshold for ischemia were not independently predictive. 
"" Poldcrmans D, Arncsc M, Fioretti PM, Boersma E, Borst F. Thompson IR, Rimbaldi 
R, van Urk H. Circulation 1996 (in press). 
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Conclusion: Patients with a history of myocardial infarction or 
stress-induced ischemia have a high risk of fatal and non-fatal cardiac 
events after vascular surgery. Patients with hoth a history of infarction 
and extensive stress-induced ischemia are especially high-risk, and 
deserve intensive management. 
Introduction 
Coronary artery disease is a major cause of late morbidity and 
mortality in survivors of major vascular surgery. For example, Krupski 
et al (I) found that cardiac occurred in 19% of 129 patients followed 
for two years after vascular surgery. The high incidence reflects the 
frequency and severity of underlying coronary artery disease. Hetzer 
et al (2) obtained coronary angiograms in 1000 vascular surgery can-
didates and found severe correctable coronary artery disease in 36% 
of patients with aortic aneurysm and in 28% of those with lower ex-
tremity ischemia. Therefore, the preoperative evaluation of vascular 
surgery candidates should include an assessment of the risk of late 
postoperati ve cardiac events, since these will determine the likelihood 
that individual pat ients will survive to enjoy the benefits of successful 
surgery. 
Several clinical and laboratory variables have been associated with 
an increased risk of late cardiac events after major surgery. Clinical 
predictors include a preoperative history of coronary artery disease or 
congestive heart failure (2,3). Of particular interest is the finding by 
Mangano et al (4) that patients who slll'vived a postoperative 
myocardial infarction or episode of unstable angina had a 20-fold 
increase in the odds of a late cardiac event. Non-invasive laboratory 
indicators of late cardiac risk include left ventricular dilatation and 
thallium redistribution during dipyridamole-thallium myocardial 
perfusion scintigraphy (4-8), impaired left ventricular function on 
radionuclide ventriculography (9) and ischemic ST-segment changes 
on perioperative ambulatory electrocardiographic monitoring (10, 11). 
We have found dobutamine stress echocardiography to be an ex-
tremely useful tool for the assessment of perioperative cardiac risk in 
patients undergoing major vascular surgery (12,13). Therefore, we 
hypothesized that this would also predict the risk of late cardiac events 
after major vascular surgery. Dohutamine and atropine unfavourably 
alter myocardial oxygen balance and may induce ischemia in patients 
with coronary artery disease (14,15). Pharmacologically-induced 
ischemia can be detected echocardiographically as new regional wall 
motion abnormalities. The test is safe, inexpensive, widely available 
and applicable in patients who cannot exercise. It also provides infor-
mation about resting left ventricular tilllction. This report summarizes 
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data from 316 patients who were followed for up to 36 months aftcr 
major vascular surgery. 
Methods 
Patient characteristics: The study protocol was approved by the 
Hospital Ethics Committee and all patients gave informed consent. 
Between 1991 and 1994 we studied 318 consecutive patients. Beta 
blockers were used by 72 (23%) patients and calcium antagonists by 
89 (28%). Five patients suffered fatal peri operative myocardial 
infarction, and 2 more were lost to follow-up. The remaining 316 
survivors form the basis of this report. These included 264 men and 
52 women, aged 22 to 90 years (mean 67). They underwent aortic 
aneurysm resection (n= III), aortofemoral bypass (n= III) or 
infrainguinal arterial reconstruction (n=94). Preoperative clinical 
examination included a history, physical and twelve-lead 
electrocardiogram (ECG). We specially searched for clinical cardiac 
risk factors. These included: smoking, hypertension, angina, diabetes 
mellitus, history of congestive heart failure, age> 70 years and previous 
myocardial infarction (Q wave on ECG). The occurrence of a non 
fatal pcrioperative cardiac event (i.e. unstable angina or myocardial 
infarction) were also noted. 
Dobu/allline stress echocardiography: Preoperatively, each subject 
underwent dobutamine stress echocardiography. A resting two-dimen-
sional transthoracic echocardiographic examination, including stand-
ard apical and parasternal views of the left ventricle, was performed 
and recorded on video tape. A resting 12-lead ECG was also obtained. 
Dobutamine was administered intravenously with an infusion pump, 
starting at I 0 ~lg/kg/min for 3 minutes (stage I). The infusion rate was 
increased by I 0 ~lg/kg/min every 3 minutes to a maximum of 40 ~lg/ 
kg/min (stage IV), and continued for 6 minutes. If signs and symp-
toms of ischemia were absent during stage IV, and the patient did not 
reach a target heart rate [(nO-age) X 0.85 in men, and (200-age) X 
0.85 in women), atropine was administered iv in 0.25mg increments, 
to a maximum of I mg, while the dobutamine infusion was continued. 
During the test, the 12-lead ECG was monitored continuously and 
recorded each minute. Blood pressure was measured noninvasively 
(Accutorr A I, Datascope Corp., Paramus NY, USA) at rest and at 
each stage of the protocol. The two-dimensional echocardiogram was 
monitored continuously and recorded on video tape during the last 
minute of each stage. A quad-screen video display, for side-by-side 
comparison of resting and stress images, was used during the last 150 
examinations (Vingmed CFM 800, Diasonics Sonatron, Zug, Swit-
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zerland). The criteria for stopping the test included a decline in systolic 
blood pressure of more then 40 mmHg from the resting value or a 
systolic blood pressure of less than 100 mmHg, significant cardiac 
arrhythmia's, severe chest pain, horizontal or downsloping 
electrocardiographic ST depression of 30.2 m V measured 80 ms after 
the J point, ST-segment elevation of 0.2 mV in the absence of Q 
waves, and severe new echocardiographic wall motion abnormalities 
in multiple location. 
Off-line assessment of echocardiographic images was performed 
by two investigators who knew the doses of dobutamine and atropine 
used, but were blinded to clinical information. The left ventricular 
wall was divided into 16 segments (16) and wall motion was subjec-
tively scored on a four-point scale: 1= normal; 2= hypokinetic; 3= 
akinetic and 4= dyskinetic. The test was considered positive when 
wall motion in any segment deteriorated one or more grades. Agree-
ment between the two investigators was required for a test to be des-
ignated as positive. In the event of disagreement, a third investigator 
resolved the dispute. 
For each patient, a wall motion score index (total score divided 
by the number of assessable segments) was calculated at rest and 
during peak stress. The severity of ischemia was defined as the 
difference between these two values. The extellt of ischemia was 
defined as the number of segments exhibiting deteriorating wall motion 
during stress. The ischemic threshold was defined as the heart rate at 
which new echocardiographic wall-motion abnormalities occurred, 
divided by the maximal age-related heart rate (220-age in men, and 
200-age in women). 
FollOW-lip: All patients left hospital within one month of surgery. 
Thereafter, they visited our hospital out-patients clinic at regular in-
tervals for 19±11 months (mean ± SD) (range 1-36 months) . If a 
patients did not appear for a scheduled visit, his family physician was 
contacted. The physician performing the follow-up was blinded to 
the results of preoperative dobutamine-atropine stress 
echocardiography, because the test was still considered investigational 
at that time. Therefore, postoperative management was not influenced 
by preoperative stress testing. The occurrence of all late cardiac events 
(cardiac death, nonfatal myocardial infarction and myocardial 
revascularization) was documented. "Hard" cardiac events were de-
fined as nonfatal myocardial infarction or cardiac death. The occur-
rence of stroke and noncardiac death were also noted. Cardiac death 
was determined by reviewing the clinical presentation, including car-
diac isoenzymes, 12-lead ECG, and autopsy results when these were 
available. Nonfatal myocardial infarction was defined as elevated car-
diac isoenzymes (creatinine kinase> 110 UIL with MB-isoenzymes 
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> 1 0%) and ECG changes (new Q waves >0.03 second). Myocardial 
revascularisation included coronary artery bypass grafting or 
percutaneous transluminal angioplasty. When more than one cardiac 
event occurred in the same patient, the most serious event was con-
sidered for analysis (i.e. death> myocardial infarction> 
re vascul a ri sat i on). 
Statistical a/wlysis: Uni- and multivariate Cox proportional-ha 
ards regression models were used to identify independent predictors 
of late cardiac events. The risk associated with a given variable was 
expressed by hazard ratio (HR) with corresponding 95% confidence 
interval (CI). Variables were considered to be significant if the null 
hypothesis of no contribution could be rejected at the 0.05 probability 
level. In addiction, likelihood ratios were computed to describe the 
predictive utility of significant risk factors. Kaplan-Meier life-table 
analysis of cardiac events was used to assess the prognostic impor-
tance of stress-induced new wall motion abnormalities with respect 
to event-free survival. 
Receiver-operator characteristics (ROC) clll'ves were used to de-
termine the "optimal" cut-off point for prediction of late events with 
respect to: I) the number of segments with resting wall motion ab-
normalities, 2) thc number ischemic segments at peak stress, 3) the 
ischemic heart rate threshold, and 4) the severity of ischemia at peak 
stress. The best cut-off was defined as the point with the highest sum 
of sensitivity and specificity. 
Results 
Clillical pro,lile alld restillg ec/zocalyliogram: One hundred seventy 
two patients (54%) were over 70 years of age, smoking was present 
in 104 (43%), hypertension in64 (20%), typical angina in 57 (18%), 
previous myocardial infarction in 92 (29%), a history of heart faillll'e 
in 13 (4%), and diabetes mellitus in 32 (10%). Twenty-two (7%) 
patients experienced a nonfatal perioperative cardiac event. 
Resting wall motion abnormalities were prescnt in 102 (32%). In 
48 (15%) patients more than 3 segments were abnormal at rest. 
HemodYllamic data: Heart rate increased from 73 ±14 bpm to 
132± 15 bpm (p=O.OOO 1) Systolic blood pressure increased during 
dobutamine infusion from 144±25 mmHg to 153±32 mmHg 
(p=O.OO I). Diastolic blood pressure decrease from 83± 14 mmHg to 
80±17 at the maximum dose of dobutamine (p=O.OI). 
Stress test results: During the stress test 25(8%) patients 
experienced typical chest pain, 74(23%) ST-segment changes, and 
84(25%) new wall motion abnormalities. The mean dobutamine dose 
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was 36 ~tg/Kg/lllin, and atropine was administrated to III (35%) 
patients. The stress test was inconclusive (prematurely stopped due 
to side-effects without signs or symptoms of myocardial ischemia) in 
4 patients. Two of these patients developed intolerable chills, one 
marked hypertension (240/130 mmHg), and one severe hypotension. 
Side effects: There were no fatal complications. Besides chest pain, 
hypotension and cardiac arrhythmias were the most important side 
effects of dobutamine stress test. Cardiac arrhythmias occurred in 
7(2%) patients and hypotension in 12(4%). Cardiac arrhythmias 
consisted of ventricular fibrillation in I patient, nonsustained 
ventricular tachycardia in 3, paroxysmal atrial fibrillation in 3. The 
patients who developed ventricular fibrillation, during the recovery 
phase of the test, was successfully resuscitated with one counter shock. 
No electrocardiographic or enzymatic evidence of a new myocardial 
infarction was subsequently apparent. Hypotension was usually mild 
(decline of systolic blood pressure of >20 nUllHg compared to base-
line). Stress test results were available in all these patients as cardiac 
arrhythmias occurred during the recovery phase of the test and pa-
tients with mild hypotension were able to continue the test. 
FollOW-lip: Thirty-two cardiac events occurred during follow-up 
in 316 patients (10.1 %). There were II cardiac deaths, II nonfatal 
infarctions and coronary revascularisation was performed in 10 
patients. Eight patients had a stroke and there were 7 noncardiac deaths 
(mostly secondary to infected prosthetic grafts). Among 22 patients 
who experienced a nonfatal perioperative cardiac event, II late cardiac 
events occurred during follow-up. Two of these II events were fatal. 
There were no late cardiac events in the four patients in whom the 
stress test was prematurely discontinued due to side effects. 
Predictioll of late cardiac evellts: ROC-curve analysis defined the 
following optimal cut-off point for predicting of late events: I) Resting 
wall motion abnormalities, ~2 segments, 2) Extent of ischemia, 2 3 
segments, 3) Heart rate threshold, echocardiographically-detected new 
wall motion abnormalities at a heart rate of ~ 70% of the maximal 
age and sex related value, and 4) Severity of ischemia, (wall motion 
score at peak stress-wall motion score at rest divided by the number 
of segments) > 0.14 wall motion score units. 
The univariate predictors oflate cardiac events (all cardiac events 
and "hard" cardiac events) are presented in tables I and II. A history 
of angina, myocardial infarction, or the occurrence of a nonfatal 
peri operative cardiac event were significant predictors of both all and 
"hard" late cardiac events. Diabetes mellitus and a history of heart 
failure were significant predictors of all cardiac events only. Stress 
test results were also predictive. Left ventricular dysfunction at rest 
(22 segments), extensive new wall motion abnormalities during stress 
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Table I and 11- Univariate predictors of all cardiac events (cardiac death, myocardial infarction or coronary revascularization) and "hard cardiac 
events" (cardiac death or myocardial infarction), after major vascular surgery (n = 316. follow~up period 19 ± 11 months). 
Characteristic All cardiac events, Hard cardiac events. 
hazard ratios (95 % CI) hazard ratios (95 % CI) 
Perioperative cardiac events 4.7 (2.5-9.6) 3.4 (1.6-7.4) 
Previous myocardial infarction 4.5 (2.2-9.0) 3.4 (1.5-7.4) 
History of hean failure 3.4 (1.2-9.9) NS 
Angina pectoris 3.1 (1.5-6.0) 2.9 (1.2-7.4) 
Diabetes mellitus 
_L...- __________ 2.6 (1.2-5.7) NS 
Characteristic All cardiac evt:Ots. Hard cardiac events, 
hazard racias (95 % CI) hazard ratios (95 % CI) 
Ischemia :2: 3 segments 9.0 (4.5-18.2) 8.8 (3.7-20) 
NWMA 7.9 (3.7-17) 5.6 (2.5-12) 
Low ischemic bean rare threshold 5.6 (2.5-12) 4.5 (1.6-12) 
Severity of iSChemia 3.1 (1.4-6.8) NS 
ST changes during Slres$ 3.0 (1.5-6.0) 3.9 (1.8-9.0) 
Angina during stress 2.9 (1.2-7.4) NS 
R~ting wall motion abnormalities ~ 2 segments 2.7 (1.3-5.5) 2.4 (1.1-5.5) 
NWMA= any new wall motion abnormalities: Low ischemic threshold: echocardiographic detected ischemia at a hean rate of <70% of the maximal 
age and sex related hean rate: Severity of ischemia: difference between wall motion score at peak stress - wall motion score at rest> 0.14. 
Tab!e iii - Multivariate predictors of all cardiac events (cardiac death, myocardial infarction orcoronary revascularization) and "hard cardiac events" 
(cardiac death or myocardial infarction) after major vascular surgery (n = 316, follow-up period 19± 11 months). 
All cardiac events. Hard cardiac events. 
hazard ratios (95 % el) hazard ratios (95% el) 
Ischemia during Stress >3 segments 6.5 (3.0-15) 5.8 (2.5-15) 
Ischemia during stress 1-2 segments 2.9 (1.1-7.8) NS 
Previous myocardial infarction 3.8 (1.6-8.2) 2.8 (1.1-6.7) 
CT= confidence interval. NS= DOC significant. 
Table IV - Hazard ratios for all late cardiac events as a function of the presence of a previous myocardial infarction and the extent of stress-induced 
ischemia. 
Ischemic segments during Previous myocardial infarction No. patients Event rate Hazard ratios (95 % eI) 
DSE 
0 no 183 7/183(4%) 1.0 (1.0-1.0) 
0 yes 49 4/49(8%) 3.1 (1.4-6.6) 
1-2 no 15 1/15(7%) 2.9 (1.1-7.8) 
1-2 yes 22 6/22(27%) 8.8 (3.1-25.2) 
,,3 no 26 3/26(12%) 10.3 (4.5-23.4) 
,,3 yes 21 1lI21(52%) 31.5 (11.4-87.3) 
::; DSE= doburamine stress rest. 
(;:>. 3 segments), any new wall motion abnormalities during stress, the 
heart rate threshold for ischemia (>70% of the maximal age and sex 
related heart rate), the severity of stress-induced ischemia and stress-
induced angina or ST -segment changes also predicted all late cardiac 
events. With the exception of ST-segment changes and severity of 
ischemia during the stress these test variables were also predictive 
for "hard" cardiac events. Stroke could not be predicted by clinical 
risk factors or stress test results. 
Multivariate regression analysis was performed on all clinical risk 
factors and stress test results (table III). 
Extensive echocardiographically-detected ischemia during stress 
was the most powerful predictor of all as well as "hard" late cardiac 
events. A previous myocardial infarction was also an independent 
predictor of fatal and nonfatal late cardiac events after surgery. Event-
free survival curves for patients with a normal stress test limited 
ischemia (1-2 segments), and extensive ischemia (;:>. 3 segments) dur-
ing the stress arc presented in fig I. There was a significant decrease 
in event-free survival in patients with either limited or extensive new 
wall motion abnormalities. 
The hazard ratios for the occurrence of late cardiac events are 
presented in Table IV and fig 2. Patients with no history of myocardial 
infarction and a negative test were no risk for late cardiac events (HR, 
1.0). Patients with either limited ischemia 01' a history of infarction 
were relatively low risk (HR, 2.9 and 3.1 respectively). Patients with 
limited ischemia and history of infarction, or extensive ischemia with-
out previous infarction were moderately highly risk (HR, 8.8 and 10.3 
respectively). Those with both extensive ischemia and history of 
infarction were extremely high risk (HR, 31.5). 
Discllssion 
Patients undergoing major vascular surgery represent a high-risk 
population, with respect to the risk of both perioperative and late car-
diac events (1,16,18). 
The decision to proceed with the surgery should include a consid-
eration of both these risks. Ideally, a patients should not only survive 
the peri operative period intact, but also live long enough to enjoy the 
benefits of successful surgery (17). 
Non-invasive preoperative risk stratification in patient scheduled 
for major vascular surgery may help in appropriate decision-making. 
Pharmacological stress echocardiography is a promising tool in 
this context, since it is widely available, generally applicable and less 
expcnsive than perfusion scientigraphy (12-16). This study 
demonstrates that dobutamine stress echocardiography is the most 
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Figure 1 - Kaplan-Meier curves for cardiac events (cardiac death, myocardial 
infarction or coronary revascularizarion) during follow· up as a funclion of Ihe extent 
of ischemia (0.1-2, or > 3 segments) during dobutamine-atropine stress testing. 
Each plot represents the cumulative percentage of patients remaining events free. 
Vertical lines representing 95% confidence interval. 
powerful predictor of late cardiac events after major vascular surgery, 
and is superior to simple clinical risk assessment. The negative 
prognostic value of extensive stress-induced ischemia (2 3 segments) 
applies to both all and "hard" cardiac events increasing risk by 6.5 
and 5.8 times respectively. Limited stress-induced ischemia increased 
the risk of "all" late events 2.9 times. The only independent 
preoperative clinical risk factor was a history of myocardial infarction. 
The presence of this risk factor increase the risk of "all" and "hard" 
late events by 3.8 and 2.8 times respectively. 
A combination of semi-quantitative stress echocardiography and 
the clinical history allows us to define the risk of all late cardiac events 
for patients in six diffcrent categories (Tables IV and figure 2 ). the 
absence of previous myocardial infarction, combined with a negative 
stress test defines a large subset of patients (183/316, 58%) with a 
very low rate of late events (HR, 1.0). Patients with either limited 
ischemia or a previous myocardial infarction were also relatively low-
risk (HR, 2.9-3.1). Patients with both limitcd ischemia and a history 
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Figure 2 • Hazard ratios for all lat8 cardiac events after major vascular surgery (I.e. cardiac death, myocardial infarction or coronary 
revascularizarion) as a function of the extent of new wall motion abnormalities during dobutamine stress echocardiography, and the presence 
or absence of preoperative myocardial infarction. Error bars represent 95% confidence intervals. 
of myocardial infarction were relatively high risk (HR, 8.8), as were 
those with extensive ischemia without previous infarction (HR, 31.5). 
This approach defines a relatively large subset of low and relatively 
low risk patients 
(247/316, 78%) who need not undergo intensive postoperative 
follow-up. In patients with a relatively high risk of late cardiac events, 
meticulous follow-up is clearly indicated. In a very high-risk patients 
with extensive stress-induced ischemia and history of myocardial 
infarction, an aggressive "anti-ischemic" approach might prolong the 
period of event-free survival after successful surgery. However, this 
hypothesis remains untested, and the optimal "anti-ischemic" approach 
remains undefined. 
We have previously recommended preoperative dobutamine stress 
cchocardiography for the assessment of perioperative cardiac risk in 
all patients with inadequate physical exercise capacity, or any of the 
clinical risk factors defined by Eagle et al (i.e. age >70 years, Q-wave 
on ECG, angina pectoris, diabetes mellitus or a history of ventricular 
tachyarrhythmias) (12,19). This same recommendation also appears 
appropriate for preoperative assessment of the risk of late cardiac 
events. In our study, only six patients with an adequate physical exer-
cise capacity and no Eagle criteria had a positive stress test. None of 
these six patients suffered a late cardiac event. We recommend that 
dobutamine stress echocardiography be performed preoperatively in 
all patients with one or more of Eagles risk factors or an inadequate 
physical exercise capacity to define the risk of late cardiac events 
after surgery. 
Previous study in non-surgical patients have demonstrate a rela-
tionship between stress-induced wall motion abnormalities and the 
risk of subsequent cardiac events in patients with known or suspected 
coronary disease (15,20). 
However, patients presenting for major vascular surgery comprise 
a very different population in whom the applicability of previous re-
sults was undefined. Our study generally confirms previous work in 
medical patients, but provides unique insight into the role of 
pharmacologic stress echocardiography for the assessment of late car-
diac risk in patients presenting for major vascular surgery. The semi-
quantitative analysis of stress test results, combined with a single clini-
cal risk factor provides precise definition of late risk. By studying 
consecutive patients who underwent surgery we avoided a referral 
bias. By blinding the attending physicians to test results, we avoided 
alteration in management based on presumptions about risk. 
For example, coronary arteriography and subsequent prophylactic 
myocardial revascularization were largely avoided. These design fea-
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tures, and the relatively sample size, increases the reliability of our 
conclusions. 
Multivariate analysis indicated that the extent of ischemia was an 
independent predictor of late cardiac events. However, neither the 
severity of ischemia or the heart rate at which ischemia occurred pro-
vided additional prognostic information. These results are in partial 
agreement with a previous study of Lette at al (17), using quantitative 
dypiridamole-thallium scintigraphy. That study found that both the 
extent and the severity of reversible perfusion defects were significant 
predictors of late cardiac events. The difference between studies re-
garding the predictive power of the severity of ischemia is unexplained, 
but methodological differences are presumably involved. 
In agreement with the study of Mangano et al (4) and Yeager et al 
(18) we found that patients who survived surgery but suffered a post-
operative myocardial infarction or episode of unstable angina had 
nearly a 7-fold increase in the risk of a late cardiac event. In Mangano's 
study, the negative prognostic value of a postoperative ischemic cardiac 
event was independent of the results of perioperative Holter 
monitoring. However, in our study the occurrence of a perioperative 
non fatal infarction or unstable angina was not an independent 
predictor of adverse late outcome, when multivariate analysis included 
the results of preoperative stress echocardiography. These different 
results suggest that the prognostic power of stress echocardiography 
may be superior to that of perioperative Holter monitoring. 
Conclusion 
Preoperative dobutamine stress echocardiography is an important 
new technique for defining the risk of late cardiac events in patients 
undergoing major vascular surgery. 
The test should be performed preoperatively in all patients with 
an inadequate exercise capacity or any of the clinical risk factors 
defined by Eagle et ai. 
Extensive stress-induced ischemia is the most powerful predictor 
of late cardiac events but a history of myocardial infarction also have 
independent negative prognostic value. 
These conclusion remain valid when only "hard" ischemic events 
such as cardiac death and myocardial infarction are considered. 
Preoperative semi-quantitative stress echocardiography combined with 
information about previous myocardial infarction optimizes assess-
ment oflate risk. Patients presenting for vascular surgery with a histoty 
of myocardial infarction and extensive stress-induced ischemia are 
extremely high-risk. This information should be carefully considered 
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when deciding upon the advisability of surgery, appropriate anti-
ischemic therapy, and the need for intensive follow-up. 
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CONCLUSIONS 
Stress echocardiography is increasingly used for both the diagnosis 
and risk stratification of patients with suspected or known coronary 
artery disease. 
The first cl inical of exercise echocardiography were published in 
1979 by the Indianapolis group (I). These investigators concluded 
that exercises stress echocardiography was feasible and reliable but 
technically demanding and difficult. 
Technological advances provided beller image quality and, 
consequently, higher diagnostic accuracy. More particularly, the 
development of digital acquisition systems (cine loop) allowed a single 
cardiac cycle to be sampled and the side by side display of resting 
and stress data offering advantages for analysis. Pharmacological stress 
was introduced as an alternative to exercise stress and allowed to 
record better quality images. These advantages resulted in rapid 
acceptance of this technique. 
Dobutamine stress echocardiography is now increasingly used 
for the diagnosis of coronary artery disease (2-5), assessment of 
revascularization procedures and risk stratification in patients after 
myocardial infarction and prior to major vascular surgery (6-12). 
Currently, the assessment of viable myocardium in patients with ad-
vanced left ventricular dysfunction is an active area of research and 
the use of "low" dose dobutamine stress echocardiography for it 
detection is promising. 
The studies presented in this thesis sought to study specific aspects 
of the stress echocardiography for the detection of myocardial 
ischemia and the demonstration of myocardium viability. Also, the 
prognostic value in patients prior to major non-cardiac vascular 
surgery. 
Detection of myocardial ischemia 
Exercise echocardiography: Exercise stress was the first form of 
stress used in combination with echocardiography. 
Digital technology has allowed better acquisition, display, analysis, 
storage and retrieval of echocardiographic results, overcoming many 
of the disadvantages related to exercise echocardiography in particular 
artefacts caused hyperventilation and chest wall movements. 
We studied the relationship between exercise echocardiography 
and the percent diameter stenosis and minimal lumen diameter 
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obtained from quantitative coronary arteriography (QCA) in 34 
patients without previous myocardial infarction and with a proximal 
single-site I-vessel coronary obstruction. The severity of the coro-
nary stenosis predicts an ischemic response during exercise testing. 
New wall motion abnormalities are better predicted than ST -segment 
changes on the ECG or angina. The best cut-off point for the prediction 
of wall motion abnormalities was a minimal coronary luminal diam-
eter of 1.13 mm (sensitivity and specificity 83%). 
Using the same approach we selected a sub-group of 31 patients 
without previous myocardial infarction with a proximal single site 1-
vessel disease of the left anterior discending coronary artery. Exercise 
stress induced new wall motion abnormalities on the echocardiogram 
and transient perfusion defects by MIBI SPECT were considered as 
markers of ischemia. 
The degree of coronary artery stenosis correlates better with 
echocardiographic than with scintigraphic markers of exercise induced 
myocardial ischemia. In fact we found angiographic cut-off values to 
predict a positive exercise echocardiography and scintigraphic test 
were similar (diameter stenosis of 52% and minimal lumen diameter 
of 1.12 mm for echocardiography, 49% and 1.2 mm for SPECT, 
respectively). However both the sensitivity and specificity at the cross 
point was slightly higher, but not statistically significant for 
echocardiography than for SPECT, (diameter stenosis 81 % vs. 67% 
and minimal lumen diameter 81 % vs. 74%. It should noted that in our 
study only patients with single-site I-vessel left artery descending 
disease were included .. The few previous comparative studies between 
exercise echocardiography and perfusion scintigraphy were 
confounded by the inclusion of patients with previous myocardial 
infarction or multivessel disease (13-18). 
Dahl/tamil1e-atropil1e stress ecilac(mliagrapily: For many years 
exercise stress testing in combination with nuclear imaging has been 
used for the non-invasive detection and functional assessment of 
coronary artery disease. However a substantial number of patients 
are unable to perform adequate levels of exercise to provoke 
myocardial ischemia. 
Dobutamine stress by increasing oxygen demand of the 
myocardium is now increasingly used in combination with 
echocardiography for the evaluation of patients with suspected or 
known coronary artery disease. Atropine is added at the end of the 
test when target heart rate is not reached with the maximal dobutamine 
dose alone. We tested quantitative angiographic parameters to deter-
mine the most appropriate cut-off value of each parameter for the 
onset of left ventricular wall motion abnormalities during dobutamine-
atropine stress echocardiography. Because wall motion abnormalities 
158 
are an early and specific indicator of myocardial ischemia, dobutamine-
atropine stress echocardiography is potentially superior to stress 
scintigraphy, particularly in patients with mild to moderate stenoses 
in whom transient perfusion defects may result from a maldistibution 
of coronary flow and do not necessarily reflect true myocardial 
ischemia. Several studies indicate good agreement between the 
development of wall motion abnormalities during stress 
echocardiography and the severity of coronary stenosis (II, 15,19-
26) . However, those studies had limitations because either visual 
interpretation of angiograms was performed or arbitrary cut-off points 
for quantitative angiographic data were used. Therefore, such analytic 
approaches are not appropriate for the evaluation of new stress 
modalities. We found that a minimal lumen diameter of 1.07 mm has 
the best predictive value of a positive dobutamine-atropine 
echocardiographic stress test. It appears that the minimal luminal 
diameter is a good parameter to define the physiological importance 
of coronary stenoses in medium to large sized arteries. 
We also studied the significance of akinetic segments which 
become dyskinetic during a dobutamine-atropine stress 
echocardiography without improving at low dose suggesting that it 
could be residual ischemia. However, comparing these segments with 
the findings of SPECT we concluded that it is a mechanical 
phenomenon compatible with scar tissue. 
Patients with left bundle branch block on their ECG often 
demonstrate a false positive perfusion defect in the territory of left 
anterior descending coronary artery (27-29). 
The cause of false positive perfusion imaging in these patients 
remains uncertain. A likely explanation is that the asynchronous 
activation of the septum may cause it to contract early in diastole, 
when coronary perfusion is maximal. A perfusion defect may therefore 
be present at rest or induced by exercise, when diastole is further 
shortened. Thc use of vasodilator agent such as dipyridamole, may 
avoid this problem (28). Other authors have suggested that patients 
with known left bundle branch block should be diagnosed as having 
ischemia only when the apex is involved in the perfusion defect. 
Echocardiography allows to examine left ventricular wall 
thickening as well as other left anterior descending territory regions. 
Previous reports involving a few patients with left bundle branch block 
have also indicated that stress echocardiography is more specific than 
perfusion imaging (6) 
Our study confirms the higher diagnostic accuracy of dobutamine-
atropine stress echocardiography in patients with left bundle branch 
block. We compare the accuracy of wall thickening abnormalities 
during dobutamine-atropine stress echocardiography with that of fixed 
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or reversible defects under perfusion tomography for the non-inva-
sive identification of coronary artery disease in 24 patients with 
complete left bundle branch block. In the left anterior descending 
coronary artery territory, sensitivity of dobutamine stress 
echocardiography and scintigraphy were comparable (83% vs. 100%) 
while specificity was significantly superior with dobutamine stress 
echocardiography (92% vs. 9%). This low specificity of perfusion 
scintigraphy was improved by requiring an associated apical defect 
to indicate left anterior descending coronary artery disease and by 
restricting the diagnosis of coronary disease to those patients with 
partially reversible defects only. 
Detection of myocardial viability 
The term "viability" includes two different clinical situations: 
stunned myocardium which refers to regions with prolonged 
post ischemic dysfunction, present despite restoration of normal blood 
flow and hibernating myocardium which refers to regions of chronic 
ventricular dysfunction which results from prolonged reduction in 
blood flow. In these regions myocardial function is restored by 
myocardial revascularization. Both situations may be present in the 
same patient. Obviously, the identification of viable myocardium is 
important for the clinical management of these patients because 
ventricular function can improve after revascularization. In contrast 
with myocardial stunning, there is no valid experimental model for 
chronic hibernation because the pathophysiology of chronic regional 
dysfunction involving both post-ischemic dysfunction and ongoing 
reduction of coronary flow is more complex and more difficult to 
reproduce under laboratory conditions. Recent observations suggest 
that it could arise from repeated episodes of myocardial stunning, 
eventually resulting in prolonged post-ischemic dysfunction (30). 
Several experimental models confirm that dysfuctioning but viable 
myocardium may show functional improvement by stimulation with 
sympathomimetic agents such as isoproterenol, dopamine and 
dobutamine. The mechanism of this response is unclear, but appears 
to be an inotropic effect and unrelated to alteration in loading condi-
tions (3\-35). 
"Low-dose" dobutamine in conjunction with echocardiography 
has been proposed for the assessment of myocardial viability in 
akinetic and hypokinetic regions. These segments are considered 
viable when wall thickening improves during the infusion of 
dobutamine up to a dose of I 0 ~lg/Kg/min when its inotropic effect is 
maximal. 
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Others methods for detecting viable myocardium include positron 
emission tomography (PET) (36) which is considered the reference 
method, and scintigraphy with 20 I TI reinjection (37-38). 
While several studies have addressed the role of low dose 
dobutamine for the assessment of left ventricular functional recovery 
in patients with recent myocardial infarction (10,39-42) little data is 
available on its predictive value for post-revascularization functional 
improvement. We compared the value of 20 I TI scintigraphy and 
low dose dobutamine echocardiography as methods of assessing 
myocardial viability. In 38 patients with severe chronic left ventricular 
dysfunction improvement in systolic thickening after infusion of low 
dose dobutamine predicted the recovery of function after 
revascularization. Compared with low dose dobutamine 20 I TI 
scintigraphy has a comparable sensitivity (74% vs. 89%) but a lower 
specificity (95% vs. 48%). Low dose dobutamine allows to predict 
the post-operative functional recovery of non-contracting but viable 
myocardium and our findings are in agreement with others studies 
(43-44). 
Prognostic value 
Preoperative cardiac risk stratificatiol/: Cardiac risk stratification 
for patients scheduled for major noncardiac vascular surgery is an 
important clinical application of dobutamine stress echocardiography 
(12,45-47). 
Perioperative cardiac complications are common and the leading 
cause of perioperative morbidity and mortality; they also determine 
long-term survival (48-50). The incidence of perioperative events 
ranges from I to 15%, with a mortality range from 5-1 0% (48). Several 
methods have been used to select high cardiac risk patients before 
surgery (51-54). Since many of these patients are not able to perform 
adequate physical exercise (because of age, peripheral vascular 
disease, pulmonary disease or stroke), nonexercise dependent stress 
tests are important. Until now the most widely used method was a 
combination of a clinical scoring classification and dypiridamole 
thallium scintigraphy (54). 
In our experience, clinical risk assessment and dobutamine atropine 
stress echocardiography were performed in 300 patients to evaluate 
the predictive value of the stress test 
The heart-rate at which ischemia occurred defined a high-risk 
group with a low ischemic threshold and an intermediate-risk group 
with a high ischemic threshold. Patients who develop ischemia at a 
low heart rate increment are at highest risk for perioperative cardiac 
events (positive predictive value of 53% for all fatal complications). 
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Patients in whom ischemia occurred at a high heart rate are at lower 
risk of perioperative cardiac events (21 %). Patients with no stress 
induced ischemia had an uneventful perioperative clinical outcome. 
Therefore, this method is safe and can be easily used to define a 
high-risk population of patients in whom risk-reduction strategies can 
be prospectively planned. 
Progllostic value for late cardiac evellts. Exercise (55), 
dipyridamole (56) and recently dobutamine (57,58) stress 
echocardiography have been used as a prognostic test to predict late 
cardiac events. Several studies reported ( 47,59-60) a significant 
relation between new wall motion abnormalities and late cardiac events 
. We attempted to predict late cardiac death, myocardial infarction, 
unstable angina pectoris and all cardiac events in patients with 
suspected coronary disease (58). Using multivariate analysis there 
was a significant correlation between cardiac death and diffuse wall 
motion abnormalities at rest (odds ratio 3.9, 1.1-14.2), a history of a 
previous infarction and a new infarction (odds ratio 16.3, 2.1-128), 
unstable angina pectoris and new wall motion abnormalities (odds 
ratio 2.3, 1.3-4.1). IF all cardiac events were combined, only new wall 
motion abnormalities were predictive for late events (odds ratio 2.3, 
1.4-3.7). 
We also studied the incremental prognostic value of pre-operative 
dobutamine atropine stress echocardiography to clinical risk factors 
for late cardiac events after successful major non-cardiac vascular 
surgery (61). 
It was found that new wall motion abnormalities during stress 
provided additional information to clinical data, particularly in patients 
with intermediate "clinical" risk. 
General limitations 
The major limitation of stress echocardiography remains the semi-
quantitative subjective analysis interpretation (62) 
For exercise stress echocardiography the interobserver variability 
has been examined in small groups of patients and confined to readers 
from the same institution (63). Sawada et al. (22) reported agreement 
between two observer from the same institution on the presence or 
absence of dobutamine stress echocardiography induced abnormal-
ity in 91 % of patients. In collaboration with four other experienced 
centres we studied the interistitutional agreement in the interpreta-
tion of dobutamine stress echocardiograms in patients with coronary 
artery disease without previous infarction. A total of 150 dobutamine 
stress echocardiograms were interpreted by each centre unaware of 
any other clinical data. The results of our study showed that the 
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agreement between different centres was moderate (73%) due to a 
variety of reasons including interpretation criteria, image storage on 
video tape and image quality (64). 
However for those patients having no coronary artery disease 
majority agreement was 82%; in patients having a three-vessel disease 
majority agreement was also higher with 100% compared with those 
patients having only a one-vessel or two-vessel disease. 
In the light of these observation we think that the full potential of 
this technique will be achieved when quantitative analytic methods 
become available. 
Quantitative approaches for the analysis of regional wall motion 
have been attempted (65-67). These approaches require a contouring 
system in which the operator identifies the endocardial border in 
diastole and in systole and then measurements are made by computer. 
Therefore the operator dependence is still retained in this form of 
analysis. 
Moreover the image quality is a limiting factor because the 
endocardial "dropout" in some patients. 
Recently an automatic edge detection algorithm has been proposed 
that facilitates on-line analysis of left ventricular performance (68). 
Colour Doppler imaging has been applied for the definition of the 
acceleration of the myocardial walls, with improvement of image 
quality (69). These advances may facilitate the quantification of 
regional function in the future. 
Significant developments is also made in the sphere of backscatter 
analysis and tissue characterisation. 
It has been showed in animal models that both the mean amplitude 
of ultrasonic backscatter and its cyclic variation during systole and 
diastole may be alterate by ischemia (70-71). 
Picano (72) has recently reported that videodensitometry may be 
used to show that asynergic myocardium due to ischemia.demonstrates 
increased echodensity. 
The difference between the backscatter characteristics of 
myocardium and blood has been used to obtain automatic detection 
and tracking of left ventricular cavity (73). Moreover on-line 
quantification of left ventricular volumes has been utilized during 
dobutamine echocardiography (74) although no correlates with coro-
nary anatomy 01' regional left ventricular function have been reported. 
Finally, the development of transpulmonary contrast agents may 
enhance the ability to localize the endocardium. Besides, contrast 
echocardiography may permit quantification of myocardial perfusion. 
In the future it will be possible to evaluate both perfusion and func-
tion using ultrasound techniques at both rest and stress. 
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